FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,O,N,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature1122,α-Lactose,C12 H22 O11,342.11629,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak2,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,6538257100.461113,6874033424.207247,1.051355631720639,0.072250758105716,0.8747588832648256,0.9528926864302276,Upregulated
Feature1121,Phenacetin,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak3,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,11482994.797372013,9951882.05720758,0.8666625939328265,-0.20645765715210326,0.7797238792499219,0.907639449407689,Downregulated
Feature1120,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21535,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,4749385.013236513,2045869.7526665167,0.43076519317020784,-1.2150264134115694,0.49372984914957535,0.740594773724363,Downregulated
Feature1119,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak3",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,1556122.9889774066,2367459.48845287,1.5213832744728142,0.6053836497913018,0.2551427296886258,0.7028461383187669,Upregulated
Feature1118,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,3899487.884781943,1742124.9394422944,0.44675736684323947,-1.1624365759830328,0.4742613713421934,0.7259498753696331,Downregulated
Feature1117,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,2216007178.61774,1918968028.3046367,0.8659574963568553,-0.20763187975064448,0.03737049865352446,0.5992830975343959,Downregulated
Feature1116,NA,C30 H32 O10,552.19968,NA,NA,Feature1116,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Lignin,2446748.88888308,2173750.5472071967,0.8884240459181307,-0.17067965376139763,0.06782539366269193,0.6632182304416021,Downregulated
Feature1115,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,NA,Choline O-Sulfate,5,13,4,1,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,119356109.218745,91954012.5327294,0.7704173094667862,-0.37628797737401115,0.2891231800697857,0.7028461383187669,Downregulated
Feature1114,NA,C9 H16 O7,236.0896,NA,NA,Feature1114,9,16,7,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,1969381349.60962,1545250495.55545,0.7846375187120345,-0.3499017730261881,0.16177131566074085,0.6736684190877296,Downregulated
Feature1113,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak2,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,1307745914.0513334,1007708284.3793464,0.7705688647556275,-0.37600420057186423,0.33042343639008376,0.707999712182741,Downregulated
Feature1112,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,NA,L-alpha-Glycerylphosphorylcholine-peak2,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,1109073691.840889,925682712.2028273,0.8346449104444437,-0.26076554388551404,0.19093276049010519,0.6736684190877296,Downregulated
Feature1111,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,L-Glutamic acid,5,9,4,1,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,862656956.9840423,808984963.5598574,0.9377829240352631,-0.09267408543188581,0.6143438196774202,0.8071355570000767,Downregulated
Feature1110,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,1570203920.7556634,1555727559.8739967,0.9907805854447874,-0.013362495940700762,0.9243763706507125,0.9732960808787122,Downregulated
Feature1109,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,187170740.75790367,123672139.44470133,0.6607450445722458,-0.5978343948432261,0.09171575986270122,0.6736684190877296,Downregulated
Feature1108,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08991,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak2,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,655138375.143151,625578470.88447,0.9548799072375785,-0.06660879433310286,0.8832283682612285,0.9602540980514519,Downregulated
Feature1107,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak2,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,1915270.6015918688,714204.4603531497,0.3729000276825331,-1.423139190676179,0.18314405412420284,0.6736684190877296,Downregulated
Feature1106,Choline,C5 H13 N O,103.09967,NA,NA,Choline,5,13,1,1,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,1466623875.4210567,1284832430.8734734,0.8760476713940086,-0.19091871659922233,0.051271295261740256,0.6537090145871882,Downregulated
Feature1105,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak2,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,498107653.74608034,502361259.09798336,1.0085395301997735,0.01226763219629253,0.9763319494906832,0.991352441021309,Upregulated
Feature1104,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,DL-Carbidopa,10,14,4,2,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Lignin,348785061.4428037,395175237.74608666,1.1330050550656694,0.18015429796505117,0.4315685564781606,0.7136536716603119,Upregulated
Feature1103,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.1057,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,1396372496.7359366,1264776680.76366,0.905758802697786,-0.14280117318011512,0.2514900543291394,0.7019200023813293,Downregulated
Feature1102,Maltotriose,C18 H32 O16,504.16909,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak2,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,1175956986.3032234,1252783916.5923867,1.065331411934274,0.09130230554655383,0.1430061860454901,0.6736684190877296,Upregulated
Feature1101,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,Other,L-Iditol,6,14,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,62899380.68636883,52553668.10673427,0.8355196431707217,-0.25925434826235094,0.014341214750639254,0.5000414976159331,Downregulated
Feature1100,NA,C32 H36 O10,580.23111,NA,NA,Feature1100,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,1650677.4953030932,1641752.07592098,0.9945928751027926,-0.007821998645828566,0.936834837853159,0.978637034430813,Downregulated
Feature1099,Maltotriose,C18 H32 O16,504.16908,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak1,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,985898151.67215,994862330.0154597,1.009092397960282,0.01305828145712539,0.9190504107572636,0.9725088410337925,Upregulated
Feature1098,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,12229868.5556654,9604117.416402146,0.7853001340683344,-0.3486839514857953,0.15892946258020205,0.6736684190877296,Downregulated
Feature1097,Dambonitol,C8 H16 O6,208.09467,NA,NA,Dambonitol,8,16,6,0,0,0,2,0.75,-0.5,74.55,1,-5,-2.5,-0.4,-5,Carbohydrate,94224390.09375347,82033944.86483753,0.8706232514024614,-0.19987954474192055,0.3335060652665798,0.708700388691482,Downregulated
Feature1096,NA,C6 H11 N O7,209.05352,NA,NA,Feature1096,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,847248569.2094843,658860046.3351626,0.7776466910412189,-0.3628132518292709,0.3452305766770745,0.7116802007632078,Downregulated
Feature1095,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak2",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,1149782.9146958534,1178463.43114327,1.0249442882485373,0.035545492899556747,0.9663976720082461,0.9883481899775874,Upregulated
Feature1094,D-Gluconic acid,C6 H12 O7,196.05831,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Gluconic acid,6,12,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,60104395.49458283,55429085.838569835,0.9222135150425999,-0.11682728628123991,0.390053900960924,0.7136536716603119,Downregulated
Feature1093,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Other,Other,Proline,5,9,2,1,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,889981418.462701,625265749.0585134,0.7025604536087494,-0.5093057238326997,0.2509973257592751,0.7019200023813293,Downregulated
Feature1092,N-Acetylneuraminic acid,C11 H19 N O9,309.10605,Metabolic pathways;Other,Other,N-Acetylneuraminic acid,11,19,9,1,0,0,1.7272727272727273,0.8181818181818182,0.18181818181818168,55.11818181818182,3,-6,-7,-0.4545454545454546,-7,Carbohydrate,761610698.7613983,720514088.1179789,0.9460398721942136,-0.08002710560954045,0.4442764755833271,0.7147297968682652,Downregulated
Feature1091,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16789,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak3",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,1246357.9104501293,776738.185604088,0.6232063672011875,-0.6822181216247317,0.3265087907587945,0.707999712182741,Downregulated
Feature1090,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,364398169.0735037,447105044.0602136,1.2269684153380775,0.29509811157489074,0.33065227199978275,0.707999712182741,Upregulated
Feature1089,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13223,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak7,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,706733376.2618237,648944311.5239866,0.9182307406457794,-0.12307136330011503,0.3727027780683028,0.7136536716603119,Downregulated
Feature1088,NA,C16 H29 N O12,427.16894,NA,NA,Feature1088,16,29,12,1,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,757542612.7367674,705042526.2814187,0.9306968537839976,-0.10361676465548922,0.3209150332874224,0.7028461383187669,Downregulated
Feature1087,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13226,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak6,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,699617027.6993957,464738836.0069477,0.6642760504774792,-0.5901451938385274,0.31614308285109877,0.7028461383187669,Downregulated
Feature1086,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,NP-019445,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,2588091.8307179,2272429.3161750766,0.8780327224883427,-0.18765338782380958,0.4576673454117133,0.7162499996920834,Downregulated
Feature1085,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,DL-Tryptophan,11,12,2,2,0,0,1.0909090909090908,0.18181818181818185,-0.18181818181818168,65.48181818181817,7,5,0.42857142857142855,0.5,3,Lignin,390205436.726668,274987244.732573,0.7047242781632401,-0.5048691782726472,0.2308739288603295,0.6871102073774262,Downregulated
Feature1084,Beauvericin,C45 H57 N3 O9,783.40966,NA,NA,Beauvericin,45,57,9,3,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Lignin,871489.1342070057,658288.9729674393,0.7553610792479201,-0.4047616455315717,0.27373820216313227,0.7028461383187669,Downregulated
Feature1083,1-Linoleoyl glycerol,C21 H38 O4,354.27701,NA,NA,1-Linoleoyl glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,7868796.341201753,6261266.169494793,0.7957082504105765,-0.3296885370327399,0.7029522907351005,0.856365331384129,Downregulated
Feature1082,α-Lactose,C12 H22 O11,342.11628,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak1,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,611207499.517831,575412411.3848066,0.9414354565981891,-0.08706590566400715,0.7471912342657983,0.8899666293484348,Downregulated
Feature1081,g-Butyrobetaine,C7 H15 N O2,145.1103,NA,NA,g-Butyrobetaine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,840916.5101639964,690846.6494780687,0.8215401185824489,-0.2835970663137013,0.43387834886884774,0.7136536716603119,Downregulated
Feature1080,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,NA,DL-Stachydrine,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,11232020.259024633,12031584.617028767,1.0711861570372174,0.09920922191489005,0.2946299196463556,0.7028461383187669,Upregulated
Feature1079,trans-3-Indoleacrylic acid,C11 H9 N O2,187.06331,Microbial metabolism in diverse environments;Other,NA,trans-3-Indoleacrylic acid,11,9,2,1,0,0,0.8181818181818182,0.18181818181818185,-0.18181818181818168,65.48181818181817,8,6,0.625,0.6666666666666666,5,Lignin,351906916.80889034,247751587.96359965,0.7040259117673036,-0.5062995664647869,0.22817155142003187,0.6845146542600956,Downregulated
Feature1078,Crotonic acid,C4 H6 O2,86.03675,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak3,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,248838774.40378168,181772775.18291074,0.7304841282008351,-0.45307516807995296,0.27436643956783957,0.7028461383187669,Downregulated
Feature1077,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15209,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,12,6,2,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,806015.0319478944,579256.245673358,0.7186668023715028,-0.4766050502086473,0.21933567632692108,0.6777335289635477,Downregulated
Feature1076,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03787,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,2,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Lignin,915103.5951095483,196891617.19253024,215.1577354135081,7.749250899185252,0.4226505470271685,0.7136536716603119,Upregulated
Feature1075,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Lysine degradation;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,6,2,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,13261399.910543634,12989358.182469767,0.9794861982966385,-0.029902930918522433,0.8498772383861455,0.9413744745889566,Downregulated
Feature1074,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",C20 H34 O4,338.24575,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",20,34,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,3984320.0276429765,2915162.3376642764,0.7316586813908151,-0.4507573063556073,0.08559561275828467,0.6736684190877296,Downregulated
Feature1073,L-Tyrosine,C9 H11 N O3,181.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,L-Tyrosine,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,427265985.884425,326101500.20409566,0.7632283190740715,-0.3898133923204671,0.3332673178709263,0.708700388691482,Downregulated
Feature1072,NA,C9 H17 N O6,235.10555,NA,NA,Feature1072,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,29330128.8923104,27625260.906021267,0.9418731505562492,-0.0863953210219675,0.48598950540557484,0.7338899395222812,Downregulated
Feature1071,NA,C74 H117 N10 O14 P3,1462.79612,Other,NA,Feature1071,74,117,14,10,0,3,1.5810810810810811,0.1891891891891892,-1,88.8,23,9,-0.0851063829787234,0.05555555555555555,-4,Lipid,205540.28507624267,188553623.33877075,917.3560466203941,9.84133797484679,0.4227085237032238,0.7136536716603119,Upregulated
Feature1070,L-Glutamine,C5 H10 N2 O3,146.06916,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Glutamine,5,10,3,2,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,33834370.6496863,41523973.89075874,1.2272719454630594,0.29545496448571273,0.5138407195371419,0.7467995949749654,Upregulated
Feature1069,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak2,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,4663011.158240453,3521485.2451865734,0.7551955433268521,-0.40507784401072916,0.16868933376653047,0.6736684190877296,Downregulated
Feature1068,Acetylagmatine,C7 H16 N4 O,172.13243,NA,NA,Acetylagmatine,7,16,1,4,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,5852811.725057524,5307311.82213488,0.9067969501586381,-0.14114855603452092,0.050542523769524964,0.6537090145871882,Downregulated
Feature1067,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,516033.996629573,450686.755812899,0.8733664036798287,-0.19534105973523444,0.5436286601447579,0.7574167055561227,Downregulated
Feature1066,NA,C29 H30 O10,538.18407,NA,NA,Feature1066,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,826891.172336623,736625.1045213323,0.8908368225044446,-0.166766902111217,0.27854749847320315,0.7028461383187669,Downregulated
Feature1065,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,NA,Tris(hydroxymethyl)aminomethane,4,11,3,1,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,231073657.71035033,158754780.04382068,0.6870310602120602,-0.5415527710973078,0.2067442452360274,0.6777335289635477,Downregulated
Feature1064,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak2,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,358324343.457874,279569482.2101023,0.7802134778570231,-0.35805917436449136,0.21992192546140854,0.6777335289635477,Downregulated
Feature1063,L-Pyroglutamic acid,C5 H7 N O3,129.0426,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Lignin,48783661.3679594,54043400.0876956,1.1078176293506075,0.1477204022474904,0.6793247943677008,0.8434328503077431,Upregulated
Feature1062,2-Hydroxy-N-(2-hydroxyethyl)propionamide,C5 H11 N O3,133.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Hydroxy-N-(2-hydroxyethyl)propionamide,5,11,3,1,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-2,-3,-0.6,-3,Amino Sugar,311815639.51351434,257030779.87701628,0.8243036823875421,-0.2787521550998277,0.6706836563506261,0.8394394607519873,Downregulated
Feature1061,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10046,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,292667114.4534863,234156786.57267058,0.8000789122137096,-0.32178579408131114,0.6524086951746537,0.8289949671415192,Downregulated
Feature1060,NA,C9 H19 N O7,253.11617,NA,NA,Feature1060,9,19,7,1,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,334955561.3579857,238411167.53256834,0.7117695450882962,-0.4905178901796683,0.1859108035036854,0.6736684190877296,Downregulated
Feature1059,hercynine,C9 H15 N3 O2,197.1165,NA,NA,hercynine,9,15,2,3,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,14088339.797127267,12840808.587648667,0.9114493810169895,-0.13376555906572904,0.38788420441233734,0.7136536716603119,Downregulated
Feature1058,NA,C6 H14 O4,150.08923,NA,NA,Feature1058,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,1411281.5100215534,6648572.412052379,4.711017869107376,2.236038804224833,0.45338528287977153,0.7162499996920834,Upregulated
Feature1057,NA,C75 H119 N10 O14 P3,1476.81198,NA,NA,Feature1057,75,119,14,10,0,3,1.586666666666667,0.18666666666666668,-1.0133333333333336,89.18,23,9,-0.08333333333333333,0.05454545454545454,-4,Lipid,221574.58660528465,147114860.30412784,663.9518663130797,9.374934845882327,0.42273957222430447,0.7136536716603119,Upregulated
Feature1056,NA,C23 H33 N3 O5,431.24199,NA,NA,Feature1056,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,1227090.2992884133,1247402.57274052,1.0165532018824415,0.023685721413284833,0.8241418257070525,0.9265402088610349,Upregulated
Feature1055,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.09171,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,1.3,0.5,1.2000000000000002,26.09999999999999,7,2,-Inf,-0.2,-3,Lignin,254256064.46030802,129126099.88323766,0.5078584857251087,-0.977501547466147,0.01408783088893322,0.5000414976159331,Downregulated
Feature1054,L-glycero-Î±-D-manno-Heptopyranose,C7 H14 O7,210.07395,Metabolic pathways;Other,NA,L-glycero-Î±-D-manno-Heptopyranose,7,14,7,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,6267021.12342031,4837941.487857967,0.7719682752908283,-0.373386534986031,0.3545816401044938,0.7136536716603119,Downregulated
Feature1053,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",C9 H12 N2 O6,244.06954,Metabolic pathways;ABC transporters;Other,Other,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,264679933.80165267,235386270.708697,0.8893242012259686,-0.16921864856933067,0.6886754018180268,0.850048185742383,Downregulated
Feature1052,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10013,NA,NA,N-(Carboxymethyl)norleucine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,662233.2779023607,982461.7290727344,1.483558380189991,0.5690617000931242,0.4803083557142551,0.7312157057142391,Upregulated
Feature1051,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,174237826.44121367,263458182.401741,1.5120607722378212,0.5965161250379449,0.2996008954681306,0.7028461383187669,Upregulated
Feature1050,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",C12 H12 O5,236.06846,NA,NA,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",12,12,5,0,0,0,1,0.4166666666666667,-0.16666666666666696,65.05000000000001,7,2,0.2857142857142857,0.47368421052631576,2,Lignin,627815.4381310956,600206.857600686,0.9560243682242096,-0.0648807031790667,0.7019716464419128,0.856365331384129,Downregulated
Feature1049,2-Acetamido-2-deoxy-D-gluconolactone,C8 H13 N O6,219.07432,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,2-Acetamido-2-deoxy-D-gluconolactone,8,13,6,1,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,237486096.395459,192983409.04484367,0.8126092936551957,-0.29936623040008614,0.1560698429467025,0.6736684190877296,Downregulated
Feature1048,NA,C6 H15 N O7,213.0849,NA,NA,Feature1048,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,31509591.4707794,26979160.486922767,0.8562205737241007,-0.22394559309099388,0.3381295231447345,0.7116802007632078,Downregulated
Feature1047,NA,C10 H20 O7,252.12091,NA,NA,Feature1047,10,20,7,0,0,0,2,0.7,-0.5999999999999996,77.39999999999999,1,-6,-2,-0.38461538461538464,-6,Amino Sugar,35784761.9488956,35341449.941632666,0.9876117100374725,-0.0179841523790913,0.7821377549671935,0.907639449407689,Downregulated
Feature1046,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,11572521.860935943,8061015.487801856,0.6965651553454841,-0.5216697888699869,0.30119066578609766,0.7028461383187669,Downregulated
Feature1045,NA,C12 H18 O9,306.09515,NA,NA,Feature1045,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,234802351.53608933,106215755.88157067,0.45236240261948657,-1.1444490678771684,0.007431446893446694,0.42988943204243457,Downregulated
Feature1044,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,NA,Acetyl-L-carnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,1185403.2497381796,1140551.8452866673,0.9621635890896886,-0.05564588997321877,0.8681397238509356,0.9482111623798329,Downregulated
Feature1043,3-Deoxy-D-glycero-hexitol,C6 H14 O5,166.08414,NA,NA,3-Deoxy-D-glycero-hexitol,6,14,5,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,4533947.729984989,4379922.76973209,0.9660285099375396,-0.04986232762905032,0.6800048485581746,0.8434328503077431,Downregulated
Feature1042,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",C21 H22 O6,370.14172,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,643058.9327560713,653980.9759213853,1.0169845135631714,0.02429771029106291,0.9001817179126874,0.9678405764193425,Upregulated
Feature1041,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,280318743.14505136,258944945.036523,0.92375180528878,-0.11442281616592122,0.6060608734545465,0.7990602820399544,Downregulated
Feature1040,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,1592322.14477327,1083780.1986704846,0.6806287297001723,-0.5550600453752471,0.208593849361113,0.6777335289635477,Downregulated
Feature1039,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,Other,(+)-Piperitol,20,20,6,0,0,0,1,0.3,-0.4000000000000003,71.7,11,5,0.35714285714285715,0.4705882352941176,5,Lignin,596727.3925893747,558583.466711055,0.936078138272148,-0.09529913239428495,0.48186320286838824,0.7323781635036145,Downregulated
Feature1038,5-Aminolevulinic acid,C5 H9 N O3,131.05823,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,5-Aminolevulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,7740772.2545687705,6927542.132738713,0.8949419909169823,-0.1601339232687499,0.5128778859696903,0.7463670402827399,Downregulated
Feature1037,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12595,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak2",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,447152.26130607136,311340.5302563973,0.6962740820028812,-0.522272773138036,0.11738617144864827,0.6736684190877296,Downregulated
Feature1036,.alpha.-Glucoheptitol,C7 H16 O7,212.08964,NA,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,9201091.183872893,6066921.43421643,0.6593697761467854,-0.6008403358779677,0.6431219457965776,0.8227854312243558,Downregulated
Feature1035,NA,C9 H17 N O6,235.10557,NA,NA,Feature1035,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,6098850.720978786,3279054.71633089,0.5376512504317608,-0.8952574284604063,0.39276632309062814,0.7136536716603119,Downregulated
Feature1034,diphthinate,C13 H22 N4 O4,298.16416,NA,NA,diphthinate,13,22,4,4,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,210411.746243793,152513.144368787,0.7248318931400249,-0.4642816584565051,0.3045009935824603,0.7028461383187669,Downregulated
Feature1033,NA,C62 H107 N2 O15 P3,1212.68834,NA,NA,Feature1033,62,107,15,2,0,3,1.7258064516129032,0.24193548387096775,-1.387096774193548,99.83225806451613,12,-3,-0.1904761904761905,-0.0101010101010101,-8,Lipid,158866.33482445034,146212.724833713,0.9203505890362501,-0.11974456337433287,0.794935586365641,0.9110497731381503,Downregulated
Feature1032,Inosine,C10 H12 N4 O5,268.08079,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Inosine,10,12,5,4,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Lignin,152608013.61618933,152397129.857103,0.9986181344341672,-0.001994989320205961,0.9957447224780723,0.9966329871725219,Downregulated
Feature1031,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak2,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,515320.6622621977,696695.7306885803,1.3519654492994075,0.43505828271378816,0.4538356303851853,0.7162499996920834,Upregulated
Feature1030,2'-Deoxyadenosine,C10 H13 N5 O3,251.10191,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak2,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,98749133.55149743,65768730.1492103,0.6660183009596946,-0.5863662744361061,0.14798513284692535,0.6736684190877296,Downregulated
Feature1029,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,769691.5704118457,601862.308822928,0.7819525793960355,-0.35484697526338094,0.09169297422084588,0.6736684190877296,Downregulated
Feature1028,NA,C22 H33 N O6,407.23081,NA,NA,Feature1028,22,33,6,1,0,0,1.5,0.2727272727272727,-0.8181818181818183,83.61818181818182,7,1,0,0.16666666666666666,0,Lipid,745051.9945109977,773822.9093068333,1.0386159825190708,0.054662331312072314,0.8968149660353741,0.9675787131014654,Upregulated
Feature1027,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,NA,N-Caffeoylputrescine,13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,493496.82695434697,288396.02540828264,0.584392866694079,-0.7749895266841544,0.1903933320148427,0.6736684190877296,Downregulated
Feature1026,Succinyl proline,C9 H13 N O5,215.07946,Other,NA,Succinyl proline-peak2,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,33698680.623231165,55972746.816382535,1.6609773967766588,0.7320324406813227,0.3917538594740331,0.7136536716603119,Upregulated
Feature1025,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13231,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak5,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,268380728.91146666,244583040.40254334,0.9113286240579006,-0.1339567128604316,0.5025159503560187,0.74277838767447,Downregulated
Feature1024,2-Deoxyhexopyranose,C6 H12 O5,164.0685,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Other,Other,2-Deoxyhexopyranose,6,12,5,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,5617526.8281835765,6220070.67306177,1.1072614093901936,0.14699586304923692,0.7994016283643256,0.9152332928824217,Upregulated
Feature1023,Glutarylcarnitine,C12 H21 N O6,275.13695,NA,NA,Glutarylcarnitine,12,21,6,1,0,0,1.75,0.5,-0.5,74.55,3,-3,-0.8,-0.125,-4,Protein,206240706.942507,175954889.53727284,0.8531530566675335,-0.22912350892775227,0.5327632317634807,0.7543471763776491,Downregulated
Feature1022,NA,C10 H15 N O8,277.07983,NA,NA,Feature1022,10,15,8,1,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,202031139.42353368,191833009.88045335,0.9495219916485191,-0.07472668021575625,0.6298152902225425,0.814953315245881,Downregulated
Feature1021,NA,C6 H11 N3 O2,157.08515,NA,NA,Feature1021,6,11,2,3,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,152987016.72503966,142045526.64222267,0.928480923956561,-0.10705582521776134,0.34460903814703603,0.7116802007632078,Downregulated
Feature1020,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Pinolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,9363167.70222994,8151323.463605347,0.870573263540289,-0.19996238115959286,0.441156708030607,0.7146808569581701,Downregulated
Feature1019,NA,C22 H14 N3 O4 P,415.07208,NA,NA,Feature1019,22,14,4,3,0,1,0.6363636363636364,0.18181818181818185,-0.09090909090909084,62.89090909090909,18,14,0.7142857142857143,0.75,10,Condensed HC,938828.9636530554,806502.5953870463,0.8590516767280837,-0.2191831747961736,0.06353565419001456,0.6632182304416021,Downregulated
Feature1018,4-Acetamidobutanoic acid,C6 H11 N O3,145.07391,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak2,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,10236679.689249713,23598338.28876924,2.305272706105241,1.2049374267821182,0.46090240621896983,0.7162499996920834,Upregulated
Feature1017,Valylproline,C10 H18 N2 O3,214.13174,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Valylproline,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,90493438.84311646,63131129.3086494,0.6976321169327689,-0.5194616358031198,0.18656204833337164,0.6736684190877296,Downregulated
Feature1016,D-Glucose 6-phosphate,C6 H13 O9 P,260.02974,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,D-Glucose 6-phosphate,6,13,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,131307120.69126967,130268978.07056801,0.9920937827648925,-0.01145158966365035,0.9075966361917317,0.971254691401256,Downregulated
Feature1015,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,426565.97112840036,363164.918763573,0.8513687057663982,-0.23214403373812154,0.11573858258260974,0.6736684190877296,Downregulated
Feature1014,1-linoleoyl-sn-glycerol,C21 H38 O4,354.27689,NA,NA,1-linoleoyl-sn-glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,4031446.4408155633,4150013.946147287,1.0294106611789036,0.04181862912812401,0.9359671893582882,0.978637034430813,Upregulated
Feature1013,NA,C10 H17 N O9,295.09039,NA,NA,Feature1013,10,17,9,1,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,152623497.95198435,137107769.82472765,0.8983398471699425,-0.15466676676485658,0.14673982150861328,0.6736684190877296,Downregulated
Feature1012,(5S)-5-(Carboxymethyl)-L-proline,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,(5S)-5-(Carboxymethyl)-L-proline,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,38990406.423358835,35336378.6067312,0.9062839259239284,-0.14196499786983918,0.28260050886363286,0.7028461383187669,Downregulated
Feature1011,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak2,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,65852127.71960647,184458037.46495467,2.801094571315349,1.485990692896324,0.07182404828094317,0.6684892873383756,Upregulated
Feature1010,N-Acetyl-α-D-glucosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-α-D-glucosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,12368408.921700906,13601418.762398534,1.0996902551090673,0.13709722343560202,0.6638939651923168,0.8359156812273637,Upregulated
Feature1009,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12119,NA,NA,Cyclo(phenylalanyl-prolyl)-peak2,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,173146428.488512,151843819.49373832,0.8769676673048611,-0.18940444158886896,0.017103402592596465,0.5000414976159331,Downregulated
Feature1008,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13225,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak4,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,250050047.80892968,208414612.44560367,0.8334915920706368,-0.26276044893203243,0.06908104335290124,0.6632182304416021,Downregulated
Feature1007,NA,C7 H15 N O5,193.09509,NA,NA,Feature1007,7,15,5,1,0,0,2.142857142857143,0.7142857142857143,-0.2857142857142856,68.44285714285714,1,-4,-5,-0.7142857142857143,-5,Carbohydrate,74256905.40308397,84438172.7414201,1.13710869424291,0.18537016553205762,0.30525702744535943,0.7028461383187669,Upregulated
Feature1006,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09546,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,114504676.71211733,103681364.0500664,0.9054771126138155,-0.14324991968194062,0.4607195732295303,0.7162499996920834,Downregulated
Feature1005,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",C7 H13 N O3,159.08956,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,10880919.760379834,10323415.828342456,0.9487631611743531,-0.07588010125857447,0.3030359270495306,0.7028461383187669,Downregulated
Feature1004,Proacacipetalin,C11 H17 N O6,259.1056,NA,NA,Proacacipetalin-peak2,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,178136004.69971535,157977572.252693,0.8868368442359336,-0.17325938569672134,0.21309717223001984,0.6777335289635477,Downregulated
Feature1003,NA,C6 H14 O4,150.08924,NA,NA,Feature1003,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,708250.006785974,690282.21878417,0.9746307266789286,-0.03707238853963578,0.9418934431513915,0.978637034430813,Downregulated
Feature1002,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,Other,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,1741313.3211417133,1744969.83127319,1.0020998576689686,0.003026277979921781,0.9893260832367592,0.994957412988361,Upregulated
Feature1001,Buphedrine,C11 H17 N O,179.13104,NA,NA,Buphedrine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,296987.6641519693,391978.6402492073,1.3198482211996216,0.40037203328628196,0.32846530509303073,0.707999712182741,Upregulated
Feature1000,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05587,Metabolic pathways;Other,NA,Glycerylphosphorylethanolamine,5,14,6,1,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,8445075.571883067,6580913.898068067,0.7792605101105882,-0.35982238686261425,0.23063975071620266,0.6871102073774262,Downregulated
Feature0999,Linolenelaidic acid,C18 H30 O2,278.22466,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Linolenelaidic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,5254056.35791907,5579150.70056915,1.0618749249158868,0.08661384539797691,0.8552889261670469,0.9426661838501245,Upregulated
Feature0998,Glutaric acid,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Glutaric acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,78726622.5887635,71815371.29847014,0.912212018462992,-0.13255891694916458,0.38874705149879624,0.7136536716603119,Downregulated
Feature0997,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,"DL-2,6-Diaminopimelic acid",7,14,4,2,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,31711460.300771434,34338524.53351443,1.0828427391178541,0.11482373604982639,0.6403147481824621,0.8201291637679481,Upregulated
Feature0996,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,Methionine,5,11,2,1,1,0,2.2,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Protein,46694805.170032136,29601777.901861034,0.6339415657495645,-0.6575782303721326,0.17898556963905837,0.6736684190877296,Downregulated
Feature0995,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Aspartic acid,4,7,4,1,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,127387665.30638066,94974571.72069234,0.7455554781718352,-0.4236123847590351,0.3039039496416142,0.7028461383187669,Downregulated
Feature0994,UQ1000000,C6 H6 O3,126.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,UQ1000000,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,146150276.122786,129838577.4884335,0.88839091470037,-0.17073345592383654,0.7056628864115044,0.8578078015448143,Downregulated
Feature0993,Pyrogallol,C6 H6 O3,126.03165,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,134502873.97895434,142816127.16896665,1.0618072532138836,0.0865219016693654,0.8211869845148768,0.9241442293136327,Upregulated
Feature0992,Methylhippuric acid,C10 H11 N O3,193.07397,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak2,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,2076852.9677115735,1569816.1242147293,0.7558629082657046,-0.40380349999136733,0.5600303973014603,0.7700004054129788,Downregulated
Feature0991,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.1028,NA,NA,L-alpha-Glycerylphosphorylcholine-peak1,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,32039114.226745967,19244939.0310361,0.6006701338506605,-0.7353551620313298,0.22510603803008009,0.6843823216756625,Downregulated
Feature0990,(Z)-dehydrobutyrine,C4 H7 N O2,101.04767,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak2,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,66396684.1119044,119008373.49383667,1.792384289752497,0.8418799864370812,0.31733258329427705,0.7028461383187669,Upregulated
Feature0989,Î²-Glycerophosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,Î²-Glycerophosphate,3,9,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,17035513.532669567,13190160.52752066,0.7742743124371011,-0.36908331523509263,0.2898873738075379,0.7028461383187669,Downregulated
Feature0988,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Lignin,660848.308175309,510268.7763308953,0.7721420634938387,-0.3730617869762429,0.02018536114270576,0.536051174383958,Downregulated
Feature0987,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,53984314.08227933,45312075.69169773,0.8393563290002362,-0.2526446919134592,0.06437269436429742,0.6632182304416021,Downregulated
Feature0986,NA,C18 H31 N O11,437.18971,NA,NA,Feature0986,18,31,11,1,0,0,1.7222222222222223,0.6111111111111112,-0.33333333333333304,69.79999999999998,4,-7,-1.3333333333333333,-0.21739130434782608,-8,Amino Sugar,168733792.461085,161515383.53771967,0.957220134638827,-0.06307735133514891,0.25473769021471987,0.7028461383187669,Downregulated
Feature0985,3-Hydroxy-5-methyl-L-tyrosine,C10 H13 N O4,211.08446,NA,NA,3-Hydroxy-5-methyl-L-tyrosine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,64522933.31662513,59708739.80193013,0.9253878695955913,-0.11186990736192108,0.21954572308173126,0.6777335289635477,Downregulated
Feature0984,Mephedrone,C11 H15 N O,177.11538,NA,NA,Mephedrone,11,15,1,1,0,0,1.3636363636363635,0.09090909090909093,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,381064.74760584335,273864.31245697,0.7186818360333956,-0.47657487104559604,0.03697159069246683,0.5992830975343959,Downregulated
Feature0983,Anhydroecgonine,C9 H13 N O2,167.09466,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak3,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,8555669.060257146,7309999.642094803,0.854404207387037,-0.22700934350624463,0.049443145946394686,0.6537090145871882,Downregulated
Feature0982,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak2,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,44735009.38749953,50950251.2850669,1.1389346282176955,0.187684942609934,0.5357752617323747,0.7543471763776491,Upregulated
Feature0981,Linoleamide,C18 H33 N O,279.25629,NA,NA,Linoleamide,18,33,1,1,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909093,1,Lipid,13448334.972203366,32743974.93347287,2.434797690654795,1.2838019025685599,0.44456380243002824,0.7147297968682652,Upregulated
Feature0980,Acrylic acid,C3 H4 O2,72.02113,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid,3,4,2,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,156584414.65003768,142289935.83269066,0.9087107177984806,-0.1381070000501648,0.4188268977950969,0.7136536716603119,Downregulated
Feature0979,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak3",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,723410.039818642,747888.9517853963,1.033838225376152,0.0480104509264273,0.9396321280041366,0.978637034430813,Upregulated
Feature0978,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak2,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,90644565.05532016,60594488.59290144,0.668484520345161,-0.5810339417188276,0.5687277613753379,0.7762926377896947,Downregulated
Feature0977,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak2,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,98003676.95274283,99305715.2767209,1.013285606871729,0.01904087260131992,0.8515999034828797,0.9413744745889566,Upregulated
Feature0976,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,90948861.675485,129529689.46104267,1.4242035257485472,0.5101553293147365,0.41758158609976964,0.7136536716603119,Upregulated
Feature0975,Methylhippuric acid,C10 H11 N O3,193.07394,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak1,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,1248275.6911243498,849784.8210600014,0.6807669388278972,-0.5547671200656273,0.06741717679078969,0.6632182304416021,Downregulated
Feature0974,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,8,1,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,84640432.20651937,76238724.08174373,0.9007364694892414,-0.15082301967286033,0.44888656308456953,0.7155219105026039,Downregulated
Feature0973,Methylglutaric acid,C6 H10 O4,146.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Methylglutaric acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,17598663.51306033,14312945.540110158,0.8132973012120054,-0.2981452683193854,0.5428763693166938,0.7574167055561227,Downregulated
Feature0972,NA,C11 H20 N4 O3,256.15356,NA,NA,Feature0972,11,20,3,4,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,1224435.1959400433,857484.3791817303,0.7003101364816686,-0.5139341252934145,0.40051015966813475,0.7136536716603119,Downregulated
Feature0971,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1839248.9957459266,1790005.1525179166,0.9732261138421671,-0.03915306334391655,0.9249135209504671,0.9732960808787122,Downregulated
Feature0970,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10595,NA,NA,α-Aspartylphenylalanine-peak3,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,124832745.70678233,106313736.346514,0.85164942695591,-0.23166841335115393,0.0076629132271378705,0.42988943204243457,Downregulated
Feature0969,NA,C43 H79 N O9,753.57577,NA,NA,Feature0969,43,79,9,1,0,0,1.837209302325581,0.20930232558139536,-1.348837209302325,98.74186046511628,5,-4,-0.15151515151515152,-0.01333333333333333,-5,Lipid,13191164.897555033,15521928.630257163,1.1766912741068178,0.23473585330844382,0.8542599660616634,0.9424578976609502,Upregulated
Feature0968,NA,C77 H123 N10 O14 P3,1504.84348,NA,NA,Feature0968,77,123,14,10,0,3,1.5974025974025974,0.18181818181818185,-1.0389610389610393,89.91038961038961,23,9,-0.08,0.05263157894736842,-4,Lipid,187461.546600187,55768406.20711528,297.4925109630972,8.21670954043936,0.422913750164904,0.7136536716603119,Upregulated
Feature0967,NA,C8 H16 N2 O2,172.12119,NA,NA,Feature0967,8,16,2,2,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,1667029.1688209933,1437976.1410470267,0.862598068433341,-0.21323960935605735,0.28453458285136063,0.7028461383187669,Downregulated
Feature0966,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak2,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,78564889.3624484,42009396.55676203,0.5347095489813193,-0.9031726538998791,0.34714857877879984,0.7116802007632078,Downregulated
Feature0965,DL-Mevalonic acid,C6 H12 O4,148.07354,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,DL-Mevalonic acid,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,7616664.55378157,7326445.724604736,0.9618968608729468,-0.05604588517922286,0.7015249522573133,0.856365331384129,Downregulated
Feature0964,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,801062.6917948104,696320.4121421097,0.8692458396507997,-0.2021638378864558,0.17050286319791516,0.6736684190877296,Downregulated
Feature0963,NA,C12 H18 N6,246.15928,NA,NA,Feature0963,12,18,0,6,0,0,1.5,0,0,60.3,7,7,0.16666666666666666,0.16666666666666666,1,Lipid,807642.3275418567,739300.8811976386,0.9153815445108946,-0.12755488958961633,0.6927728909062623,0.8532285220601825,Downregulated
Feature0962,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak2,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,825209.2947083809,423942.41791423335,0.5137392666717957,-0.9608917473701829,0.09686381886231428,0.6736684190877296,Downregulated
Feature0961,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,115449876.75295067,97343424.09097517,0.8431661152768382,-0.24611120502839148,0.036300275560705,0.5992830975343959,Downregulated
Feature0960,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,L-Threonine,4,9,3,1,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,112480847.49682367,86523051.19337717,0.7692247446465984,-0.37852292242699587,0.2953790430925448,0.7028461383187669,Downregulated
Feature0959,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.15227,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,414015.0491428283,336991.84110408067,0.8139603664209415,-0.2969695467840827,0.03406735889299602,0.5992830975343959,Downregulated
Feature0958,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,4-Phenylbutyric acid,10,12,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Lignin,2410451.3957162867,1947352.33127428,0.8078786963864946,-0.30778940742946437,0.31027283920014037,0.7028461383187669,Downregulated
Feature0957,Cantharidin,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,Cantharidin,10,12,4,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,1379261.4674305099,1022615.817510013,0.7414227408346957,-0.43163172887206186,0.2191852056847098,0.6777335289635477,Downregulated
Feature0956,NA,C9 H15 N O7,249.08484,NA,NA,Feature0956,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,71588580.23391743,62453118.56078603,0.8723894000512225,-0.19695585423749323,0.2654549669879272,0.7028461383187669,Downregulated
Feature0955,NA,C23 H35 N O6,421.24649,NA,NA,Feature0955,23,35,6,1,0,0,1.5217391304347827,0.2608695652173913,-0.8695652173913047,85.08260869565218,7,1,0,0.15789473684210523,0,Lipid,3477254.4886969435,3065851.754315323,0.8816874819720807,-0.18166071813602194,0.25084407798636543,0.7019200023813293,Downregulated
Feature0954,NA,C11 H19 N3 O2,225.14773,NA,NA,Feature0954,11,19,2,3,0,0,1.7272727272727273,0.18181818181818185,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,131540472.73378399,104951587.38692631,0.7978653657367557,-0.32578277271417866,0.016607102414633017,0.5000414976159331,Downregulated
Feature0953,N-Acetyltyramine,C10 H13 N O2,179.09456,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,83520099.2147255,80145215.55554436,0.9595919582123041,-0.05950702760182849,0.34653157550523117,0.7116802007632078,Downregulated
Feature0952,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13229,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak3,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,113890185.85726634,94474589.96308187,0.8295235384151782,-0.2696451754626559,0.06197545682079531,0.6632182304416021,Downregulated
Feature0951,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20371,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak1,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,1697158.237064356,1314229.1187541706,0.7743704093422935,-0.36890427025880584,0.6686649686146539,0.8391969740331562,Downregulated
Feature0950,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",C19 H32 O2,292.24009,Other,NA,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",19,32,2,0,0,0,1.6842105263157894,0.10526315789473684,-1.473684210526316,102.3,4,2,0.1176470588235294,0.16666666666666666,2,Lipid,33403959.719414033,19782678.319015354,0.5922255470664416,-0.7557813689259251,0.5723876469605711,0.7775422437416534,Downregulated
Feature0949,NA,C18 H30 O15,486.1586,Metabolic pathways;ABC transporters;Other,NA,Feature0949,18,30,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,136047710.59076,131049334.747015,0.963260125274872,-0.0540026490847367,0.5835022373034316,0.7831214237493425,Downregulated
Feature0948,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14735,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,2062930.524516235,2525758.4713165504,1.2243545971616518,0.29202145139519287,0.8260715900691544,0.927780104161753,Upregulated
Feature0947,L-Lysine,C6 H14 N2 O2,146.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,L-Lysine,6,14,2,2,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,54742939.1825521,30786209.674864233,0.5623777264169356,-0.8303886388555988,0.07274765463714498,0.6690399057612841,Downregulated
Feature0946,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11624,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak1,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,12644904.801351143,13062651.153604541,1.033036733673848,0.04689155579721415,0.9549938375203437,0.986651091802786,Upregulated
Feature0945,NA,C75 H89 N10 O16 P3 S,1510.53964,NA,NA,Feature0945,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Lignin,117423063.83678867,98133559.22018193,0.8357264409024615,-0.25889731399143895,0.1395715039601521,0.6736684190877296,Downregulated
Feature0944,Misoprostol,C22 H38 O5,382.2719,NA,NA,Misoprostol,22,38,5,0,0,0,1.7272727272727273,0.2272727272727273,-1.2727272727272725,96.57272727272726,4,-1,-0.0588235294117647,0.07692307692307693,-1,Lipid,1139479.0103012617,1123194.6786689234,0.9857089674446633,-0.0207663440267048,0.9697601914661701,0.9883481899775874,Downregulated
Feature0943,NA,C15 H18 O11,374.08496,NA,NA,Feature0943,15,18,11,0,0,0,1.2,0.7333333333333333,0.2666666666666666,52.7,7,-4,-1,0.15789473684210523,-4,Tannin,165646.09829430765,26983463.484535467,162.89827386452083,7.34782750634356,0.25313293734813314,0.7028461383187669,Upregulated
Feature0942,"Norspermidine-2,3-dihydroxybenzoate",C13 H21 N3 O3,267.15832,NA,Other,"Norspermidine-2,3-dihydroxybenzoate",13,21,3,3,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,309053.7111769317,243682.64115686668,0.7884799060618936,-0.3428541056220448,0.6377608321261933,0.8201291637679481,Downregulated
Feature0941,Mevalonolactone,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1237004.3372259533,1354358.0561433933,1.0948692865383252,0.13075864067622597,0.5700775235245821,0.777189527818446,Upregulated
Feature0940,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak2,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,92690701.7210103,71385981.139929,0.770152559150902,-0.37678383800239384,0.3057029740797678,0.7028461383187669,Downregulated
Feature0939,NA,C10 H21 N O9,299.12162,NA,NA,Feature0939,10,21,9,1,0,0,2.1,0.9,0,60.3,1,-8,-Inf,-1,-9,Carbohydrate,58063619.44972934,53955277.597021736,0.9292441309783565,-0.105870423702572,0.5595741127720528,0.7700004054129788,Downregulated
Feature0938,NA,C5 H14 N O4 P,183.06609,NA,NA,Feature0938,5,14,4,1,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,16666554.512271801,21960649.892562333,1.3176478603536455,0.39796486351695237,0.24509663669894868,0.6979655491782245,Upregulated
Feature0937,NA,C16 H27 N O14,457.14329,NA,NA,Feature0937,16,27,14,1,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,74687345.3798503,65824060.2923277,0.8813281548240193,-0.18224880084036504,0.15673429064962285,0.6736684190877296,Downregulated
Feature0936,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,42707879.14463803,39166138.9350173,0.9170705668238411,-0.12489534417520888,0.6232352139076667,0.8121601742211405,Downregulated
Feature0935,"9S,13R-12-Oxophytodienoic acid",C18 H28 O3,292.20376,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,"9S,13R-12-Oxophytodienoic acid",18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,9098774.128838006,8348690.3343455335,0.9175621040954156,-0.12412228653558337,0.7650275088183238,0.9016395639644531,Downregulated
Feature0934,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.0954,Metabolic pathways;ABC transporters;Other,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,15838425.647982366,17301130.670489065,1.0923516677109275,0.1274373870148581,0.36641297102518455,0.7136536716603119,Upregulated
Feature0933,NA,C23 H41 N,331.32396,NA,NA,Feature0933,23,41,0,1,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,77912679.68472274,106437394.49730434,1.366111330376624,0.4500750599365226,0.5320557658453201,0.7543471763776491,Upregulated
Feature0932,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,27249440.2400305,38469032.57935154,1.411736616990723,0.49747095489445864,0.49160961425458044,0.7393914037448247,Upregulated
Feature0931,Caffeic acid,C9 H8 O4,180.04227,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak2,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,644848.628686271,370891.74536964664,0.5751609430034026,-0.7979623837284177,0.21554707771806125,0.6777335289635477,Downregulated
Feature0930,Isoamylamine,C5 H13 N,87.10481,NA,NA,Isoamylamine,5,13,0,1,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,1441708.8673649335,1491548.8915060335,1.0345701030695569,0.049031406361925045,0.771382125097658,0.9043790432179438,Upregulated
Feature0929,NA,C9 H15 N O7,249.08488,NA,NA,Feature0929,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,55232691.10674067,51889783.58365633,0.9394759252880879,-0.09007190281361667,0.6458784996692114,0.8234950870782445,Downregulated
Feature0928,2'-Deoxyguanosine,C10 H13 N5 O4,267.09677,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,2'-Deoxyguanosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,13016090.632738434,12299757.92966136,0.9449656027075185,-0.08166627952873969,0.7857607069906702,0.907639449407689,Downregulated
Feature0927,NP-007065,C8 H10 O3,154.063,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak3,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,2060669.5478419317,1737144.5183679038,0.843000043450516,-0.24639538935957486,0.7742142091121309,0.9067519234069007,Downregulated
Feature0926,Isoprenaline,C11 H17 N O3,211.12084,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Isoprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,846000.8969849123,781060.4572083143,0.9232383322428603,-0.11522496991976071,0.6390497016461596,0.8201291637679481,Downregulated
Feature0925,NA,C20 H29 N5 O7,451.2068,NA,NA,Feature0925,20,29,7,5,0,0,1.45,0.35,0,60.3,9,2,-0.375,0.04347826086956521,-3,Lignin,6790724.174037657,8189766.073717013,1.2060224894758917,0.2702568103497919,0.5723662175243124,0.7775422437416534,Upregulated
Feature0924,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,9668391.044782337,9377535.639828214,0.9699168761785772,-0.044066984148000546,0.8312121375290816,0.9316883299776519,Downregulated
Feature0923,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21537,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,444782.8601465743,378580.800227272,0.851158698207287,-0.23249994796882173,0.0290573554300737,0.5847007711817204,Downregulated
Feature0922,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,2041972.7939920002,11038381.148381824,5.40574349514329,2.434493056995746,0.44895492423692795,0.7155219105026039,Upregulated
Feature0921,Methionine sulfoxide,C5 H11 N O3 S,165.04597,Metabolic pathways;Other,Other,Methionine sulfoxide,5,11,3,1,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,98180714.3545662,71396124.15299967,0.7271909215812216,-0.45959390617974527,0.30481350438804483,0.7028461383187669,Downregulated
Feature0920,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.2507,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.0588235294117647,0.13513513513513514,1,Lipid,1439665.7944204947,728601.3039390947,0.5060905848863185,-0.9825324596321414,0.2875139325036722,0.7028461383187669,Downregulated
Feature0919,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12596,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak1",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,444455.30846100696,314421.06333002367,0.7074301000448249,-0.4993404901239767,0.11358879073246501,0.6736684190877296,Downregulated
Feature0918,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak5,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1371534.2732491468,855749.564841439,0.6239359683037154,-0.6805301154003259,0.016965444208445826,0.5000414976159331,Downregulated
Feature0917,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",C22 H31 N O4,373.22538,NA,NA,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",22,31,4,1,0,0,1.4090909090909092,0.18181818181818185,-0.9090909090909092,86.2090909090909,8,4,0.17647058823529413,0.2631578947368421,3,Lignin,1708755.5566792067,1333222.5681888699,0.780230128866327,-0.3580283852626668,0.02549892149755803,0.5618339157949356,Downregulated
Feature0916,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak2,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,859490.0345610153,693550.749347792,0.8069328572285578,-0.30947945926941856,0.2612600585259654,0.7028461383187669,Downregulated
Feature0915,NA,C5 H13 O6 P,200.04503,NA,NA,Feature0915,5,13,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,1590429.153727167,1967664.9315719833,1.2371911863919025,0.30706846098243895,0.5268959941539247,0.7540080121300391,Upregulated
Feature0914,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak2,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,86844989.07442953,62428869.616267435,0.7188540211889884,-0.476229264819458,0.09964800259517131,0.6736684190877296,Downregulated
Feature0913,"16?,17-isopropylidenedioxy-6?-methylprogesterone",C25 H36 O4,400.26153,NA,NA,"16?,17-isopropylidenedioxy-6?-methylprogesterone",25,36,4,0,0,0,1.44,0.16,-1.12,92.22,8,4,0.1904761904761905,0.2608695652173913,4,Lignin,3615491.7812195,3030885.6443148865,0.8383052231120197,-0.2544524766229427,0.11317712804657784,0.6736684190877296,Downregulated
Feature0912,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,18417834.180175565,15362539.412499815,0.8341121579341624,-0.26168670784074805,0.3875418067860529,0.7136536716603119,Downregulated
Feature0911,NP-021733,C7 H13 N O2,143.09463,ABC transporters,NA,NP-021733,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,429532.241832781,35679001.363169156,83.06478044798128,6.376164997352403,0.42502943606519394,0.7136536716603119,Upregulated
Feature0910,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,79645605.7314965,64675358.748765334,0.8120392601043267,-0.3003786150279161,0.43354766364541547,0.7136536716603119,Downregulated
Feature0909,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,47935435.14028043,53592544.71260577,1.1180151918047705,0.1609397919311001,0.5116296296311259,0.7463670402827399,Upregulated
Feature0908,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",C19 H34 O4,326.24576,NA,NA,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",19,34,4,0,0,0,1.7894736842105263,0.21052631578947367,-1.3684210526315788,99.29999999999998,3,-1,-0.06666666666666667,0.0588235294117647,-1,Lipid,3529147.7979301866,2784440.44901854,0.7889838024498688,-0.34193241234839633,0.4233706223808181,0.7136536716603119,Downregulated
Feature0907,Glucosamine,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,64183298.8194623,57127229.85741276,0.890063784631931,-0.16801936726359054,0.8270823876048007,0.9279864388925865,Downregulated
Feature0906,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Lignin,752726.3009359833,454666.59637765365,0.6040264513307094,-0.7273163659196974,0.1783428139127239,0.6736684190877296,Downregulated
Feature0905,"5,6,7,4'-Tetramethoxyisoflavone",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,NA,"5,6,7,4'-Tetramethoxyisoflavone",19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,252486.680563409,204785.76461785668,0.8110755155911172,-0.3020918513487317,0.011521756452100766,0.5000414976159331,Downregulated
Feature0904,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak2,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,5015851.68143896,2672484.617226667,0.532807743720998,-0.9083130444851374,0.4253852245783915,0.7136536716603119,Downregulated
Feature0903,NA,C17 H30 N2 O8,390.20035,NA,NA,Feature0903,17,30,8,2,0,0,1.7647058823529411,0.4705882352941176,-0.47058823529411775,73.71176470588236,4,-4,-0.8571428571428571,-0.18181818181818185,-6,Protein,2579656.37135459,2603919.84680997,1.0094057005905166,0.013506139351954598,0.9709352832629575,0.9883481899775874,Upregulated
Feature0902,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Lignin,1124943.7013810533,34685501.615152515,30.833099978754813,4.946408041067572,0.41004073440168537,0.7136536716603119,Upregulated
Feature0901,Leu-Glu,C11 H20 N2 O5,260.13724,NA,NA,Leu-Glu-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,20452839.0236054,18367254.196500335,0.8980295681837611,-0.15516514750467728,0.37951938204661156,0.7136536716603119,Downregulated
Feature0900,mycosporine,C11 H19 N O6,261.12123,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak3,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,50119042.0826584,20086751.92844213,0.40078084284440685,-1.3191145449218609,0.20470142495942475,0.6777335289635477,Downregulated
Feature0899,NA,C12 H18 O9,306.09516,NA,NA,Feature0899,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,65554909.54377624,68097347.2119912,1.0387833296683475,0.0548947670325178,0.861955511020528,0.945243606173105,Upregulated
Feature0898,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",C21 H32 N4 O6,436.23229,NA,NA,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",21,32,6,4,0,0,1.5238095238095235,0.2857142857142857,-0.3809523809523814,71.15714285714287,8,2,-0.18181818181818185,0.07142857142857142,-2,Lipid,7402839.083799327,8337245.827942164,1.126222755022155,0.17149220555503197,0.16286025763929554,0.6736684190877296,Upregulated
Feature0897,Veronal,C8 H12 N2 O3,184.0848,NA,NA,Veronal,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,11336616.718410766,8890378.646903321,0.7842179785848513,-0.35067337815669497,0.053765602706572116,0.6632182304416021,Downregulated
Feature0896,Imidazoleacetic acid riboside,C10 H14 N2 O6,258.08518,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Imidazoleacetic acid riboside,10,14,6,2,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Lignin,40712658.889085166,33273321.415943332,0.8172721292065678,-0.29111155863743887,0.3512597115208318,0.7136536716603119,Downregulated
Feature0895,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09574,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak2,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,3644703.72562664,3138967.8906508735,0.861240892800192,-0.215511272781862,0.1042579782233609,0.6736684190877296,Downregulated
Feature0894,AC-LYS-OH,C8 H16 N2 O3,188.1161,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,26635544.0935372,25236998.1337304,0.9474932460588954,-0.07781243541584011,0.5282088213317386,0.7540080121300391,Downregulated
Feature0893,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,633034.6766109806,819128.0265843944,1.2939702307773795,0.3718044269101159,0.3128946863674239,0.7028461383187669,Upregulated
Feature0892,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",C31 H42 O3,462.31357,NA,NA,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",31,42,3,0,0,0,1.3548387096774193,0.0967741935483871,-1.161290322580645,93.39677419354838,11,8,0.2857142857142857,0.3220338983050847,8,Unsaturated HC,824901.308032644,29800735.51987067,36.12642534286218,5.174982604148088,0.4226008935388711,0.7136536716603119,Upregulated
Feature0891,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak4,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,11712540.714878734,3248959.0941321533,0.2773914877414188,-1.8500045782484351,8.243689334517714e-5,0.04624709716664437,Downregulated
Feature0890,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15318,NA,NA,4-Hydroxyprolyllysine-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,8113532.85105486,8054651.0447437,0.9927427660191818,-0.010508151820848891,0.9587503695287357,0.9877112482048052,Downregulated
Feature0889,ALA-GLU,C8 H14 N2 O5,218.09029,NA,NA,ALA-GLU,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,23389641.0427801,18622564.637893,0.7961885607321623,-0.3288179512821852,0.08355450471883019,0.6736684190877296,Downregulated
Feature0888,MFCD01318772,C8 H13 N3 O2,183.10077,NA,NA,MFCD01318772,8,13,2,3,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,19191628.670436766,15860838.667664934,0.8264456831690028,-0.27500809109607643,0.04119070576307651,0.6245401603536735,Downregulated
Feature0887,NP-008177,C28 H41 N O5,471.29851,NA,NA,NP-008177,28,41,5,1,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Lignin,1871725.94777091,1634392.9757719901,0.8732010034473442,-0.19561430667080282,0.4102980847254857,0.7136536716603119,Downregulated
Feature0886,Valylvaline,C10 H20 N2 O3,216.14739,NA,NA,Valylvaline,10,20,3,2,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,33125513.7628025,30590019.125459667,0.9234579528185309,-0.11488182143405248,0.17854872907894942,0.6736684190877296,Downregulated
Feature0885,NA,C6 H15 N O6,197.08997,NA,NA,Feature0885,6,15,6,1,0,0,2.5,1,0,60.3,0,-6,7,-2,-7,Carbohydrate,52437880.899835035,56621429.16520417,1.079781032215249,0.11073877927215005,0.6455109049493335,0.8234950870782445,Upregulated
Feature0884,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak1,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,62733354.099269,47320587.96367287,0.7543130547235362,-0.4067647003536961,0.27898941371392455,0.7028461383187669,Downregulated
Feature0883,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",C10 H16 N2 O3 S,244.08813,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;ABC transporters;Other,Other,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",10,16,3,2,1,0,1.6,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,57011827.33419203,52102743.4338574,0.9138935878768005,-0.1299019046367238,0.2912705198014886,0.7028461383187669,Downregulated
Feature0882,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,L-Cystathionine,7,14,4,2,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,3978568.610931793,2851915.4320944333,0.716819467247168,-0.48031827652145187,0.24993190738969998,0.7019200023813293,Downregulated
Feature0881,Pyrogallol,C6 H6 O3,126.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,71879923.28509137,54458232.50028706,0.7576278606238058,-0.40043871016772264,0.17886498535555767,0.6736684190877296,Downregulated
Feature0880,afegostat,C6 H13 N O3,147.08955,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak2,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,13290760.658458633,11420096.139768487,0.8592507557120442,-0.21884887943725673,0.11269046409047827,0.6736684190877296,Downregulated
Feature0879,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",C14 H19 N3 O2,261.14775,NA,NA,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",14,19,2,3,0,0,1.3571428571428572,0.14285714285714285,-0.4285714285714288,72.51428571428572,7,5,0.2222222222222222,0.3,2,Lignin,200860.53638430368,171972.20073851667,0.8561771457658792,-0.22401876919869634,0.06994703713313481,0.6632182304416021,Downregulated
Feature0878,NA,C11 H21 N O8 S,327.09883,NA,NA,Feature0878,11,21,8,1,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,16913049.824625168,19903398.2087125,1.1768071645915348,0.23487793509186317,0.1683111453290546,0.6736684190877296,Upregulated
Feature0877,Maraniol,C12 H12 O3,204.07864,NA,NA,Maraniol,12,12,3,0,0,0,1,0.25,-0.5,74.55,7,4,0.4444444444444444,0.5238095238095238,4,Lignin,1261527.3443194525,798220.9439381537,0.6327416900889805,-0.6603114396018057,0.26663280086265784,0.7028461383187669,Downregulated
Feature0876,NA,C30 H46 O11,582.30426,NA,NA,Feature0876,30,46,11,0,0,0,1.5333333333333334,0.36666666666666664,-0.7999999999999998,83.1,8,-3,-0.15789473684210523,0.1020408163265306,-3,Protein,815530.0068930946,703693.889857005,0.8628669502154199,-0.21278997472129152,0.15365127196900147,0.6736684190877296,Downregulated
Feature0875,4-O-(beta-L-Araf)-cis-L-Hyp,C10 H17 N O7,263.10053,NA,Other,4-O-(beta-L-Araf)-cis-L-Hyp,10,17,7,1,0,0,1.7,0.7,0,60.3,3,-4,-2.5,-0.2727272727272727,-5,Amino Sugar,38002190.3913348,38536502.442719966,1.0140600330108076,0.020143063350392554,0.9539516867082278,0.986651091802786,Upregulated
Feature0874,NA,C15 H21 N3 O5,323.14822,NA,NA,Feature0874,15,21,5,3,0,0,1.4,0.3333333333333333,-0.13333333333333375,64.10000000000001,7,2,-0.14285714285714285,0.15789473684210523,-1,Lignin,28189670.2007511,27034038.981128633,0.9590051529020132,-0.0603895277709549,0.5562243975500898,0.7676307183901608,Downregulated
Feature0873,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26144,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak2,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,3433896.1366668968,2279401.0503108567,0.6637944071667095,-0.5911916209198457,0.4033522642784217,0.7136536716603119,Downregulated
Feature0872,RV0540000,C5 H12 O4,136.07356,NA,NA,RV0540000,5,12,4,0,0,0,2.4,0.8,-0.7999999999999998,83.1,0,-4,-4,-0.6666666666666666,-4,Carbohydrate,1316231.323093038,1301042.89619286,0.9884606705267533,-0.016744530617057374,0.9678323532624598,0.9883481899775874,Downregulated
Feature0871,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,135056.585521799,140308.23291257,1.038884793144155,0.05503567582530125,0.8497423049922409,0.9413744745889566,Upregulated
Feature0870,"N-Acetyl-1,6-anhydro-Î²-muramic acid",C11 H17 N O7,275.10045,Metabolic pathways;Other,NA,"N-Acetyl-1,6-anhydro-Î²-muramic acid",11,17,7,1,0,0,1.5454545454545454,0.6363636363636364,0,60.3,4,-3,-1.3333333333333333,-0.07692307692307693,-4,Amino Sugar,1697207.07753447,26569636.84644475,15.654917539610086,3.9685440041618425,0.42210291930892735,0.7136536716603119,Upregulated
Feature0869,N-(3-Hydroxy-4-methoxybenzoyl)glycine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,N-(3-Hydroxy-4-methoxybenzoyl)glycine,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,227667.71460292934,254091.28569918766,1.1160620035315203,0.15841717923037066,0.6533779519184515,0.8292874005118807,Upregulated
Feature0868,α-Linolenic acid,C18 H30 O2,278.22444,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Linolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,5319417.6819947995,3176146.2982501616,0.5970853368030871,-0.7439909553834424,0.18502991924908993,0.6736684190877296,Downregulated
Feature0867,Propionylcarnitine,C10 H19 N O4,217.13141,NA,NA,Propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,279092.18344432965,316219.853672132,1.1330301328027275,0.18018622997306724,0.696882633383124,0.856346251177756,Upregulated
Feature0866,Glu-Gly,C7 H12 N2 O5,204.07472,NA,NA,Glu-Gly,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,48976503.504833035,52457381.82536897,1.0710724137379966,0.09905602202005652,0.3475942513531532,0.7116802007632078,Upregulated
Feature0865,arg-leu,C12 H25 N5 O3,287.19577,NA,NA,arg-leu,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,5363281.213117046,5105344.795367713,0.9519069749468861,-0.07110750175358382,0.49495646956869677,0.7409615456815796,Downregulated
Feature0864,Tridemorph,C19 H39 N O,297.30319,NA,NA,Tridemorph,19,39,1,1,0,0,2.0526315789473686,0.05263157894736842,-1.7894736842105263,111.3,1,0,-0.0588235294117647,-0.02857142857142857,-1,Lipid,386547.4316898507,343067.57666689064,0.8875174132372804,-0.17215266919155933,0.2965846152291861,0.7028461383187669,Downregulated
Feature0863,ornithinoalanine,C8 H17 N3 O4,219.12181,NA,NA,ornithinoalanine,8,17,4,3,0,0,2.125,0.5,0,60.3,2,-2,-5,-1,-5,Protein,279438.3305880763,24447939.008129574,87.4895686525146,6.451039110113362,0.42214567155146765,0.7136536716603119,Upregulated
Feature0862,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Superpathway of indole-3-acetate conjugate biosynthesis,Indole-3-acetic acid,10,9,2,1,0,0,0.9,0.2,-0.20000000000000015,66,7,5,0.5714285714285714,0.625,4,Lignin,1960514.65815044,1673588.9863763934,0.8536477804023491,-0.2282871658895778,0.6466336500002161,0.8235220832011833,Downregulated
Feature0861,NA,C11 H18 N3 O6 P S,351.06552,NA,NA,Feature0861,11,18,6,3,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,1195966.8949462266,936163.7257968544,0.7827672569807598,-0.35334468534504015,0.06318701671792401,0.6632182304416021,Downregulated
Feature0860,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,567180.526752344,408026.30420934304,0.7193940640834189,-0.4751458394351224,0.35150004558362347,0.7136536716603119,Downregulated
Feature0859,NA,C22 H33 N6 O10 P S,604.17155,NA,NA,Feature0859,22,33,10,6,1,1,1.5,0.4545454545454546,0.09090909090909084,57.70909090909091,10,0,-2,-0.3333333333333333,-8,Protein,249144.39894437668,217794.74031878333,0.8741707268619255,-0.1940130271255207,0.23473240481322946,0.6875073975489493,Downregulated
Feature0858,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14749,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,10337787.385414984,8965860.213768307,0.8672900572919255,-0.20541352447018066,0.47310046189186516,0.7253425911661145,Downregulated
Feature0857,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,C19 H32 O3,308.23512,NA,NA,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,19,32,3,0,0,0,1.6842105263157894,0.15789473684210523,-1.3684210526315788,99.29999999999998,4,1,0.0625,0.14285714285714285,1,Lipid,660447.873569663,468241.914591694,0.7089763376190272,-0.49619061716778534,0.01263313039305526,0.5000414976159331,Downregulated
Feature0856,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",C6 H6 O4,142.02662,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",6,6,4,0,0,0,1,0.6666666666666666,0.3333333333333335,50.8,4,0,0,0.5,0,Tannin,6282054.171945724,6593166.333302104,1.0495239539235015,0.06973509451217395,0.44874957157043205,0.7155219105026039,Upregulated
Feature0855,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,426853.1084610486,4900523.451089174,11.480585133272745,3.521124268900791,0.4265733737748971,0.7136536716603119,Upregulated
Feature0854,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Eleostearic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,4928553.518792204,4080037.0348749766,0.8278366095281511,-0.2725820444142993,0.12691608552402373,0.6736684190877296,Downregulated
Feature0853,imazamethabenz-methyl,C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,imazamethabenz-methyl,16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,196327.51139934832,143993.17857168167,0.7334335241421475,-0.44726188391242067,0.13694250994154525,0.6736684190877296,Downregulated
Feature0852,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,5431976.10191679,4506565.541955583,0.8296364817152535,-0.26944875952061903,0.37110834416330385,0.7136536716603119,Downregulated
Feature0851,Isobutyraldehyde,C4 H8 O,72.05754,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Isobutyraldehyde,4,8,1,0,0,0,2,0.25,-1.5,103.05,1,0,0,0.14285714285714285,0,Lipid,1848889.0316154135,3427917.2946710302,1.8540416628876781,0.8906736636862567,0.4859398371967101,0.7338899395222812,Upregulated
Feature0850,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,C12 H16 O5,240.09978,NA,NA,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Lignin,11515918.656542568,7554183.519890836,0.6559774990768157,-0.6082817656035033,0.005587428661203066,0.36877029163940234,Downregulated
Feature0849,"3,4,5-Trimethoxyphenyl acetate",C11 H14 O5,226.08413,NA,NA,"3,4,5-Trimethoxyphenyl acetate",11,14,5,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Lignin,319397.69124432,265495.37761218334,0.8312376228452301,-0.2666671410015085,0.5442850072789759,0.7574167055561227,Downregulated
Feature0848,NA,C18 H33 N O15,503.18514,NA,NA,Feature0848,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,61062138.3692113,58451023.996822834,0.9572384059562342,-0.06304981358653154,0.5157881994553104,0.7476929713034344,Downregulated
Feature0847,pentobarbital,C11 H18 N2 O3,226.13174,NA,NA,pentobarbital,11,18,3,2,0,0,1.6363636363636365,0.2727272727272727,-0.5454545454545459,75.84545454545456,4,1,-0.16666666666666666,0.06666666666666667,-1,Lipid,11393707.1008844,10438860.582534589,0.9161952725399011,-0.1262729761493599,0.14715752526328732,0.6736684190877296,Downregulated
Feature0846,5-Hydroxy-2-furoic acid,C5 H4 O4,128.01093,NA,NA,5-Hydroxy-2-furoic acid,5,4,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,49573428.03407063,39177743.102959864,0.7902972349629309,-0.33953273431120917,0.3822343645224305,0.7136536716603119,Downregulated
Feature0845,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak3,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,26200473.92807513,23408115.187513866,0.8934233499658526,-0.1625841343588788,0.25803259028896336,0.7028461383187669,Downregulated
Feature0844,DL-2-(acetylamino)-3-phenylpropanoic acid,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,DL-2-(acetylamino)-3-phenylpropanoic acid,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,3191673.7664339067,2638926.734335967,0.8268159365436868,-0.2743618984909978,0.2679100739774926,0.7028461383187669,Downregulated
Feature0843,NA,C16 H21 N8 O2 P,388.15237,NA,NA,Feature0843,16,21,2,8,0,1,1.3125,0.125,0.125,56.7375,11,9,0,0.16666666666666666,0,Unsaturated HC,522201.69096658035,484021.5580668137,0.9268862327329956,-0.10953582350621084,0.3008666035968681,0.7028461383187669,Downregulated
Feature0842,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11068,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak2,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,557768.213760199,477964.778074036,0.8569236580403757,-0.22276141222103718,0.32983885563423937,0.707999712182741,Downregulated
Feature0841,NA,C14 H31 N O,229.24056,NA,NA,Feature0841,14,31,1,1,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.2285714285714,0,-1,-0.16666666666666666,-0.12,-2,Lipid,23575581.38074879,30946456.010648932,1.3126486897972751,0.3924808527850092,0.5967167943174547,0.795085753247542,Upregulated
Feature0840,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,39688702.18317257,42550888.04647933,1.072115884517894,0.10046085447425397,0.7926877141197332,0.9104709761392166,Upregulated
Feature0839,NA,C12 H19 N O7,289.11624,NA,NA,Feature0839,12,19,7,1,0,0,1.5833333333333333,0.5833333333333334,-0.16666666666666696,65.05000000000001,4,-3,-1,-0.06666666666666667,-4,Amino Sugar,35760203.05906457,27082526.919075232,0.7573370563456658,-0.4009925736801979,0.1123648963171934,0.6736684190877296,Downregulated
Feature0838,"1D-myo-Inositol 1,2-cyclic phosphate",C6 H11 O8 P,242.01913,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis",Other,"1D-myo-Inositol 1,2-cyclic phosphate",6,11,8,0,0,1,1.8333333333333333,1.3333333333333333,0,60.3,2,-6,2.3333333333333335,-3,-7,Carbohydrate,6709993.74790853,6934029.00352223,1.0333882957318001,0.04738244884704495,0.911694235023079,0.9725088410337925,Upregulated
Feature0837,APM,C7 H13 N O4,175.08447,NA,NA,APM-peak3,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,1602253.1467787134,1652274.3226647768,1.0312192714282569,0.044351130152568204,0.7531836282055975,0.8942561172980744,Upregulated
Feature0836,NA,C16 H23 N5 O9,429.1496,NA,NA,Feature0836,16,23,9,5,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Lignin,3348322.9439955535,3223216.4957943135,0.9626360866936119,-0.05493758773036108,0.6021809524350068,0.7967535715000916,Downregulated
Feature0835,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,264517.02725676,327389.30648448004,1.237687077764909,0.30764660661860344,0.27846492972798703,0.7028461383187669,Upregulated
Feature0834,NA,C11 H20 N2 O8,308.12197,NA,NA,Feature0834,11,20,8,2,0,0,1.818181818181818,0.7272727272727273,0.18181818181818168,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,1754755.0789044467,5696383.074479926,3.2462553566372194,1.6987764894928474,0.16489449814953136,0.6736684190877296,Upregulated
Feature0833,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,776033.9626294724,592328.2608611453,0.7632762087552607,-0.38972287152039803,0.027608481176836085,0.5736428866742609,Downregulated
Feature0832,cis-4-Decenedioic acid,C10 H16 O4,200.10487,NA,NA,cis-4-Decenedioic acid,10,16,4,0,0,0,1.6,0.4,-0.7999999999999998,83.1,3,-1,-0.16666666666666666,0.125,-1,Protein,3203578.50235753,2879716.1626162566,0.8989060703513457,-0.15375772321671421,0.7310443140342964,0.8781924200711783,Downregulated
Feature0831,EDDA,C6 H12 N2 O4,176.07974,Other,NA,EDDA,6,12,4,2,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,27519243.895486202,26143467.5095039,0.9500067519584736,-0.07399032777810312,0.1352819524140786,0.6736684190877296,Downregulated
Feature0830,Neolinustatin,C17 H29 N O11,423.17418,NA,NA,Neolinustatin,17,29,11,1,0,0,1.7058823529411764,0.6470588235294118,-0.23529411764705888,67.00588235294117,4,-7,-1.6,-0.23809523809523808,-8,Amino Sugar,25197946.971592367,33469579.09800907,1.3282661137330738,0.4095442148337837,0.5051794855728039,0.7430681588649243,Upregulated
Feature0829,NA,C12 H19 N3 O4 S,301.10964,NA,NA,Feature0829,12,19,4,3,1,0,1.5833333333333333,0.3333333333333333,0,60.3,5,1,-0.75,-0.16666666666666666,-3,Protein,521471.07133226667,359287.5298034623,0.6889884205571482,-0.5374483583223222,0.1052210331189009,0.6736684190877296,Downregulated
Feature0828,Gly-Phe,C11 H14 N2 O3,222.10044,NA,NA,Gly-Phe,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,24291303.512729768,19534942.209260534,0.8041948921770838,-0.3143829219599729,0.3174503160714602,0.7028461383187669,Downregulated
Feature0827,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",C9 H16 N2 O4,216.11101,Metabolic pathways;Other,Other,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,4749093.776897623,3985459.5319750803,0.8392042185738029,-0.25290616470787297,0.48237741785131116,0.7323781635036145,Downregulated
Feature0826,N-Acetyl-6-oxo-L-norleucine,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetyl-6-oxo-L-norleucine,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,1497182.6275097732,20605380.113757998,13.76276997551756,3.7826989593869147,0.42835665834646514,0.7136536716603119,Upregulated
Feature0825,Hymexazol N-glucoside,C10 H15 N O7,261.08485,NA,NA,Hymexazol N-glucoside,10,15,7,1,0,0,1.5,0.7,0.20000000000000015,54.599999999999994,4,-3,-2,-0.09090909090909093,-4,Amino Sugar,302473.51109740534,309395.798004955,1.0228855970971966,0.0326447983286196,0.9311220869503326,0.9774430411480743,Upregulated
Feature0824,"(2Z,4E)-2,4-Pentadecadienal",C15 H26 O,222.19833,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2Z,4E)-2,4-Pentadecadienal",15,26,1,0,0,0,1.7333333333333334,0.06666666666666667,-1.5999999999999996,105.89999999999998,3,2,0.14285714285714285,0.1724137931034483,2,Lipid,803028.900063355,805986.722299379,1.0036833322384668,0.005304162643502523,0.9908826515083862,0.995279868734723,Upregulated
Feature0823,pro-his,C11 H16 N4 O3,252.12227,NA,NA,pro-his,11,16,3,4,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818168,55.11818181818182,6,3,-0.25,0.09090909090909093,-1,Lignin,1632082.0936909167,1599873.63220919,0.9802654158107402,-0.028755669914099613,0.8886802335229499,0.9643125938227753,Downregulated
Feature0822,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,C11 H23 N3 O2,229.17901,NA,NA,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,11,23,2,3,0,0,2.090909090909091,0.18181818181818185,-0.9090909090909092,86.2090909090909,2,0,-0.5,-0.2857142857142857,-3,Lipid,584425.353127192,957444.5964841917,1.6382667031144649,0.7121702409467696,0.5356150444211131,0.7543471763776491,Upregulated
Feature0821,NA,C12 H19 N O8,305.11113,NA,NA,Feature0821,12,19,8,1,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,290647.30064726167,327668.9299473594,1.1273764773237247,0.1729693711171786,0.6071197353428889,0.7994614192754439,Upregulated
Feature0820,NA,C18 H33 N O15,503.18519,NA,NA,Feature0820,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,46107314.789003,46570429.5182824,1.0100442789045234,0.014418540061947612,0.9208199047406507,0.9725088410337925,Upregulated
Feature0819,2762577,C15 H23 N3 O4,309.16894,NA,NA,2762577,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,975565.0661126436,977882.1773045966,1.0023751477707028,0.0034225509850697665,0.9832608773846505,0.9929337204459302,Upregulated
Feature0818,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10012,NA,NA,N-(Carboxymethyl)norleucine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,6928110.915093566,6715125.55836859,0.969257802114431,-0.0450476517806567,0.7672315973464382,0.903288407369049,Downregulated
Feature0817,2'-Deoxycytidine,C9 H13 N3 O4,227.0906,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxycytidine,9,13,4,3,0,0,1.4444444444444444,0.4444444444444444,0.44444444444444464,47.633333333333326,5,1,-1,0,-2,Lignin,6824730.14346831,8881003.727833997,1.3012974199915683,0.37995073708101396,0.03782225717653626,0.5992830975343959,Upregulated
Feature0816,NA,C7 H17 N O6,211.10558,NA,NA,Feature0816,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,895191.3768788001,775208.2404604896,0.8659692893416299,-0.20761223263762288,0.678519839096341,0.8434328503077431,Downregulated
Feature0815,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,754526.041713502,4041015.5017566797,5.355700503828438,2.421075285956758,0.3566374281891613,0.7136536716603119,Upregulated
Feature0814,Tiglic acid,C5 H8 O2,100.05241,NA,NA,Tiglic acid-peak2,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,5866140.787961236,6038313.034601304,1.0293501729439238,0.0417338537863591,0.8918236062649849,0.96585529558814,Upregulated
Feature0813,"(2E,4E,7E)-2,4,7-Decatrienoic acid",C10 H14 O2,166.0994,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2E,4E,7E)-2,4,7-Decatrienoic acid",10,14,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Lignin,1769640.1518024108,751819.5167166643,0.4248431614477793,-1.2349977523717128,0.15830483997679123,0.6736684190877296,Downregulated
Feature0812,NA,C32 H36 O10,580.23105,NA,NA,Feature0812,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,285673.22228330333,250765.198480635,0.8778043544870653,-0.18802866795556988,0.1179951683051871,0.6736684190877296,Downregulated
Feature0811,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08922,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak2",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,1671685.1242804767,1648754.864452289,0.9862831465716025,-0.01992621348405346,0.9613018565415752,0.9877112482048052,Downregulated
Feature0810,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,C14 H18 N2 O8,342.10633,Biosynthesis of secondary metabolites;Other,NA,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,14,18,8,2,0,0,1.2857142857142858,0.5714285714285714,0.2857142857142856,52.15714285714286,7,-1,-0.75,0.125,-3,Lignin,755011.9525937546,509477.376583297,0.674793789466574,-0.5674813991916504,0.06341634780687924,0.6632182304416021,Downregulated
Feature0809,10-Deoxymethymycin,C25 H43 N O6,453.30918,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,10-Deoxymethymycin,25,43,6,1,0,0,1.72,0.24,-1.12,92.22,5,-1,-0.1111111111111111,0.04761904761904761,-2,Lipid,1009620.6819430649,871363.6810685487,0.8630604509721079,-0.212466481875579,0.13554024994510847,0.6736684190877296,Downregulated
Feature0808,NA,C46 H84 N10 O13 P2 S,1078.54184,NA,NA,Feature0808,46,84,13,10,1,2,1.826086956521739,0.2826086956521739,-0.7826086956521738,82.60434782608695,11,-2,-0.75,-0.32075471698113206,-15,Lipid,446699.1211565877,18580231.841229722,41.59451174455419,5.378321277069582,0.4243866582483048,0.7136536716603119,Upregulated
Feature0807,Diethyl tartrate,C8 H14 O6,206.07905,NA,NA,Diethyl tartrate,8,14,6,0,0,0,1.75,0.75,-0.25,67.425,2,-4,-2,-0.2,-4,Carbohydrate,318459.24571808235,216464.547634814,0.6797244876552911,-0.556977996815217,0.39266856486876134,0.7136536716603119,Downregulated
Feature0806,NA,C9 H19 N O3,189.13649,NA,NA,Feature0806,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,816276.8861901283,809299.7967063683,0.9914525455739355,-0.012384373268890702,0.9606191383944342,0.9877112482048052,Downregulated
Feature0805,5-guanidino-2-oxopentanoic acid,C6 H11 N3 O3,173.08005,Metabolic pathways;Other,NA,5-guanidino-2-oxopentanoic acid,6,11,3,3,0,0,1.8333333333333333,0.5,0.6666666666666665,41.3,3,0,-Inf,-1,-3,Protein,2376712.5374144735,2462666.7939739465,1.036165188345823,0.05125401982928199,0.7466866890336623,0.8899666293484348,Upregulated
Feature0804,"(E,E)-alpha-Farnesene",C15 H24,204.18778,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,"(E,E)-alpha-Farnesene",15,24,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,573390.5860532296,559496.4437350694,0.9757684505882863,-0.035389257366042724,0.954407423060849,0.986651091802786,Downregulated
Feature0803,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,1718357.0904256634,1368661.7164924666,0.7964943515631132,-0.3282639641484282,0.05729332437770525,0.6632182304416021,Downregulated
Feature0802,NA,C11 H17 N O5,243.11065,NA,NA,Feature0802,11,17,5,1,0,0,1.5454545454545454,0.4545454545454546,-0.3636363636363633,70.66363636363636,4,-1,-0.4,0.06666666666666667,-2,Protein,613923.4171962527,628732.4479580167,1.02412195128408,0.03438752006162083,0.9450186673841446,0.9790498105309422,Upregulated
Feature0801,8722455,C11 H17 N O8,291.09546,NA,NA,8722455,11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,30776908.310486335,33827476.4690137,1.0991187330368715,0.13634724280306038,0.5633289142086514,0.7707988313928134,Upregulated
Feature0800,2-methylbutyrylcarnitine,C12 H23 N O4,245.1627,NA,NA,2-methylbutyrylcarnitine,12,23,4,1,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,236830.50015266868,208359.04425682835,0.8797812955785395,-0.18478316545443585,0.26043115415982865,0.7028461383187669,Downregulated
Feature0799,dihydropyranone,C5 H6 O2,98.03675,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak1,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,25484262.078879833,30352575.435402125,1.191032149232091,0.2522123560330243,0.7570360144087606,0.895572642953768,Upregulated
Feature0798,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,3642220.8280601697,2541528.0626878766,0.6977962574667618,-0.5191222350286524,0.45832405729284004,0.7162499996920834,Downregulated
Feature0797,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04732,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak1,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,339771.54080758436,742079.7404153442,2.184055023123878,1.127009202680847,0.46982806780766767,0.723109865679291,Upregulated
Feature0796,UNII:74D1OHC38H,C19 H32 O4,324.23008,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak2,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1680999.3070683063,1586570.5394843274,0.9438258140934844,-0.083407464464356,0.9165526200721165,0.9725088410337925,Downregulated
Feature0795,NA,C7 H17 N O6,211.10569,NA,NA,Feature0795,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,26037651.067754768,18996772.931143764,0.7295885823844347,-0.4548449425040109,0.14640560239018652,0.6736684190877296,Downregulated
Feature0794,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",C11 H19 N O7,277.11616,NA,NA,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",11,19,7,1,0,0,1.7272727272727273,0.6363636363636364,-0.18181818181818168,65.48181818181817,3,-4,-1.6666666666666667,-0.2307692307692308,-5,Amino Sugar,13723947.137441548,11256684.17972798,0.8202220590764007,-0.28591355081723296,0.5944987906515741,0.7934066356374954,Downregulated
Feature0793,NP-019722,C8 H13 N O4,187.08445,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,38988212.59101653,38124914.43112113,0.9778574573563725,-0.032303916573721815,0.9155456741767771,0.9725088410337925,Downregulated
Feature0792,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,3572795.4412403433,3106561.24236634,0.8695043680664394,-0.20173481977417565,0.17349506116947624,0.6736684190877296,Downregulated
Feature0791,NA,C15 H27 N O5,301.18898,NA,NA,Feature0791,15,27,5,1,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.04347826086956521,-3,Protein,975893.496438995,1725505.2604395924,1.7681286602850694,0.8222232582144737,0.4173633698219935,0.7136536716603119,Upregulated
Feature0790,Bis(4-ethylbenzylidene)sorbitol,C24 H30 O6,414.20433,NA,NA,Bis(4-ethylbenzylidene)sorbitol,24,30,6,0,0,0,1.25,0.25,-0.75,81.675,10,4,0.2222222222222222,0.3333333333333333,4,Lignin,5674821.389879207,4098806.1400597035,0.7222793209614919,-0.46937122863867303,0.13689354939268994,0.6736684190877296,Downregulated
Feature0789,NA,C31 H40 O6,508.28264,NA,NA,Feature0789,31,40,6,0,0,0,1.2903225806451613,0.1935483870967742,-0.903225806451613,86.04193548387097,12,6,0.24,0.32142857142857145,6,Lignin,163936.69601380534,172710.874473584,1.0535217475594347,0.07522009561920767,0.8600212317757746,0.9450967900820817,Upregulated
Feature0788,Apocynin,C9 H10 O3,166.06303,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak2,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,1445705.1334887054,1552762.8060512757,1.0740522185905392,0.10306413640548716,0.8428453853982201,0.9413744745889566,Upregulated
Feature0787,NA,C6 H9 O7 P,224.00856,NA,NA,Feature0787,6,9,7,0,0,1,1.5,1.1666666666666667,0,60.3,3,-4,2.5,-1,-5,Carbohydrate,5046907.790919157,5531000.97081652,1.0959187684721299,0.13214086703423283,0.37765455767018186,0.7136536716603119,Upregulated
Feature0786,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.2981,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak2,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,174643.20176644868,156813.708518536,0.8979090335748874,-0.15535880076494846,0.14846609903078087,0.6736684190877296,Downregulated
Feature0785,Glycylproline,C7 H12 N2 O3,172.08476,NA,NA,Glycylproline,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,6292423.318308147,5516562.894675233,0.8766992644351334,-0.1898460573656527,0.25833199925285355,0.7028461383187669,Downregulated
Feature0784,Phosphoric acid,H3 O4 P,97.97687,ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of purine nucleotide salvage;Other,Phosphoric acid,0,3,4,0,0,1,Inf,Inf,NA,NA,0,-4,1,1,-5,Other,36021324.533504464,34581173.21259803,0.9600194790292371,-0.05886441612254919,0.5454480375127871,0.7574167055561227,Downregulated
Feature0783,NA,C52 H85 N10 O8 P3,1070.57651,NA,NA,Feature0783,52,85,8,10,0,3,1.6346153846153846,0.15384615384615383,-1.0384615384615383,89.89615384615384,17,9,-0.12903225806451613,0,-4,Lipid,185017.536262353,15836717.942999184,85.59576709822186,6.419467548787166,0.4235818644873478,0.7136536716603119,Upregulated
Feature0782,Glycylglutamic acid,C7 H12 N2 O5,204.07457,NA,NA,Glycylglutamic acid,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,7418923.680162467,5734881.098069177,0.7730071564698437,-0.37144632426148116,0.15546180971103427,0.6736684190877296,Downregulated
Feature0781,NA,C12 H22 N4 O6,318.15394,NA,NA,Feature0781,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,12913965.466295134,11976071.48838608,0.9273736653271286,-0.10877733587105597,0.6823762640581624,0.8450619958865986,Downregulated
Feature0780,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",C12 H14 N2 O5,266.0903,NA,NA,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",12,14,5,2,0,0,1.1666666666666667,0.4166666666666667,0.16666666666666652,55.55,7,2,0,0.3333333333333333,0,Lignin,195272.73870754533,172878.30421279932,0.885317148502303,-0.17573372827076533,0.11778615984467816,0.6736684190877296,Downregulated
Feature0779,Pipecolic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,554508.600749061,898150.963738975,1.6197241350732934,0.6957481199915458,0.4433480325947616,0.7147297968682652,Upregulated
Feature0778,NA,C11 H14 N O P S,239.05347,NA,NA,Feature0778,11,14,1,1,1,1,1.2727272727272727,0.09090909090909093,-1.0909090909090908,91.39090909090908,6,5,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,297589.441172131,263164.7740637417,0.8843216111001819,-0.1773569488481646,0.12118861671013169,0.6736684190877296,Downregulated
Feature0777,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",C13 H21 N O2,223.15721,NA,NA,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",13,21,2,1,0,0,1.6153846153846154,0.15384615384615383,-1.0769230769230766,90.99230769230768,4,2,0.1,0.18181818181818185,1,Lipid,31882099.134638432,27868370.367369235,0.8741071360979344,-0.1941179784971996,0.2318310196035712,0.6875073975489493,Downregulated
Feature0776,NA,C16 H21 N5 O9,427.13398,NA,NA,Feature0776,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,18261079.764596634,18109687.8823677,0.9917095875939143,-0.012010391491608888,0.9222365480035253,0.9725088410337925,Downregulated
Feature0775,NA,C4 H11 O6 P,186.02935,NA,NA,Feature0775,4,11,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,420972.9875194673,373432.0327028907,0.887068870863411,-0.17288197706234398,0.10508449912336086,0.6736684190877296,Downregulated
Feature0774,NA,C13 H19 N O6,285.1213,NA,NA,Feature0774,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Lignin,321992.2293904143,305155.53760175966,0.947710875444015,-0.07748110135796055,0.6653054396934365,0.8359156812273637,Downregulated
Feature0773,Kanosamine,C6 H13 N O5,179.07944,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,26694435.252773635,36568257.0287603,1.3698831491466277,0.4540528367358665,0.2352966494285174,0.6875073975489493,Upregulated
Feature0772,Ser-Glu,C8 H14 N2 O6,234.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,Ser-Glu,8,14,6,2,0,0,1.75,0.75,0.5,46.05,3,-3,-Inf,-0.6666666666666666,-5,Carbohydrate,19230104.084272366,18614422.656337466,0.9679834583714789,-0.046945701033506884,0.9014773842651849,0.9678405764193425,Downregulated
Feature0771,Apocynin,C9 H10 O3,166.06304,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak1,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,1093729.1022782768,857187.9768750137,0.7837296960366699,-0.3515719321645718,0.04771640919091556,0.6537090145871882,Downregulated
Feature0770,Ethyl lactate,C5 H10 O3,118.06297000000001,Metabolic pathways;Other,NA,Ethyl lactate,5,10,3,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,1178913.9305656035,1053181.7524462463,0.8933491454638803,-0.16270396435104892,0.5607249487424204,0.7700004054129788,Downregulated
Feature0769,Furan,C4 H4 O,68.02622,Other,NA,Furan,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,37378657.795414634,35622879.742671,0.9530272578979809,-0.06941061708806912,0.8203178578680536,0.9241442293136327,Downregulated
Feature0768,Acetylcholine,C7 H15 N O2,145.11029,NA,NA,Acetylcholine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,660325.1710654927,749172.2702321314,1.1345505261040951,0.18212085946125348,0.7197129186169604,0.869805973434988,Upregulated
Feature0767,3-Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,3-Methylhippuric acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,9771923.664542804,8236749.58450157,0.842899501393817,-0.24656746548026198,0.35620390373072197,0.7136536716603119,Downregulated
Feature0766,glycidyl oleate,C21 H38 O3,338.28215,NA,NA,glycidyl oleate,21,38,3,0,0,0,1.8095238095238095,0.14285714285714285,-1.5238095238095235,103.72857142857144,3,0,0,0.07692307692307693,0,Lipid,2006588.5804259533,1920906.1527055334,0.957299454130138,-0.06295780820015374,0.8681230343000087,0.9482111623798329,Downregulated
Feature0765,Muramic acid,C9 H17 N O7,251.10052,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak1,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,13734239.947110966,9967432.482630081,0.7257360087644863,-0.4624832410297915,0.31711918226484065,0.7028461383187669,Downregulated
Feature0764,NP-001346,C11 H15 N5 O3 S,297.08963,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,NP-001346,11,15,3,5,1,0,1.3636363636363635,0.2727272727272727,0.7272727272727271,39.57272727272728,7,4,-1,-0.14285714285714285,-2,Lignin,357171.680702612,4274668.346352961,11.968105472259241,3.581122889433008,0.3907891347096686,0.7136536716603119,Upregulated
Feature0763,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",C8 H15 N O5,205.09502,NA,NA,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,31124954.5586999,27073981.92099197,0.8698480786512306,-0.20116464256418065,0.13964330991955634,0.6736684190877296,Downregulated
Feature0762,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,2843129.4338896433,1873432.8672207133,0.65893337281437,-0.6017954985004602,0.4138025677453661,0.7136536716603119,Downregulated
Feature0761,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10594,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,5,2,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Lignin,18458496.259493034,15474911.794928515,0.8383625392545133,-0.25435384084497087,0.44590985544365924,0.7147297968682652,Downregulated
Feature0760,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08948,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak2",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,245635.05160487833,1164583.7151054994,4.741113727444795,2.24522600012036,0.20946354220661095,0.6777335289635477,Upregulated
Feature0759,Fluoranthene,C16 H10,202.07831,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak2,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,39291050.93179597,27290687.4557446,0.694577691574542,-0.5257920198592944,0.00901564296339368,0.48169292404417663,Downregulated
Feature0758,Icacine,C22 H31 N O6,405.21526,NA,NA,Icacine-peak2,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,678690.713937271,558060.871186072,0.8222609499820732,-0.28233177944645066,0.01604528665254726,0.5000414976159331,Downregulated
Feature0757,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,510378.116178129,430621.3992550803,0.8437301396848832,-0.24514645661027581,0.44142052929769326,0.7146808569581701,Downregulated
Feature0756,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,14063901.859918233,17038579.193794366,1.2115115252868685,0.27680812942410865,0.5004970154249796,0.7417294916342253,Upregulated
Feature0755,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature0755,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,126057.80599777566,114726.743861586,0.9101121739625581,-0.1358837222728332,0.25911473345894714,0.7028461383187669,Downregulated
Feature0754,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,NA,Cytidine 5'-diphosphocholine,14,26,11,4,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,3345211.027681433,1934493.931561212,0.5782875625942231,-0.790141020911545,0.10344747964507951,0.6736684190877296,Downregulated
Feature0753,NA,C18 H28 O,260.21405,NA,NA,Feature0753,18,28,1,0,0,0,1.5555555555555556,0.05555555555555555,-1.4444444444444446,101.46666666666668,5,4,0.2352941176470588,0.2571428571428571,4,Lipid,1768741.7702859566,1234632.7622508733,0.6980288377829553,-0.5186414549179807,0.23367131496215385,0.6875073975489493,Downregulated
Feature0752,Pogostone,C12 H16 O4,224.10484,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,Pogostone,12,16,4,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,5,1,0.125,0.3,1,Lignin,139226.61685653034,119489.336379693,0.8582362990463517,-0.22055317382123993,0.10318188849604745,0.6736684190877296,Downregulated
Feature0751,NA,C13 H18 O9,318.09513,NA,NA,Feature0751,13,18,9,0,0,0,1.3846153846153846,0.6923076923076923,0,60.3,5,-4,-1,0.0588235294117647,-4,Tannin,179286.51388454967,146233.85873645067,0.8156433831415617,-0.29398958218776894,0.2660520369083504,0.7028461383187669,Downregulated
Feature0750,Acetylarginine,C8 H16 N4 O3,216.12223,NA,NA,Acetylarginine,8,16,3,4,0,0,2,0.375,0.25,53.175,3,0,-4,-1,-4,Protein,5923251.241924027,6415104.212334037,1.0830376680510758,0.11508342075366618,0.7824176649302691,0.907639449407689,Upregulated
Feature0749,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11096,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,8807651.395707041,6394276.119969543,0.7259910539926901,-0.46197632413176404,0.21396883255555846,0.6777335289635477,Downregulated
Feature0748,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",C11 H17 N O8,291.09544,NA,NA,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,8047105.4273726335,7108857.476376044,0.8834055351375052,-0.17885222301369746,0.11193778783514062,0.6736684190877296,Downregulated
Feature0747,NA,C6 H15 N O4 S,197.07221,NA,NA,Feature0747,6,15,4,1,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,706968.1721275783,821057.0262970503,1.1613776385804306,0.21583716145417392,0.5345205166615371,0.7543471763776491,Upregulated
Feature0746,NA,C10 H25 N10 O4 P,380.1797,NA,NA,Feature0746,10,25,4,10,0,1,2.5,0.4,0.7999999999999998,37.5,4,0,2.2,3,-11,Other,5697574.623247483,5287479.600482604,0.9280228781749357,-0.10776772291525168,0.6799936047576056,0.8434328503077431,Downregulated
Feature0745,4149853,C21 H41 N O4,371.30356,NA,NA,4149853,21,41,4,1,0,0,1.9523809523809523,0.1904761904761905,-1.4285714285714288,101.01428571428572,2,-2,-0.1875,-0.05555555555555555,-3,Lipid,251455.8414065597,227035.82422091268,0.9028854647040625,-0.14738510827061896,0.12542835181988227,0.6736684190877296,Downregulated
Feature0744,Terpendole I,C27 H35 N O5,453.2516,Biosynthesis of secondary metabolites;Other,NA,Terpendole I,27,35,5,1,0,0,1.2962962962962965,0.18518518518518515,-0.8148148148148149,83.52222222222223,11,6,0.23809523809523808,0.3191489361702128,5,Lignin,2052965.5645562932,880169.8688693524,0.4287309461323494,-1.2218555391265729,0.03280926334211925,0.5992830975343959,Downregulated
Feature0743,mycosporine,C11 H19 N O6,261.12118,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak2,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,33041924.0120291,30821945.698565,0.9328132855503237,-0.10033975868485097,0.496615937925622,0.7409615456815796,Downregulated
Feature0742,N-Benzylformamide,C8 H9 N O,135.06844,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,N-Benzylformamide,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,4376828.057351966,4977933.78505589,1.1373382092756004,0.18566133100185467,0.05574671599821472,0.6632182304416021,Upregulated
Feature0741,Arg-Glu,C11 H21 N5 O5,303.15426,NA,NA,Arg-Glu,11,21,5,5,0,0,1.9090909090909092,0.4545454545454546,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,4660408.525376697,4178966.2102915035,0.8966952548336352,-0.15731033163898667,0.5987945289609385,0.795085753247542,Downregulated
Feature0740,Mesalazine,C7 H7 N O3,153.04261,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,Mesalazine,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,3634379.2028623065,7131625.482646846,1.9622678549971435,0.9725219868681932,0.19037982008257123,0.6736684190877296,Upregulated
Feature0739,Fluoranthene,C16 H10,202.07828,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak1,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,30265583.0060236,31293652.012601566,1.0339682538536712,0.04819189096138493,0.8050743751261602,0.9186650985659187,Upregulated
Feature0738,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak2,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,1113476.60638949,1121756.3259771566,1.0074359169650757,0.01068807178840462,0.8968644043008236,0.9675787131014654,Upregulated
Feature0737,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,9938144.033073304,10400412.445334688,1.046514561544187,0.06559238586159206,0.8115896100632555,0.9216635045455188,Upregulated
Feature0736,1726033,C6 H13 N O6,195.07432,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak2,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,7945140.374383593,9156765.230075,1.1524988607624707,0.204765324560777,0.45003717364336676,0.7162293742239114,Upregulated
Feature0735,Norharman,C11 H8 N2,168.06878,NA,NA,Norharman,11,8,0,2,0,0,0.7272727272727273,0,-0.18181818181818168,65.48181818181817,9,9,0.7777777777777778,0.7777777777777778,7,Condensed HC,5863276.249135227,6213074.91167343,1.0596592498246684,0.08360041797686234,0.3666561374679217,0.7136536716603119,Upregulated
Feature0734,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11607,NA,Other,N1-Acetyl-5-methoxykynuramine,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,6905852.7436089935,6953583.08601057,1.0069115783631135,0.009936999076633516,0.9815900879813109,0.9929337204459302,Upregulated
Feature0733,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature0733,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,738859.2546654933,854055.6761587297,1.155911184391119,0.20903055115952004,0.6304629925431593,0.814953315245881,Upregulated
Feature0732,4-Acetamidobutanoic acid,C6 H11 N O3,145.07388,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak1,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,1204882.2202326069,1344826.2659896037,1.1161474901090167,0.15852768056264102,0.7812224014576528,0.907639449407689,Upregulated
Feature0731,N-Acetylglucosaminitol,C8 H17 N O6,223.10552,NA,NA,N-Acetylglucosaminitol-peak1,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,590851.6711253431,677760.5375093693,1.147090836213594,0.1979796404958252,0.03971948985226707,0.6189620501978286,Upregulated
Feature0730,D-Alanyl-D-alanine,C6 H12 N2 O3,160.08481,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,D-Alanyl-D-alanine,6,12,3,2,0,0,2,0.5,0,60.3,2,-1,-3,-0.6,-3,Protein,29839822.148557335,27345377.83787257,0.9164055235226874,-0.12594194054990965,0.36298594897530634,0.7136536716603119,Downregulated
Feature0729,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08924,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak1",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,1392672.1943071033,1304287.8447770667,0.9365361426103502,-0.09459342315415889,0.7830612861452505,0.907639449407689,Downregulated
Feature0728,cys-val,C8 H16 N2 O3 S,220.08814,NA,NA,cys-val-peak2,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,1584914.95758141,1235086.16652905,0.7792759861474203,-0.3597937353659766,0.04232931238269683,0.626552738766846,Downregulated
Feature0727,NA,C29 H30 O10,538.18408,NA,NA,Feature0727,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,438371.88362302934,496145.19719274936,1.1317906456322853,0.17860711855763037,0.6711026704942358,0.8394394607519873,Upregulated
Feature0726,2'-O-Methyladenosine,C11 H15 N5 O4,281.11245,NA,NA,2'-O-Methyladenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Lignin,5932178.75375571,6840436.59537784,1.153106957717197,0.20552633797796585,0.32849614589476317,0.707999712182741,Upregulated
Feature0725,Imidazoleacetic acid,C5 H6 N2 O2,126.04288,Metabolic pathways;Other,Other,Imidazoleacetic acid,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Lignin,6831979.20635503,6566859.829577933,0.9611943525046907,-0.05709992294622878,0.7232709623315681,0.8716541565370778,Downregulated
Feature0724,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10594,NA,NA,α-Aspartylphenylalanine-peak2,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,3885724.901843657,3639020.868032913,0.9365101647587841,-0.09463344151086724,0.4896192595251218,0.7383774317032079,Downregulated
Feature0723,Indole-3-lactic acid,C11 H11 N O3,205.07389,Metabolic pathways;Other,Other,Indole-3-lactic acid,11,11,3,1,0,0,1,0.2727272727272727,-0.18181818181818168,65.48181818181817,7,4,0.42857142857142855,0.5294117647058824,3,Lignin,1042659.7851592021,1078390.4402983997,1.0342687573144886,0.04861112227133731,0.9187892018078936,0.9725088410337925,Upregulated
Feature0722,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10622,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak3,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,1872122.1709903767,4507555.132741747,2.4077248817352515,1.2676705522172689,0.3416980053852104,0.7116802007632078,Upregulated
Feature0721,N-Acetylvaline,C7 H13 N O3,159.08955,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,6065306.2020954,5514869.9399130065,0.9092483967269068,-0.1372536181010866,0.7462464550035797,0.8899666293484348,Downregulated
Feature0720,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06372,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,14750510.060271833,13384504.419196766,0.9073926504579535,-0.14020112044314403,0.14136065033669298,0.6736684190877296,Downregulated
Feature0719,Prolylglycine,C7 H12 N2 O3,172.08478,NA,NA,Prolylglycine,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,26178734.977926366,31720643.1168536,1.2116950320021236,0.27702663677980904,0.3620583257795939,0.7136536716603119,Upregulated
Feature0718,NA,C10 H22 N2 O6,266.14776,NA,NA,Feature0718,10,22,6,2,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-5,-3.5,-0.8,-7,Amino Sugar,298024.7689005073,273702.3140028717,0.9183878072035165,-0.1228246064057619,0.12802128564729534,0.6736684190877296,Downregulated
Feature0717,Acetyl-L-methionine,C7 H13 N O3 S,191.06162,NA,NA,Acetyl-L-methionine-peak2,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,187195.79672851833,162696.38213510334,0.8691241201908748,-0.2023658709007818,0.29342705687431014,0.7028461383187669,Downregulated
Feature0716,NP-007735,C18 H24 O12,432.1269,NA,NA,NP-007735,18,24,12,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,7,-5,-0.8333333333333334,0.08333333333333333,-5,Tannin,186420.45533855967,2243728.2511338857,12.03584792805614,3.5892658784537965,0.3113879619686653,0.7028461383187669,Upregulated
Feature0715,NA,C16 H28 N2 O8,376.18453,NA,NA,Feature0715,16,28,8,2,0,0,1.75,0.5,-0.375,70.9875,4,-4,-1,-0.2,-6,Protein,316321.5829199657,380675.3976925943,1.2034442739524074,0.26716933869328935,0.29294785478186475,0.7028461383187669,Upregulated
Feature0714,HC blue 2,C12 H19 N3 O5,285.1325,NA,NA,HC blue 2-peak2,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,1804937.3939488863,1480470.5319699254,0.8202337305068048,-0.28589302199241323,0.8488649733790067,0.9413744745889566,Downregulated
Feature0713,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Stavudine,10,12,4,2,0,0,1.2,0.4,0.20000000000000015,54.599999999999994,6,2,0,0.3333333333333333,0,Lignin,260105.89977943234,208659.49753012366,0.8022097834269242,-0.31794853410088575,0.6395506460706786,0.8201291637679481,Downregulated
Feature0712,val-his,C11 H18 N4 O3,254.1379,NA,NA,val-his,11,18,3,4,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909093,-2,Lipid,16304360.898248734,13143510.123744,0.806134641263722,-0.31090727590957695,0.18697242002938985,0.6736684190877296,Downregulated
Feature0711,lamifiban,C24 H28 N4 O6,468.20096,NA,NA,lamifiban-peak3,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,3734926.0630491534,3234061.54365821,0.8658970724089667,-0.20773255024755252,0.1506455737026341,0.6736684190877296,Downregulated
Feature0710,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,738815.6020886523,1066533.5828959693,1.4435720900869569,0.5296431556611794,0.26527724694279464,0.7028461383187669,Upregulated
Feature0709,NA,C6 H19 N4 O P,194.12956,NA,NA,Feature0709,6,19,1,4,0,1,3.1666666666666665,0.16666666666666666,-1.666666666666667,107.8,0,-1,-Inf,-11,-6,Other,823959.0011535106,1281148.0097202882,1.5548686377923304,0.636792700220251,0.3061634864529419,0.7028461383187669,Upregulated
Feature0708,indospicine,C7 H15 N3 O2,173.11643,NA,NA,indospicine,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,858676.155998503,809455.6253922783,0.9426785869592604,-0.08516213739320876,0.7444559280707628,0.8895415881740104,Downregulated
Feature0707,ser-gln,C8 H15 N3 O5,233.10121,NA,NA,ser-gln,8,15,5,3,0,0,1.875,0.625,0.5,46.05,3,-2,-Inf,-1,-5,Amino Sugar,10884756.627879433,10599525.00872725,0.973795314961695,-0.03830953523101831,0.8883044132134617,0.9643125938227753,Downregulated
Feature0706,Isovalerylglutamic acid,C10 H17 N O5,231.11068,NA,NA,Isovalerylglutamic acid-peak6,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,373407.53055880766,239724.78400548332,0.6419923659459493,-0.6393719528005363,0.14290371896295015,0.6736684190877296,Downregulated
Feature0705,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",C9 H12 O4,184.07358,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",9,12,4,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Lignin,808085.0595871743,724421.9102871884,0.896467397451047,-0.15767697848749251,0.764868628657281,0.9016395639644531,Downregulated
Feature0704,NA,C26 H40 O3 S2,464.24195,Other,NA,Feature0704,26,40,3,0,2,0,1.5384615384615383,0.1153846153846154,-1.1538461538461542,93.1846153846154,7,4,0.09523809523809525,0.15555555555555556,2,Lipid,6218097.5992263565,3203112.48302919,0.5151274054346968,-0.9569987995689581,0.42533727656485415,0.7136536716603119,Downregulated
Feature0703,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",C21 H22 O7,386.13664,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",21,22,7,0,0,0,1.0476190476190477,0.3333333333333333,-0.3809523809523814,71.15714285714287,11,4,0.2857142857142857,0.42857142857142855,4,Lignin,233843.38749909165,210145.96262810566,0.8986611290384336,-0.1541508941866275,0.31479363058266363,0.7028461383187669,Downregulated
Feature0702,nicotianamine,C12 H21 N3 O6,303.14313,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,nicotianamine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,889940.6222656231,928621.5342353117,1.043464598650654,0.06138165539232548,0.6225426352531753,0.8121601742211405,Upregulated
Feature0701,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,3319143.513505033,4055286.739800647,1.2217871036007848,0.28899291744977856,0.7887241204745961,0.907639449407689,Upregulated
Feature0700,N-(2-morpholinophenyl)-2-furamide,C15 H16 N2 O3,272.11607,NA,NA,N-(2-morpholinophenyl)-2-furamide,15,16,3,2,0,0,1.0666666666666669,0.2,-0.2666666666666666,67.89999999999999,9,6,0.4,0.4782608695652174,4,Lignin,1267303.9384228888,2126604.20574678,1.6780538127209308,0.7467889816304087,0.02102161468172384,0.536051174383958,Upregulated
Feature0699,17-Methyl-6Z-octadecenoic acid,C19 H36 O2,296.27159,NA,NA,17-Methyl-6Z-octadecenoic acid,19,36,2,0,0,0,1.894736842105263,0.10526315789473684,-1.6842105263157894,108.3,2,0,0,0.05555555555555555,0,Lipid,13741743.603315083,3945117.7580956332,0.2870900427180075,-1.8004248011603385,0.21751841475782457,0.6777335289635477,Downregulated
Feature0698,NA,C23 H33 N3 O5,431.24203,NA,NA,Feature0698,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,130815.284971297,119056.58344547133,0.910112174365513,-0.13588372163407567,0.2591147355801752,0.7028461383187669,Downregulated
Feature0697,threonylphenylalanine,C13 H18 N2 O4,266.12655,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak4,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,155375.94801257233,267836.074830675,1.7237936646990104,0.7855870965090131,0.3562233049058013,0.7136536716603119,Upregulated
Feature0696,NA,C27 H33 N8 O7 P,612.22109,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Feature0696,27,33,7,8,0,1,1.2222222222222223,0.25925925925925924,0,60.3,16,9,0,0.2413793103448276,0,Lignin,732706.4007437327,641058.4960573444,0.8749186514634494,-0.1927792111836772,0.16780675327537484,0.6736684190877296,Downregulated
Feature0695,Phenacetin,C10 H13 N O2,179.09465,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,3506786.081231767,1319802.3943668376,0.3763566878032246,-1.4098274867117466,0.013196011077789798,0.5000414976159331,Downregulated
Feature0694,2181,C11 H15 N O2,193.11028,NA,NA,2181,11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Lignin,266237.52670687967,127884.25271293799,0.48033894505688934,-1.0578753103331604,0.00488859312734685,0.34281259305519785,Downregulated
Feature0693,N-Acetyl-L-leucine,C8 H15 N O3,173.10517,Other,NA,N-Acetyl-L-leucine-peak4,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,7196905.83317737,5701367.4209721405,0.7921970292690403,-0.33606880372670206,0.21841440460211606,0.6777335289635477,Downregulated
Feature0692,NA,C20 H30 N4 O6,422.21665,NA,NA,Feature0692,20,30,6,4,0,0,1.5,0.3,-0.2999999999999998,68.85,8,2,-0.2,0.07692307692307693,-2,Lipid,1801006.59593359,1909330.5830452067,1.0601463577957995,0.08426344883607981,0.6968680934623985,0.856346251177756,Upregulated
Feature0691,1â€²-Acetoxyeugenol acetate,C14 H16 O5,264.09978,NA,NA,1â€²-Acetoxyeugenol acetate,14,16,5,0,0,0,1.1428571428571428,0.35714285714285715,-0.4285714285714288,72.51428571428572,7,2,0.2222222222222222,0.391304347826087,2,Lignin,330817.89164861,322675.528277487,0.97538717349734,-0.03595309406725105,0.918363021212848,0.9725088410337925,Downregulated
Feature0690,Val-lys,C11 H23 N3 O3,245.17392,NA,NA,Val-lys,11,23,3,3,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,5348269.470360413,3954332.99079883,0.7393668199991338,-0.4356377926345516,0.09084284563297029,0.6736684190877296,Downregulated
Feature0689,Crotanecine,C8 H13 N O3,171.08958,Other,NA,Crotanecine-peak2,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,626965.3177098574,535991.3251546737,0.8548978867164643,-0.22617598731647,0.8478478373446676,0.9413744745889566,Downregulated
Feature0688,thiodiglycol,C4 H10 O2 S,122.04011,NA,NA,thiodiglycol,4,10,2,0,1,0,2.5,0.5,-1,88.8,0,-2,-3,-1,-3,Other,883925.9589856826,959186.817293225,1.085143848919094,0.11788630199352858,0.931271489293486,0.9774430411480743,Upregulated
Feature0687,NA,C17 H29 N3 O7,387.20043,NA,NA,Feature0687,17,29,7,3,0,0,1.7058823529411764,0.4117647058823529,-0.35294117647058787,70.35882352941175,5,-2,-0.7142857142857143,-0.14285714285714285,-5,Protein,10518603.071222933,8921623.93417239,0.8481757390941389,-0.23756487767943263,0.037025150120369936,0.5992830975343959,Downregulated
Feature0686,NA,C16 H22 N2 O8,370.13769,NA,NA,Feature0686,16,22,8,2,0,0,1.375,0.5,0,60.3,7,-1,-0.5,0.1,-3,Lignin,5881303.451163753,5443602.931634457,0.9255776337399005,-0.11157409224229908,0.058101422726641705,0.6632182304416021,Downregulated
Feature0685,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10596,NA,NA,α-Aspartylphenylalanine-peak1,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,19116138.17858899,11742726.936949303,0.6142834304316618,-0.7030236260515395,0.5834932578425049,0.7831214237493425,Downregulated
Feature0684,N-Acetyl-L-leucine,C8 H15 N O3,173.10514,Other,NA,N-Acetyl-L-leucine-peak3,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,5686913.720762993,5341161.52100303,0.9392021372686529,-0.09049240340769131,0.6332696418186523,0.8176392843734498,Downregulated
Feature0683,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",C23 H28 O7,416.18357,NA,NA,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",23,28,7,0,0,0,1.2173913043478262,0.30434782608695654,-0.6086956521739131,77.64782608695651,10,3,0.1875,0.3333333333333333,3,Lignin,286193.8785860517,247735.07486065032,0.8656197542889174,-0.20819467163591668,0.09606046935789428,0.6736684190877296,Downregulated
Feature0682,MFCD00672375,C5 H9 N O5,163.04806,Metabolic pathways;Other,NA,MFCD00672375,5,9,5,1,0,0,1.8,1,0.7999999999999998,37.5,2,-3,4,-1,-4,Carbohydrate,11894448.330559334,11677513.882252634,0.9817617057741678,-0.026555200303138786,0.8210384975373045,0.9241442293136327,Downregulated
Feature0681,Phe-his,C15 H18 N4 O3,302.13799,NA,NA,Phe-his,15,18,3,4,0,0,1.2,0.2,0,60.3,9,6,0.25,0.3684210526315789,2,Lignin,2121683.3380467067,1200939.8311715033,0.5660316078445189,-0.8210454778596646,0.1612066595810691,0.6736684190877296,Downregulated
Feature0680,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",C10 H14 O4,198.08925,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",10,14,4,0,0,0,1.4,0.4,-0.5999999999999996,77.39999999999999,4,0,0,0.25,0,Lignin,3344441.8336585467,2617605.605683527,0.7826733834446987,-0.35351771124153347,0.34616447701750447,0.7116802007632078,Downregulated
Feature0679,lamifiban,C24 H28 N4 O6,468.20102,NA,NA,lamifiban-peak2,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,894270.3683614474,1351369.6959032433,1.5111422045430503,0.5956394302814728,0.25274317546303865,0.7028461383187669,Upregulated
Feature0678,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10008,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak3",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,1121348.1241071913,979680.2614513877,0.8736629066298225,-0.1948513560569414,0.5522448491818066,0.7640181513957917,Downregulated
Feature0677,NA,C14 H27 N O9,353.16869,Biosynthesis of secondary metabolites;Other,NA,Feature0677,14,27,9,1,0,0,1.9285714285714288,0.6428571428571429,-0.4285714285714288,72.51428571428572,2,-7,-2,-0.4117647058823529,-8,Amino Sugar,149773.33451603932,290484.55866308836,1.9394945008183695,0.955680685303036,0.371337836098194,0.7136536716603119,Upregulated
Feature0676,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07865,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak1",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,597103.0386639477,452647.945891654,0.7580734254919883,-0.39959050313626326,0.7273457488340771,0.8746858844499834,Downregulated
Feature0675,met-pro,C10 H18 N2 O3 S,246.10387,NA,NA,met-pro,10,18,3,2,1,0,1.8,0.3,-0.4000000000000003,71.7,3,0,-0.75,-0.2727272727272727,-3,Lipid,1895592.85056678,1337905.0144313765,0.7057976685401322,-0.5026734304131721,0.1775872444599752,0.6736684190877296,Downregulated
Feature0674,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,456280.603312533,10590924.028120503,23.21142724725067,4.536763330160189,0.4249090533167147,0.7136536716603119,Upregulated
Feature0673,NA,C18 H35 N5 O8,449.24869,NA,NA,Feature0673,18,35,8,5,0,0,1.9444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,-4,-1.8,-0.5555555555555556,-9,Protein,3682942.3969522766,3269817.1059629135,0.8878273818968132,-0.17164889071009626,0.5799928015506758,0.7822997277740023,Downregulated
Feature0672,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07395,NA,NA,Phenyl D-glucopyranosiduronic acid-peak3,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,27837163.580399536,22924174.361417234,0.8235097047587997,-0.2801424432054412,0.27277441782883055,0.7028461383187669,Downregulated
Feature0671,Borrelidin,C28 H43 N O6,489.30914,NA,NA,Borrelidin,28,43,6,1,0,0,1.5357142857142858,0.21428571428571427,-1,88.8,8,2,0.04761904761904761,0.16666666666666666,1,Lipid,694402.6788353933,567645.2028351723,0.8174582560470384,-0.2907830344070142,0.13380518152400026,0.6736684190877296,Downregulated
Feature0670,L-Ergothioneine,C9 H15 N3 O2 S,229.08852,NA,NA,L-Ergothioneine,9,15,2,3,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,3531095.7657043366,3475964.9620681168,0.9843870550972658,-0.02270240871844589,0.9008828493010425,0.9678405764193425,Downregulated
Feature0669,Propoxur,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Propoxur,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,11200632.979326833,10264717.96848538,0.916440882174348,-0.12588627658237692,0.15746182677410275,0.6736684190877296,Downregulated
Feature0668,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0668,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Lignin,275625.0228578233,248649.458205366,0.9021294787651694,-0.1485935827297823,0.15469107750330716,0.6736684190877296,Downregulated
Feature0667,NA,C5 H10 N9 O2 P,259.06957,NA,NA,Feature0667,5,10,2,9,0,1,2,0.4,3.2,-30.90000000000001,6,4,0.8571428571428571,0.8333333333333334,-6,Protein,18837948.916623868,15680983.769927533,0.8324146030616731,-0.2646258203717066,0.12338762764335971,0.6736684190877296,Downregulated
Feature0666,NA,C11 H19 N5 O2,253.15395,NA,NA,Feature0666,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,16230741.6005277,16593385.279032767,1.0223430134882607,0.03187932624770688,0.8447396174390649,0.9413744745889566,Upregulated
Feature0665,NA,C16 H30 N2 O9,394.19526,NA,NA,Feature0665,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,2713860.3943502265,2921902.1219599564,1.076658964493102,0.10656134352248511,0.7574852390045685,0.895572642953768,Upregulated
Feature0664,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak1,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,1219638.3208266334,957127.8713990527,0.7847636918708333,-0.3496697999785607,0.2232651122046184,0.6807159127542984,Downregulated
Feature0663,NA,C9 H19 N O9,285.106,NA,NA,Feature0663,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,5298263.861917097,5275086.093150357,0.9956254030809342,-0.006325054171326169,0.9664076980080121,0.9883481899775874,Downregulated
Feature0662,NA,C13 H25 N3 O4,287.18454,NA,NA,Feature0662,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,15865821.530380033,12028768.65561271,0.7581560546726122,-0.3994332595121335,0.33683384914684317,0.7109768007209386,Downregulated
Feature0661,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak1,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,392722.04917315766,437596.505776176,1.1142651824553718,0.15609261857125223,0.6182884861653797,0.8104201886420047,Upregulated
Feature0660,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,NA,N8-Acetylspermidine,9,21,1,3,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666664,1,0,-0.6,-0.4545454545454546,-3,Lipid,276213.39076464303,488078.0208569766,1.7670324364283265,0.8213285228803534,0.43055289153967574,0.7136536716603119,Upregulated
Feature0659,NA,C19 H41 N O2,315.3138,NA,NA,Feature0659,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,161887.981112799,142326.179646175,0.8791645844728035,-0.1857948237441593,0.18286057111675263,0.6736684190877296,Downregulated
Feature0658,Guanine,C5 H5 N5 O,151.0494,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak1,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,2253761.0802726434,5663391.562872424,2.5128624380128652,1.329331695719676,0.4607810811643791,0.7162499996920834,Upregulated
Feature0657,NA,C18 H34 N2 O8,406.23161,NA,NA,Feature0657,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,2776131.6444706,2699659.6342952535,0.9724537522103245,-0.04029845460175191,0.902103694602158,0.9678405764193425,Downregulated
Feature0656,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,C9 H15 N3 O3 S,245.08343,NA,NA,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,9,15,3,3,1,0,1.6666666666666667,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,1418689.17020725,1718951.80647996,1.211647937108624,0.27697056253016483,0.3924421837606503,0.7136536716603119,Upregulated
Feature0655,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Lignin,11841006.036068866,11011648.022262,0.9299588218027623,-0.1047612592002415,0.2153869042447977,0.6777335289635477,Downregulated
Feature0654,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07396,NA,NA,Phenyl D-glucopyranosiduronic acid-peak2,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,10959770.7660261,2679166.4238164467,0.2444546041164951,-2.0323615172218883,1.7546979623361974e-5,0.019687711137412134,Downregulated
Feature0653,Glu-Glu,C10 H16 N2 O7,276.09576,Other,NA,Glu-Glu,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,16315144.058826333,16583446.643783934,1.0164450025074987,0.02353215639638758,0.8538793078338123,0.9424578976609502,Upregulated
Feature0652,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",C25 H34 O3,382.25081,NA,NA,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",25,34,3,0,0,0,1.36,0.12,-1.12,92.22,9,6,0.2727272727272727,0.3191489361702128,6,Unsaturated HC,564502.90548383235,684585.4551446093,1.212722642335835,0.27824963431598926,0.6401922991072522,0.8201291637679481,Upregulated
Feature0651,387122,C12 H18 O,178.13575,NA,NA,387122,12,18,1,0,0,0,1.5,0.08333333333333333,-1.333333333333333,98.29999999999998,4,3,0.2727272727272727,0.30434782608695654,3,Lipid,631610.8570609661,1000657.1641901421,1.5842937989483514,0.6638399004313231,0.424924929044375,0.7136536716603119,Upregulated
Feature0650,NA,C19 H41 N O2,315.31381,NA,NA,Feature0650,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,235701.43935750634,212403.83575311632,0.901156294726513,-0.1501507490351842,0.05308616635427202,0.6632182304416021,Downregulated
Feature0649,NA,C12 H21 N O8,307.12685,NA,NA,Feature0649,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,1756543.14796905,1980766.3296681533,1.1276502555364805,0.173319680464763,0.13337036587002601,0.6736684190877296,Upregulated
Feature0648,NA,C62 H106 N2 O14 P2 S2,1228.65592,NA,NA,Feature0648,62,106,14,2,2,2,1.7096774193548387,0.2258064516129032,-1.258064516129032,96.1548387096774,12,-2,-0.1904761904761905,-0.02040816326530612,-8,Lipid,125299.44149451566,111517.89843653367,0.8900111373713887,-0.16810470517918508,0.19040125713707712,0.6736684190877296,Downregulated
Feature0647,gamma glutamyl ornithine,C10 H19 N3 O5,261.13251,NA,NA,gamma glutamyl ornithine,10,19,5,3,0,0,1.9,0.5,0,60.3,3,-2,-2.5,-0.5555555555555556,-5,Protein,2356997.5545914234,10681802.293707313,4.531953065839716,2.1801329202866477,0.4195128558173559,0.7136536716603119,Upregulated
Feature0646,NA,C20 H28 N2 O9,440.17967,NA,NA,Feature0646,20,28,9,2,0,0,1.4,0.45,-0.20000000000000015,66,8,-1,-0.3333333333333333,0.1111111111111111,-3,Lignin,480277.7781182943,620015.435486313,1.2909517444581846,0.3684350739742973,0.5226631608662111,0.7518308544767806,Upregulated
Feature0645,Anhalamine,C11 H15 N O3,209.10518,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak2,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,627133.013728074,291028.88627066836,0.4640624554918727,-1.1076091124551517,0.1871370681573161,0.6736684190877296,Downregulated
Feature0644,NA,C24 H40 N8 O7,552.30201,NA,NA,Feature0644,24,40,7,8,0,0,1.6666666666666667,0.2916666666666667,-0.08333333333333304,62.67499999999999,9,2,-0.6666666666666666,-0.2,-6,Lipid,95107.92648220116,250736.23028969934,2.6363336849386894,1.398532986104252,0.19374178298697434,0.6763335886956496,Upregulated
Feature0643,MFCD02728197,C14 H20 N2 O4,280.14234,NA,NA,MFCD02728197,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,1900838.8188748537,2098216.24963346,1.1038370159524824,0.14252717063469927,0.8783406813718424,0.9558663865171747,Upregulated
Feature0642,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,13320441.147434,11670485.045361504,0.8761335241220343,-0.19077733931999405,0.2204748111155926,0.6777335289635477,Downregulated
Feature0641,DiisopropylSulfate,C6 H14 O4 S,182.0613,NA,NA,DiisopropylSulfate,6,14,4,0,1,0,2.3333333333333335,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,8239247.494070889,8578030.15166416,1.0411181552486517,0.05813380765573117,0.3576744747998283,0.7136536716603119,Upregulated
Feature0640,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C24 H32 O8,448.20981,Other,NA,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",24,32,8,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,9,1,0.0625,0.25,1,Lignin,407285.83229822735,360153.7559399757,0.8842776433142902,-0.1774286803119427,0.08203937611537314,0.6736684190877296,Downregulated
Feature0639,NA,C17 H25 N3 O4,335.18462,NA,NA,Feature0639,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,972542.9505848873,1358978.6627889236,1.3973456513891072,0.48268893403563495,0.4709453834867107,0.7238366031124512,Upregulated
Feature0638,NA,C7 H9 O7 P,236.00858,NA,NA,Feature0638,7,9,7,0,0,1,1.2857142857142858,1,0,60.3,4,-3,4,-0.2,-4,Tannin,1287220.00782245,1214667.7643742799,0.943636485598989,-0.08369689358944958,0.7155254823528199,0.8660405514561639,Downregulated
Feature0637,MFCD00020424,C18 H20 N2 O3,312.14738,NA,NA,MFCD00020424,18,20,3,2,0,0,1.1111111111111112,0.16666666666666666,-0.44444444444444464,72.96666666666667,10,7,0.38461538461538464,0.4482758620689655,5,Lignin,2492630.46971396,4223220.400892713,1.6942825870925609,0.7606745198863961,0.20224345174195726,0.6777335289635477,Upregulated
Feature0636,NA,C16 H22 N2 O4,306.15784,NA,NA,Feature0636,16,22,4,2,0,0,1.375,0.25,-0.5,74.55,7,3,0.1,0.25,1,Lignin,261602.04981454267,234797.37210747635,0.8975364385482876,-0.1559575836444043,0.2898317798308382,0.7028461383187669,Downregulated
Feature0635,Panthenol,C9 H19 N O4,205.13142,Other,NA,Panthenol,9,19,4,1,0,0,2.111111111111111,0.4444444444444444,-0.8888888888888893,85.63333333333334,1,-3,-1,-0.3333333333333333,-4,Protein,685195.7295454566,492687.18804398336,0.7190459117000348,-0.47584420396231264,0.19198405884514028,0.6751889597464394,Downregulated
Feature0634,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,4282062.583251653,3735734.3425548635,0.8724146996744904,-0.19691401614113244,0.46571870962557105,0.7204424122401946,Downregulated
Feature0633,Erythritol,C4 H10 O4,122.05787,ABC transporters,NA,Erythritol,4,10,4,0,0,0,2.5,1,-0.5,74.55,0,-4,-Inf,-1,-4,Carbohydrate,2985465.9688115167,2343645.4947823533,0.7850183252014541,-0.34920176270643194,0.21821582491438324,0.6777335289635477,Downregulated
Feature0632,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.0794,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak2",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,11968899.831275167,12987139.654138766,1.0850738027068203,0.1177931727877645,0.3492468319998607,0.7136536716603119,Upregulated
Feature0631,NA,C76 H121 N10 O14 P3,1490.82761,NA,NA,Feature0631,76,121,14,10,0,3,1.5921052631578947,0.18421052631578944,-1.026315789473684,89.55,23,9,-0.08163265306122448,0.05357142857142857,-4,Lipid,222695.428256991,8830759.313356306,39.65397665535186,5.309393647153978,0.4249688239852266,0.7136536716603119,Upregulated
Feature0630,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,4101202.31831195,2544056.41601441,0.6203196571539881,-0.6889162520521162,0.1666623109354333,0.6736684190877296,Downregulated
Feature0629,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08007,NA,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Lignin,5099120.835370443,4260591.618784353,0.8355541585189417,-0.2591947517063302,0.10234511871973051,0.6736684190877296,Downregulated
Feature0628,pro-asn,C9 H15 N3 O4,229.10627,NA,NA,pro-asn,9,15,4,3,0,0,1.6666666666666667,0.4444444444444444,0.22222222222222232,53.96666666666666,4,0,-1.5,-0.25,-3,Protein,756379.9560356986,1001253.5069064336,1.3237441036303423,0.404624258017642,0.14297529776670198,0.6736684190877296,Upregulated
Feature0627,NA,C15 H27 N O13,429.14831,NA,NA,Feature0627,15,27,13,1,0,0,1.8,0.8666666666666667,0.1333333333333333,56.5,3,-10,-11,-0.6,-11,Carbohydrate,22859496.1222334,10649219.381930307,0.4658553856562376,-1.1020459227892851,0.1311842220654867,0.6736684190877296,Downregulated
Feature0626,NA,C6 H2 O4,137.99529,NA,NA,Feature0626,6,2,4,0,0,0,0.3333333333333333,0.6666666666666666,1,31.799999999999997,6,2,1,1,2,Condensed HC,20293903.71421413,15195913.59554767,0.7487920416663967,-0.41736299317843373,0.26966303180025153,0.7028461383187669,Downregulated
Feature0625,NA,C12 H12 N6 O3,288.09707,NA,NA,Feature0625,12,12,3,6,0,0,1,0.25,1,31.799999999999997,10,7,0.3333333333333333,0.5555555555555556,1,Lignin,506757.299777995,441189.0645671603,0.8706121544977065,-0.19989793335199038,0.27824044604214243,0.7028461383187669,Downregulated
Feature0624,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,470154.2939667743,584644.4521964997,1.2435161386355782,0.31442523130104216,0.5122924751300622,0.7463670402827399,Upregulated
Feature0623,N-Acetylglucosamine 1-phosphate,C8 H16 N O9 P,301.05635,Metabolic pathways;Other,Other,N-Acetylglucosamine 1-phosphate,8,16,9,1,0,1,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,1759409.6278514366,1438804.8694966333,0.8177770808573324,-0.2902204646432973,0.20386057013922898,0.6777335289635477,Downregulated
Feature0622,NA,C14 H27 N3 O4,301.20023,NA,NA,Feature0622,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,7720762.534879937,6145265.70276171,0.7959402552532038,-0.32926795141085147,0.41090021674068833,0.7136536716603119,Downregulated
Feature0621,NA,C21 H33 N3 O2,359.25734,NA,NA,Feature0621,21,33,2,3,0,0,1.5714285714285714,0.09523809523809525,-0.9523809523809526,87.44285714285715,7,5,0.125,0.17647058823529413,2,Lipid,148196.67606052835,131235.60962345934,0.8855502910865454,-0.1753538538154217,0.1959076794350144,0.6763335886956496,Downregulated
Feature0620,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",C18 H18 N2 O2,294.13684,Biosynthesis of secondary metabolites;Other,NA,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",18,18,2,2,0,0,1,0.1111111111111111,-0.44444444444444464,72.96666666666667,11,9,0.5,0.5333333333333333,7,Unsaturated HC,2582370.538939927,2315444.506075023,0.8966352702527044,-0.1574068441962207,0.316146610473645,0.7028461383187669,Downregulated
Feature0619,NA,C10 H24 N2 O6 S,300.13557,NA,NA,Feature0619,10,24,6,2,1,0,2.4,0.6,-0.4000000000000003,71.7,0,-6,-9,-1.5,-9,Other,596761.9051453964,500381.1616320907,0.8384938068561477,-0.25412796685316064,0.06775472138301031,0.6632182304416021,Downregulated
Feature0618,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26122,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak1,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,1284702.6850197096,994849.146567158,0.7743808417057175,-0.36888483431779645,0.6710230848622578,0.8394394607519873,Downregulated
Feature0617,NA,C15 H28 N2 O9,380.17959,NA,NA,Feature0617,15,28,9,2,0,0,1.8666666666666667,0.6,-0.2666666666666666,67.89999999999999,3,-6,-2,-0.4117647058823529,-8,Amino Sugar,429988.795650106,685891.0192772674,1.5951369575578342,0.6736802982891167,0.2666315227729607,0.7028461383187669,Upregulated
Feature0616,4-Methyleneglutamic acid,C6 H9 N O4,159.05318,Other,NA,4-Methyleneglutamic acid-peak2,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,2376542.60155168,2561921.7179005034,1.0780037000926417,0.10836212994212885,0.38546015886311374,0.7136536716603119,Upregulated
Feature0615,threonylphenylalanine,C13 H18 N2 O4,266.12654,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak3,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,137347.144385441,122665.36706925434,0.893104604526871,-0.16309893455313007,0.16453911556971226,0.6736684190877296,Downregulated
Feature0614,CI-976,C23 H39 N O4,393.28787,NA,NA,CI-976,23,39,4,1,0,0,1.6956521739130437,0.17391304347826086,-1.2173913043478262,94.99565217391304,5,1,0,0.1,0,Lipid,963977.0982410656,819670.5768638677,0.850300882001752,-0.23395466050501174,0.10843988476947027,0.6736684190877296,Downregulated
Feature0613,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak2,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,13526006.542495733,14812420.2889357,1.0951066926071888,0.13107143365919002,0.6077901877379266,0.7994614192754439,Upregulated
Feature0612,NA,C13 H27 N O11,373.15852,NA,NA,Feature0612,13,27,11,1,0,0,2.076923076923077,0.8461538461538461,-0.1538461538461542,64.6846153846154,1,-10,-11,-0.8461538461538461,-11,Carbohydrate,129028.61511265399,731524.9186627831,5.669478185316441,2.503215956666684,0.435061596627142,0.7136536716603119,Upregulated
Feature0611,Methionylleucine,C11 H22 N2 O3 S,262.13517,NA,NA,Methionylleucine-peak2,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,2496379.5547234467,1789270.5205018367,0.7167461843357611,-0.48046577572086985,0.020225223239750408,0.536051174383958,Downregulated
Feature0610,2-ethyl-1H-perimidine,C13 H12 N2,196.10009,NA,NA,2-ethyl-1H-perimidine,13,12,0,2,0,0,0.9230769230769232,0,-0.4615384615384617,73.45384615384616,9,9,0.6363636363636364,0.6363636363636364,7,Unsaturated HC,141941.883061507,206671.08643469366,1.4560261000985726,0.54203621690013,0.5190535964036201,0.7495214094785866,Upregulated
Feature0609,NA,C12 H21 N O8,307.12682,NA,NA,Feature0609,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,19387780.583761867,16344006.733873466,0.8430055551362234,-0.2463859567910903,0.1984248580707419,0.6777335289635477,Downregulated
Feature0608,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak2,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,152029.754437951,809287.1270835693,5.323215380275244,2.4122979396935698,0.44718506767629534,0.7155219105026039,Upregulated
Feature0607,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Lignin,161417.547430742,417101.41247304966,2.5839905209315095,1.3696007776826944,0.32045559241664684,0.7028461383187669,Upregulated
Feature0606,uridine 5′-diphosphate,C9 H14 N2 O12 P2,404.00229,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,uridine 5′-diphosphate,9,14,12,2,0,2,1.5555555555555556,1.3333333333333333,0.6666666666666665,41.3,5,-7,1.5714285714285714,5,-11,Carbohydrate,570090.045416222,459029.20339687966,0.8051871929490421,-0.3126038694932943,0.09806659241593801,0.6736684190877296,Downregulated
Feature0605,DH2090000,C9 H10 O5,198.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak2,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,413339.572754032,470371.90451371163,1.1379793649557435,0.1864743974108156,0.454576491353288,0.7162499996920834,Upregulated
Feature0604,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",C6 H11 N O5,177.06376,Other,NA,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",6,11,5,1,0,0,1.8333333333333333,0.8333333333333334,0.3333333333333335,50.8,2,-3,-Inf,-0.6,-4,Carbohydrate,11234863.970136767,13632140.101664966,1.2133782961592028,0.27902941105778256,0.0608505646908109,0.6632182304416021,Upregulated
Feature0603,3-Hydroxyhexadecadienoylcarnitine,C23 H41 N O5,411.2985,NA,NA,3-Hydroxyhexadecadienoylcarnitine,23,41,5,1,0,0,1.7826086956521738,0.21739130434782608,-1.2173913043478262,94.99565217391304,4,-1,-0.1176470588235294,0.02564102564102564,-2,Lipid,250404.13060833467,211705.08922779432,0.8454536621000442,-0.24220240978545232,0.0971055509436263,0.6736684190877296,Downregulated
Feature0602,NA,C12 H21 N O8,307.12679,NA,NA,Feature0602,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,4428933.261742136,9845215.74883339,2.2229316106155865,1.1524635639548886,0.4692206242059585,0.723109865679291,Upregulated
Feature0601,NA,C17 H32 N2 O8,392.21597,NA,NA,Feature0601,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,741973.5517860977,892472.377063833,1.2028358354761441,0.2664397551442596,0.2809721868854446,0.7028461383187669,Upregulated
Feature0600,Maleic acid,C4 H4 O4,116.01093,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Tyrosine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of purine nucleotide salvage;Other,Maleic acid,4,4,4,0,0,0,1,1,1,31.799999999999997,3,-1,-Inf,0.5,-1,Tannin,808611.2396173794,617164.390869425,0.7632399361174553,-0.3897914333300682,0.22716298868907722,0.6843823216756625,Downregulated
Feature0599,NA,C12 H21 N3 O4,271.15326,NA,NA,Feature0599,12,21,4,3,0,0,1.75,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,0,-0.6,-0.14285714285714285,-3,Protein,4082825.7927610264,4131345.858430913,1.0118839421843357,0.017043829916839157,0.9569816918734707,0.9868873697445166,Upregulated
Feature0598,(Ac)2-L-Lys-D-Ala,C13 H23 N3 O5,301.16384,NA,NA,(Ac)2-L-Lys-D-Ala,13,23,5,3,0,0,1.7692307692307692,0.38461538461538464,-0.3076923076923075,69.06923076923076,4,-1,-0.8,-0.2,-4,Protein,1384419.2568180633,1614853.3609607967,1.166448207801126,0.22212225073634262,0.14642183537785833,0.6736684190877296,Upregulated
Feature0597,1-Naphthol,C10 H8 O,144.05749,Other,NA,1-Naphthol,10,8,1,0,0,0,0.8,0.1,-0.5999999999999996,77.39999999999999,7,6,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,160504.91391375865,5778880.941832087,36.004386413597,5.170100775654599,0.009833222466733916,0.5000414976159331,Upregulated
Feature0596,thr-pro,C9 H16 N2 O4,216.11107,Metabolic pathways;Other,Other,thr-pro-peak2,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,21724474.112660233,18821963.479734667,0.8663944352404789,-0.20690411818852195,0.16654701120769663,0.6736684190877296,Downregulated
Feature0595,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13227,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak1,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,12976738.524931934,12181212.717902567,0.9386960132161914,-0.0912700629181947,0.5673196053053726,0.7753137602346262,Downregulated
Feature0594,Nonivamide,C17 H27 N O3,293.199,NA,NA,Nonivamide,17,27,3,1,0,0,1.588235294117647,0.17647058823529413,-1.0588235294117645,90.47647058823529,5,2,0.07692307692307693,0.1724137931034483,1,Lipid,464086.7833602863,453840.52939423866,0.9779216854833525,-0.03220915986189975,0.862400619474518,0.945243606173105,Downregulated
Feature0593,NA,C18 H34 N2 O8,406.23163,NA,NA,Feature0593,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,1218518.8952161965,1313507.4624930518,1.077954119258858,0.10829577426263136,0.6599777202696823,0.8325662928299055,Upregulated
Feature0592,butalbital,C11 H16 N2 O3,224.11607,NA,NA,butalbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,7824511.79672976,8235930.104344433,1.0525807000235625,0.07393084712595242,0.8682487545776584,0.9482111623798329,Upregulated
Feature0591,Arg-pro,C11 H21 N5 O3,271.16445,NA,NA,Arg-pro,11,21,3,5,0,0,1.9090909090909092,0.2727272727272727,0,60.3,4,1,-1.3333333333333333,-0.5555555555555556,-4,Lipid,2858494.11564644,2171274.0512522333,0.7595866786527234,-0.3967134906245142,0.3326292231673256,0.708700388691482,Downregulated
Feature0590,NA,C10 H18 N2 O7,278.11141,NA,NA,Feature0590,10,18,7,2,0,0,1.8,0.7,0.20000000000000015,54.599999999999994,3,-4,-6,-0.5555555555555556,-6,Amino Sugar,437246.5216561567,475846.64823800564,1.088280008347793,0.12204980169958742,0.24812575415064425,0.7019200023813293,Upregulated
Feature0589,Paracetamol,C8 H9 N O2,151.06336,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak2,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,297116.51628305967,142626.59633485068,0.4800359068526903,-1.0587857709268305,0.03516778857019874,0.5992830975343959,Downregulated
Feature0588,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.0957,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak1,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,3979271.9920379366,2783539.00430858,0.6995096112751579,-0.5155842147042731,0.14418406444576967,0.6736684190877296,Downregulated
Feature0587,1-linoleoyl-sn-glycero-3-phosphoethanolamine,C23 H44 N O7 P,477.28563,NA,NA,1-linoleoyl-sn-glycero-3-phosphoethanolamine,23,44,7,1,0,1,1.9130434782608696,0.30434782608695654,-1.391304347826087,99.95217391304348,3,-4,-0.42857142857142855,-0.14285714285714285,-6,Protein,506877.8009376317,408323.8082916413,0.8055665636496934,-0.3119242917038697,0.05084158624836076,0.6537090145871882,Downregulated
Feature0586,NA,C17 H29 N O14,471.15895,NA,NA,Feature0586,17,29,14,1,0,0,1.7058823529411764,0.8235294117647058,0.11764705882352944,56.94705882352941,4,-10,-5.5,-0.4444444444444444,-11,Carbohydrate,12708161.388135932,14875233.266329465,1.1705259960120324,0.22715697537361262,0.34535576564658926,0.7116802007632078,Upregulated
Feature0585,lys-leu,C12 H25 N3 O3,259.1896,NA,NA,lys-leu-peak2,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,8338021.43167465,11086109.843313143,1.3295851940604275,0.41097622180683907,0.6926735862940832,0.8532285220601825,Upregulated
Feature0584,(+)-sesamin monocatechol,C19 H18 O6,342.11045,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak2,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,849099.432889472,743328.7433250287,0.8754319159011715,-0.1919331131573769,0.07845979046265068,0.6736684190877296,Downregulated
Feature0583,(2S)-2-Amino-4-hexynoic acid,C6 H9 N O2,127.06329,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,(2S)-2-Amino-4-hexynoic acid,6,9,2,1,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,1,0,0.25,0,Protein,650631.5708935,466153.91856242,0.7164637245042684,-0.4810344340882274,0.277520690016947,0.7028461383187669,Downregulated
Feature0582,DL-Lactic Acid,C3 H6 O3,90.03171,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,DL-Lactic Acid,3,6,3,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,1712319.3413997567,1535433.7194876666,0.8966982281660775,-0.1573055478455693,0.5348643505092213,0.7543471763776491,Downregulated
Feature0581,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",C7 H15 N O4,177.10012,NA,NA,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",7,15,4,1,0,0,2.142857142857143,0.5714285714285714,-0.5714285714285712,76.58571428571427,1,-3,-2,-0.5,-4,Amino Sugar,1437939.7644385167,1102881.4860043987,0.7669872641953464,-0.382725472875925,0.5886317845948144,0.788120360758212,Downregulated
Feature0580,thr-pro,C9 H16 N2 O4,216.111,Metabolic pathways;Other,Other,thr-pro-peak1,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,7863352.07785838,6997416.2310963,0.8898770094244691,-0.16832214100466675,0.29959118261083206,0.7028461383187669,Downregulated
Feature0579,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,14618529.128715834,10998648.185629733,0.7523772117418157,-0.4104719422050892,0.5031297456618513,0.74277838767447,Downregulated
Feature0578,N-acetyldopamine,C10 H13 N O3,195.08954,Other,NA,N-acetyldopamine,10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,681824.9734964999,623841.8979998264,0.914959003042485,-0.1282209934932735,0.4172962219594657,0.7136536716603119,Downregulated
Feature0577,NA,C16 H30 N2 O9,394.19522,NA,NA,Feature0577,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,826315.4622349043,743781.3883390327,0.900117960188419,-0.1518140163035939,0.629359308718068,0.814953315245881,Downregulated
Feature0576,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",C25 H36 O3,384.26647,NA,NA,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",25,36,3,0,0,0,1.44,0.12,-1.2000000000000002,94.5,8,5,0.2272727272727273,0.2765957446808511,5,Unsaturated HC,434328.69535566436,492989.34075163264,1.1350604876519432,0.18276918113756413,0.5801010459072815,0.7822997277740023,Upregulated
Feature0575,NA,C6 H11 N O7,209.05351,NA,NA,Feature0575,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,4010100.4350957433,3666008.3469088734,0.9141936483247571,-0.12942829953129018,0.4568962789502861,0.7162499996920834,Downregulated
Feature0574,NA,C15 H5 N10 O18 P3 S2,769.84371,NA,NA,Feature0574,15,5,18,10,2,3,0.3333333333333333,1.2,3.3333333333333335,-34.7,20,2,0.7222222222222222,0.4444444444444444,-13,Other,7661675.098368287,15228739.0563674,1.9876513766044028,0.9910647381127798,2.2300418854939396e-4,0.08340356651747334,Upregulated
Feature0573,NA,C18 H34 N2 O8,406.23164,NA,NA,Feature0573,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,580918.213911478,706167.3672398147,1.2156054851250069,0.2816750897990974,0.4846994672373955,0.7338899395222812,Upregulated
Feature0572,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13666,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,454736.37264359463,394852.240601161,0.8683102218230329,-0.20371752741702523,0.011851352347826976,0.5000414976159331,Downregulated
Feature0571,4-Methyleneglutamic acid,C6 H9 N O4,159.05324,Other,NA,4-Methyleneglutamic acid-peak1,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,10090323.568343783,8921799.01190535,0.8841935495404303,-0.1775658854539873,0.5059721361838516,0.7430681588649243,Downregulated
Feature0570,9-Nitrooleate,C18 H33 N O4,327.24099,NA,NA,9-Nitrooleate,18,33,4,1,0,0,1.8333333333333333,0.2222222222222222,-1.2222222222222223,95.13333333333333,3,-1,-0.15384615384615383,0,-2,Lipid,1860134.18538544,1651850.1241975666,0.8880273999454966,-0.1713239034970712,0.12329357666375584,0.6736684190877296,Downregulated
Feature0569,4-Nitrosodiphenylamine,C12 H10 N2 O,198.07934,NA,NA,4-Nitrosodiphenylamine,12,10,1,2,0,0,0.8333333333333334,0.08333333333333333,-0.16666666666666696,65.05000000000001,9,8,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,1452640.39965262,1892931.0460774933,1.303096792936616,0.38194425006356825,0.13192988711066148,0.6736684190877296,Upregulated
Feature0568,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",C17 H18 N2 O5,330.12166,NA,NA,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",17,18,5,2,0,0,1.0588235294117647,0.29411764705882354,-0.117647058823529,63.65294117647058,10,5,0.3,0.44,3,Lignin,1682045.8140896866,2668401.967821317,1.586402668387151,0.6657590093471193,0.09400430400219188,0.6736684190877296,Upregulated
Feature0567,3-(6-Amino-1H-purin-1-yl)-1-propanol,C8 H11 N5 O,193.09636,NA,NA,3-(6-Amino-1H-purin-1-yl)-1-propanol,8,11,1,5,0,0,1.375,0.125,0.75,38.925,6,5,0,0.2,0,Unsaturated HC,158617.98479406367,135905.69031807233,0.8568113539868819,-0.22295049688131677,0.0010551241951131753,0.16912133527385467,Downregulated
Feature0566,NA,C20 H28 N2 O8,424.18475,NA,NA,Feature0566,20,28,8,2,0,0,1.4,0.4,-0.2999999999999998,68.85,8,0,-0.2,0.14285714285714285,-2,Lignin,931862.8849649907,1161546.5802023867,1.2464779947170286,0.3178574137617489,0.20493805176761132,0.6777335289635477,Upregulated
Feature0565,NA,C17 H30 N2 O12,454.18001,NA,NA,Feature0565,17,30,12,2,0,0,1.7647058823529411,0.7058823529411765,0,60.3,4,-8,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,207118.31111234767,7275668.234014201,35.12807822224681,5.134552747022013,0.4231141775384985,0.7136536716603119,Upregulated
Feature0564,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak1,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,148491.14606548302,146855.99984993774,0.988988257826334,-0.015974702797094092,0.9802325505203118,0.9929337204459302,Downregulated
Feature0563,Aspartyl-L-proline,C9 H14 N2 O5,230.09027,Biosynthesis of secondary metabolites;Other,NA,Aspartyl-L-proline,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,347420.92715872434,357496.044691743,1.0289997428059814,0.04124262163656409,0.9448377497109566,0.9790498105309422,Upregulated
Feature0562,Tyrosylalanine,C12 H16 N2 O4,252.11103,NA,NA,Tyrosylalanine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,4340545.543484273,4182137.33123332,0.9635049993914371,-0.05363594255575726,0.7711999292253957,0.9043790432179438,Downregulated
Feature0561,NA,C11 H23 N O11,345.1272,NA,NA,Feature0561,11,23,11,1,0,0,2.090909090909091,1,0.18181818181818168,55.11818181818182,1,-10,11,-1.2222222222222223,-11,Carbohydrate,5183657.99113296,4783387.257343013,0.9227821869277177,-0.1159379398901812,0.6648838832175519,0.8359156812273637,Downregulated
Feature0560,NA,C10 H15 N O5,229.09493,NA,NA,Feature0560,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,4638961.618932056,2476327.8714312306,0.5338108126019181,-0.9055995666102188,0.14351287539627436,0.6736684190877296,Downregulated
Feature0559,NA,C9 H17 N3 O2,199.13214,NA,NA,Feature0559,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,15098501.209681766,12743849.720888034,0.8440473358187477,-0.24460418453786692,0.11522529130678984,0.6736684190877296,Downregulated
Feature0558,Myristicin,C11 H12 O3,192.07871,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,Myristicin,11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1242863.2405179634,1235583.6538466574,0.9941428900348905,-0.008474866913594906,0.9810602545990773,0.9929337204459302,Downregulated
Feature0557,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",C14 H14 O6,278.07905,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",14,14,6,0,0,0,1,0.42857142857142855,-0.14285714285714324,64.37142857142858,8,2,0.25,0.4545454545454546,2,Lignin,293936.66363510664,245418.41978881,0.8349364000860836,-0.26026178804914385,0.07801306630859535,0.6736684190877296,Downregulated
Feature0556,6-Methoxyquinoline,C10 H9 N O,159.06843,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,6-Methoxyquinoline,10,9,1,1,0,0,0.9,0.1,-0.4000000000000003,71.7,7,6,0.625,0.6470588235294118,5,Unsaturated HC,129942.51568275166,1997401.0447238632,15.371420464110614,3.9421785846940605,0.023738969589501346,0.5618339157949356,Upregulated
Feature0555,D-PANTOTHENIC ACID,C9 H17 N O5,219.11064,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak2,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,8879635.999791592,11477216.332430743,1.2925322989253294,0.3702003323136602,0.526384701585443,0.7540080121300391,Upregulated
Feature0554,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.12123,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak2,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,6590713.691472883,4349425.62133849,0.6599324177844065,-0.5996098060519153,0.17542409113122848,0.6736684190877296,Downregulated
Feature0553,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak1,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,273003.275606527,191803.55023302766,0.7025686772691675,-0.5092888367952844,0.43892734358455116,0.7146808569581701,Downregulated
Feature0552,mebutamate,C10 H20 N2 O4,232.14227,Other,NA,mebutamate,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,6853049.22681754,10398660.23867895,1.517377140381048,0.6015797084818949,0.4314725252172442,0.7136536716603119,Upregulated
Feature0551,Methyl alpha-aspartylphenylalaninate,C14 H18 N2 O5,294.12162,Other,NA,Methyl alpha-aspartylphenylalaninate,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,3200354.935731467,2864092.184161593,0.8949295442778699,-0.16015398806577083,0.17564197354690075,0.6736684190877296,Downregulated
Feature0550,Cynometrine,C16 H19 N3 O2,285.14778,NA,NA,Cynometrine,16,19,2,3,0,0,1.1875,0.125,-0.375,70.9875,9,7,0.3636363636363637,0.4166666666666667,4,Unsaturated HC,261829.51008365865,238499.97274270267,0.910897983449223,-0.13463860728514399,0.17106796964830304,0.6736684190877296,Downregulated
Feature0549,2-Amino-3-methoxybenzoic acid,C8 H9 N O3,167.05827,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,2-Amino-3-methoxybenzoic acid,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,737347.1058619787,885024.8822851897,1.2002825741759326,0.26337408947652047,0.675821115933758,0.842523657864085,Upregulated
Feature0548,NA,C7 H11 O3 P S,206.01667,NA,NA,Feature0548,7,11,3,0,1,1,1.5714285714285714,0.42857142857142855,-1.1428571428571432,92.87142857142858,3,0,-1,-0.14285714285714285,-2,Protein,1500250.84885299,1092188.600973815,0.7280039880056344,-0.45798174135873015,0.04323144241315392,0.6299438751631,Downregulated
Feature0547,NA,C15 H27 N3 O6,345.19012,NA,NA,Feature0547,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,8179855.42166314,7212853.6050882535,0.8817825295525488,-0.1815052012605135,0.49105342018456816,0.7393914037448247,Downregulated
Feature0546,Pro-Pro,C10 H16 N2 O3,212.11603,NA,NA,Pro-Pro,10,16,3,2,0,0,1.6,0.3,-0.4000000000000003,71.7,4,1,-0.2,0.07692307692307693,-1,Lipid,5559791.810164317,5140475.831398686,0.9245806330375458,-0.11312895177416157,0.6352438356742414,0.8192454984212629,Downregulated
Feature0545,NA,C79 H121 N6 O18 P3,1534.79514,NA,NA,Feature0545,79,121,18,6,0,3,1.5316455696202531,0.2278481012658228,-1.037974683544304,89.88227848101266,24,6,-0.05769230769230769,0.09836065573770492,-3,Lipid,399656.49128394265,6769833.817737642,16.939131392533543,4.0822879927090066,0.4265491473368294,0.7136536716603119,Upregulated
Feature0544,Pyroquilon,C11 H11 N O,173.08408,NA,NA,Pyroquilon,11,11,1,1,0,0,1,0.09090909090909093,-0.5454545454545459,75.84545454545456,7,6,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,205656.44421094333,182672.80342228798,0.8882425451006979,-0.1709744196240105,0.19579438430336302,0.6763335886956496,Downregulated
Feature0543,NA,C11 H19 N O5,245.12631,NA,NA,Feature0543,11,19,5,1,0,0,1.7272727272727273,0.4545454545454546,-0.5454545454545459,75.84545454545456,3,-2,-0.6,-0.06666666666666667,-3,Protein,263641.8356860467,199320.97654849468,0.756029391275566,-0.40348577337319086,0.45606429961338885,0.7162499996920834,Downregulated
Feature0542,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16888,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak4,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,7156866.246208927,5428384.617900946,0.7584862467950163,-0.39880507375653573,0.5449087296209872,0.7574167055561227,Downregulated
Feature0541,NA,C22 H40 N2 O7,444.2837,NA,NA,Feature0541,22,40,7,2,0,0,1.818181818181818,0.3181818181818182,-0.9090909090909092,86.2090909090909,4,-3,-0.38461538461538464,-0.09090909090909093,-5,Protein,431272.34686770366,392268.079981487,0.9095600096563077,-0.13675926978958283,0.6162401467900531,0.8086800522788767,Downregulated
Feature0540,NA,C20 H30 N2 O8,426.2003,NA,NA,Feature0540,20,30,8,2,0,0,1.5,0.4,-0.4000000000000003,71.7,7,-1,-0.3,0.07142857142857142,-3,Protein,1138794.3831268232,1191203.0984553439,1.0460212274533884,0.06491212924354475,0.8433358920220609,0.9413744745889566,Upregulated
Feature0539,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,C18 H20 N2 O4,328.14237,NA,NA,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,3807886.82367337,3621862.972203623,0.9511477467467654,-0.07225863503928853,0.808461957649421,0.9199739518079618,Downregulated
Feature0538,N-Methylhexanamide,C7 H15 N O,129.11533,NA,NA,N-Methylhexanamide,7,15,1,1,0,0,2.142857142857143,0.14285714285714285,-1.4285714285714288,101.01428571428572,1,0,-0.2,-0.09090909090909093,-1,Lipid,434133.65973693336,337798.293612868,0.7780974500285454,-0.3619772431866128,0.40871926450066104,0.7136536716603119,Downregulated
Feature0537,"β,β-dimethylacrylshikonin",C21 H22 O6,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"β,β-dimethylacrylshikonin",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,1408019.8711941766,1063592.8114180034,0.7553819609917465,-0.4047217631856492,0.3204250494693778,0.7028461383187669,Downregulated
Feature0536,NA,C13 H24 N2 O9,352.14823,NA,NA,Feature0536,13,24,9,2,0,0,1.8461538461538465,0.6923076923076923,0,60.3,3,-6,-4,-0.5384615384615384,-8,Amino Sugar,5850535.03182037,5753313.42601843,0.9833824419009265,-0.024175498533592646,0.940262170935653,0.978637034430813,Downregulated
Feature0535,threonylphenylalanine,C13 H18 N2 O4,266.12671,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak2,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,2217669.756245587,2608627.4441179135,1.1762921132739799,0.23424637483386984,0.5981562722397196,0.795085753247542,Upregulated
Feature0534,NA,C17 H26 N2 O8,386.16898,NA,NA,Feature0534,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,4387359.5967087,3183984.288564387,0.7257176482531638,-0.4625197404640057,0.16874325033583962,0.6736684190877296,Downregulated
Feature0533,Proacacipetalin,C11 H17 N O6,259.10561,NA,NA,Proacacipetalin-peak1,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,380891.5458207697,483640.358951998,1.2697587128373211,0.3445543734814435,0.4110329033797955,0.7136536716603119,Upregulated
Feature0532,NA,C17 H34 N6 O4,386.26429,NA,NA,Feature0532,17,34,4,6,0,0,2,0.2352941176470588,-0.47058823529411775,73.71176470588236,4,0,-0.8571428571428571,-0.4444444444444444,-6,Lipid,4751854.388422407,3754663.329430157,0.7901469663250112,-0.33980707720696524,0.4569103430514518,0.7162499996920834,Downregulated
Feature0531,Ectoine,C6 H10 N2 O2,142.07423,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,14624796.4883597,15300100.5027831,1.0461752760088587,0.06512458069068841,0.5620591194592064,0.7700004054129788,Upregulated
Feature0530,Malonyl-L-carnitine,C10 H17 N O6,247.10558,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Malonyl-L-carnitine,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,252659.59997547267,211431.78080719567,0.8368246479758567,-0.2570027492909841,0.7591738624476432,0.8966242880697428,Downregulated
Feature0529,NA,C12 H19 N O9,321.10608,NA,NA,Feature0529,12,19,9,1,0,0,1.5833333333333333,0.75,0.16666666666666652,55.55,4,-5,-3,-0.2307692307692308,-6,Carbohydrate,651709.2042680047,2955334.6719097965,4.534744411396196,2.181021239441243,0.3711239560382861,0.7136536716603119,Upregulated
Feature0528,NA,C6 H15 N O4,165.10013,NA,NA,Feature0528,6,15,4,1,0,0,2.5,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,243515.621447785,205226.17380325534,0.8427638957333186,-0.2467995849113097,0.0875813235002544,0.6736684190877296,Downregulated
Feature0527,Isovalerylglutamic acid,C10 H17 N O5,231.11065,NA,NA,Isovalerylglutamic acid-peak5,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,5238877.480171593,3452234.1779853334,0.6589644806643311,-0.6017273913391025,0.21844378495688732,0.6777335289635477,Downregulated
Feature0526,NA,C11 H20 N4 O5,288.1433,NA,NA,Feature0526,11,20,5,4,0,0,1.818181818181818,0.4545454545454546,0.18181818181818168,55.11818181818182,4,-1,-2.5,-0.5555555555555556,-5,Protein,2820514.791995853,2021774.5245871102,0.7168104667717278,-0.4803363912956699,0.02553790526340616,0.5618339157949356,Downregulated
Feature0525,Imazapyr,C13 H15 N3 O3,261.1114,NA,NA,Imazapyr,13,15,3,3,0,0,1.1538461538461535,0.2307692307692308,0,60.3,8,5,0.2857142857142857,0.4117647058823529,2,Lignin,4640039.74354251,3576490.32003346,0.7707887254652981,-0.37559262578909897,0.02191704824055514,0.5464650694645081,Downregulated
Feature0524,NA,C17 H26 N2 O8,386.16902,NA,NA,Feature0524,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,1549799.2832498634,2648072.9573994903,1.708655427847788,0.7728614884965589,0.43172608847262656,0.7136536716603119,Upregulated
Feature0523,NA,C14 H24 N2 O11,396.13811,NA,NA,Feature0523,14,24,11,2,0,0,1.7142857142857142,0.7857142857142857,0.2857142857142856,52.15714285714286,4,-7,-9,-0.5384615384615384,-9,Carbohydrate,3199657.302704117,2413322.1171587333,0.7542439357862386,-0.40689690291384834,0.18432801072573804,0.6736684190877296,Downregulated
Feature0522,NA,C22 H32 N4 O5,432.23734,NA,NA,Feature0522,22,32,5,4,0,0,1.4545454545454546,0.2272727272727273,-0.45454545454545414,73.25454545454544,9,4,0,0.16129032258064516,0,Lignin,97768.86471196507,86374.7876597469,0.8834590430625738,-0.17876484153679106,0.06646707705362545,0.6632182304416021,Downregulated
Feature0521,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak2,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,587105.2826041013,340706.48368610867,0.5803158203157489,-0.7850898353395966,0.19754335991877814,0.6777335289635477,Downregulated
Feature0520,Adipic acid,C6 H10 O4,146.05793,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,1197954.561648587,2456030.999271831,2.050187108843193,1.035755582258439,0.5398194838148269,0.7560210217591414,Upregulated
Feature0519,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",C14 H24 N2 O9,364.14823,NA,NA,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",14,24,9,2,0,0,1.7142857142857142,0.6428571428571429,0,60.3,4,-5,-2.3333333333333335,-0.3333333333333333,-7,Amino Sugar,359343.31825490366,260414.80904305534,0.7246963998321171,-0.4645513676093507,0.14436930525904856,0.6736684190877296,Downregulated
Feature0518,Stearidonic acid,C18 H28 O2,276.20889,Biosynthesis of secondary metabolites;Other,NA,Stearidonic acid,18,28,2,0,0,0,1.5555555555555556,0.1111111111111111,-1.333333333333333,98.29999999999998,5,3,0.1875,0.2352941176470588,3,Lipid,874063.3739538777,497259.501413378,0.5689055464754175,-0.8137389484063277,0.3832405131733142,0.7136536716603119,Downregulated
Feature0517,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,C26 H50 N O7 P,519.33266,NA,NA,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,26,50,7,1,0,1,1.9230769230769231,0.2692307692307692,-1.4615384615384617,101.95384615384616,3,-4,-0.35294117647058826,-0.12195121951219512,-6,Lipid,633815.057775602,513567.766141533,0.8102801595530383,-0.303507279587593,0.1408685924720555,0.6736684190877296,Downregulated
Feature0516,NA,C12 H22 N2 O9,338.1325,NA,NA,Feature0516,12,22,9,2,0,0,1.8333333333333333,0.75,0.16666666666666652,55.55,3,-6,-8,-0.6363636363636364,-8,Carbohydrate,1673434.33959367,2257022.1060364065,1.348736578803826,0.4316086036135693,0.04438845109206587,0.6385107964781783,Upregulated
Feature0515,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0515,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,1499484.5188012568,1315480.3977837667,0.8772884156452714,-0.18887687660022529,0.14341180825921082,0.6736684190877296,Downregulated
Feature0514,NA,C12 H17 N3 O7,315.10673,NA,NA,Feature0514,12,17,7,3,0,0,1.4166666666666667,0.5833333333333334,0.5,46.05,6,-1,-2,-0.09090909090909093,-4,Lignin,1646060.1409647767,1483769.41608155,0.9014065641683626,-0.14975013888926803,0.5740177664970323,0.7778356690938046,Downregulated
Feature0513,NS1800000,C8 H9 N O4,183.05316,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,NS1800000,8,9,4,1,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Lignin,3036882.85041127,2754166.732073103,0.9069058201241185,-0.14097535658633972,0.2981736847625116,0.7028461383187669,Downregulated
Feature0512,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1220935.6593759235,1364789.1199727533,1.1178223106943737,0.16069087525282635,0.49989590646426696,0.7417294916342253,Upregulated
Feature0511,methoxyresorcinol,C7 H8 O3,140.04734,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak1,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,274063.365890103,328847.60251223535,1.1998962409448783,0.26290965654521153,0.6584415077776556,0.8319497429352811,Upregulated
Feature0510,fructosylglycine,C8 H15 N O7,237.08491,NA,NA,fructosylglycine,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,2141869.27346182,2439307.5182697233,1.138868533431625,0.1876012175350683,0.5327254530132821,0.7543471763776491,Upregulated
Feature0509,Xamoterol [USAN:BAN:INN],C16 H25 N3 O5,339.17949,NA,NA,Xamoterol [USAN:BAN:INN],16,25,5,3,0,0,1.5625,0.3125,-0.375,70.9875,6,1,-0.25,0.04761904761904761,-2,Protein,1896537.59615744,2192901.2143989634,1.1562656173238977,0.20947285179853123,0.14841885376091363,0.6736684190877296,Upregulated
Feature0508,UNII:74D1OHC38H,C19 H32 O4,324.23009,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak1,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1922400.47988357,1341263.0669613318,0.6977022118942486,-0.519316687526117,0.24112150953818873,0.6954712948633618,Downregulated
Feature0507,NA,C33 H47 N O8,585.33043,NA,NA,Feature0507,33,47,8,1,0,0,1.4242424242424243,0.24242424242424243,-0.8484848484848486,84.48181818181818,11,3,0.08333333333333333,0.21428571428571427,2,Lignin,177154.91163503833,186636.55205640834,1.0535217473445129,0.07522009532489321,0.8600212323295948,0.9450967900820817,Upregulated
Feature0506,N-acetyl-L-2-aminoadipic acid 6-phosphate,C8 H14 N O8 P,283.04574,NA,NA,N-acetyl-L-2-aminoadipic acid 6-phosphate,8,14,8,1,0,1,1.75,1,0,60.3,3,-5,3.5,-1.5,-7,Carbohydrate,890616.5051373136,728325.7658903827,0.8177770810323022,-0.2902204643346214,0.20386057053697476,0.6777335289635477,Downregulated
Feature0505,NA,C29 H28 O9,520.17351,NA,NA,Feature0505,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,579913.2855504804,684389.49205696,1.1801583255801875,0.23898041908458703,0.4333164198012294,0.7136536716603119,Upregulated
Feature0504,asn-phe,C13 H17 N3 O4,279.12195,NA,NA,asn-phe-peak2,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,4325689.7946088435,3195473.0348904897,0.7387198774338937,-0.4369006967549032,0.2971865747447251,0.7028461383187669,Downregulated
Feature0503,N-Acetylvanilalanine,C12 H15 N O5,253.09509,NA,NA,N-Acetylvanilalanine-peak2,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,8622675.88225524,4477972.836064853,0.5193251952424831,-0.9452898749120172,0.2659844329354181,0.7028461383187669,Downregulated
Feature0502,gepefrine,C9 H13 N O,151.09965,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,gepefrine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,304995.649331857,263031.3544457927,0.8624101852665965,-0.21355387812946083,0.1504360877955053,0.6736684190877296,Downregulated
Feature0501,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13662,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,269067.84935073636,196422.75746391265,0.7300119948848698,-0.45400792566354675,0.21779076548436196,0.6777335289635477,Downregulated
Feature0500,Isovalerylglutamic acid,C10 H17 N O5,231.11063,NA,NA,Isovalerylglutamic acid-peak4,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,3505998.8527131532,2864825.0749487397,0.8171209390818156,-0.29137847269632183,0.1493372330101173,0.6736684190877296,Downregulated
Feature0499,NA,C20 H42 N9 O17 P,711.2437,NA,NA,Feature0499,20,42,17,9,0,1,2.1,0.85,0.7000000000000002,40.349999999999994,5,-12,3.142857142857143,-9,-22,Carbohydrate,111997.46991837966,96535.32773726444,0.8619420403658801,-0.21433723356373358,0.06772262966620571,0.6632182304416021,Downregulated
Feature0498,NA,C77 H114 N8 O16 P2,1468.7833,NA,NA,Feature0498,77,114,16,8,0,2,1.4805194805194806,0.2077922077922078,-0.883116883116883,85.46883116883116,26,10,0,0.13559322033898305,0,Lignin,214511.67808468832,5661271.215355468,26.391435962383465,4.721997944962265,0.42530851092741395,0.7136536716603119,Upregulated
Feature0497,MFCD00056023,C12 H14 N2 O3,234.10044,NA,NA,MFCD00056023,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,11107680.287953367,9083022.723176897,0.8177245372310296,-0.29031316333376034,0.050368672569688605,0.6537090145871882,Downregulated
Feature0496,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,807879.3390159577,493212.4979138137,0.6105026754546962,-0.711930477222981,0.2325169483626275,0.6875073975489493,Downregulated
Feature0495,Linamarin,C10 H17 N O6,247.10559,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,162922.17480417967,199391.60516916832,1.2238457128921965,0.29142169260953454,0.4953469213730628,0.7409615456815796,Upregulated
Feature0494,Otonecine,C9 H15 N O3,185.10524,Other,NA,Otonecine,9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,824297.7788341991,500829.324999582,0.6075830092711191,-0.7188465686665775,0.21319147054478274,0.6777335289635477,Downregulated
Feature0493,N-(Carboxyacetyl)phenylalanine,C12 H13 N O5,251.07938,NA,NA,N-(Carboxyacetyl)phenylalanine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Lignin,432395.7338301017,1335918.680452199,3.089574146855742,1.6274079971720887,0.24845179098518894,0.7019200023813293,Upregulated
Feature0492,NA,C10 H23 N O6,253.1525,NA,NA,Feature0492,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,1073007.97639857,895335.0556279724,0.8344160298165381,-0.26116122140805337,0.3217799382114571,0.7028461383187669,Downregulated
Feature0491,Meconin,C10 H10 O4,194.05794,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak1,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,191544.11932075533,141328.07029018467,0.7378356004421099,-0.4386286943851323,0.1885536442045353,0.6736684190877296,Downregulated
Feature0490,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,811846.0594055464,822828.1748559637,1.0135273372620157,0.019385002273435557,0.9372848715072599,0.978637034430813,Upregulated
Feature0489,NA,C9 H23 N10 O5 P,382.15886,NA,NA,Feature0489,9,23,5,10,0,1,2.5555555555555554,0.5555555555555556,1.3333333333333337,22.29999999999999,4,-1,1.7142857142857142,2.111111111111111,-12,Other,1892146.9152529798,2644189.665514293,1.3974547347243198,0.4828015531605047,0.37126242211163135,0.7136536716603119,Upregulated
Feature0488,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0488,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,3250819.4352519433,3002223.5129542765,0.9235282281132294,-0.11477203629298953,0.2275174741399484,0.6843823216756625,Downregulated
Feature0487,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",C8 H17 N O7,239.10053,Metabolic pathways;Biosynthesis of cofactors;Other,NA,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",8,17,7,1,0,0,2.125,0.875,0,60.3,1,-6,-Inf,-1,-7,Carbohydrate,526409.356172381,508244.086580857,0.9654921224736449,-0.05066360672600976,0.814007975720741,0.9230434867094197,Downregulated
Feature0486,ser-asn,C7 H13 N3 O5,219.08553,Biosynthesis of secondary metabolites;Other,NA,ser-asn,7,13,5,3,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,3,-2,5,-1.6666666666666667,-5,Carbohydrate,3926939.02274819,3328588.688722,0.8476293289607929,-0.23849458738699325,0.030879738204804805,0.597363211479155,Downregulated
Feature0485,D-Glucono-delta-lactone,C6 H10 O6,178.04778,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Glucono-delta-lactone,6,10,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,264350.279051157,339124.03951759764,1.2828586401906934,0.35936220680202424,0.33168833243875273,0.708700388691482,Upregulated
Feature0484,NA,C18 H29 N O12,451.16881,NA,NA,Feature0484,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,196789.73694820667,303028.9280604493,1.539861441759048,0.6228005416472526,0.16143528346905694,0.6736684190877296,Upregulated
Feature0483,lys-leu,C12 H25 N3 O3,259.18958,NA,NA,lys-leu-peak1,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,4695773.30681212,8570475.46391905,1.8251467658129772,0.8680124803198073,0.41180186945305114,0.7136536716603119,Upregulated
Feature0482,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0482,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2429016.5699498,2501764.8114111735,1.0299496686689449,0.04257383785907904,0.9215200415953255,0.9725088410337925,Upregulated
Feature0481,Zalcitabine,C9 H13 N3 O3,211.09565,Other,NA,Zalcitabine,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Lignin,6434610.682019849,3146163.498460707,0.48894387771617503,-1.0322592165957503,0.026103142851887286,0.5632255053811064,Downregulated
Feature0480,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11578,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak1,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,322915.0643693377,335841.8604139357,1.0400315670309292,0.05662731770082042,0.9173130889976343,0.9725088410337925,Upregulated
Feature0479,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12117,NA,NA,Cyclo(phenylalanyl-prolyl)-peak1,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,10070755.182066014,10683639.838132167,1.0608578646770779,0.0852313747617398,0.2822254722383401,0.7028461383187669,Upregulated
Feature0478,NA,C14 H20 N2 O10,376.1119,NA,NA,Feature0478,14,20,10,2,0,0,1.4285714285714286,0.7142857142857143,0.4285714285714284,48.08571428571429,6,-4,-3,-0.14285714285714285,-6,Tannin,106134.031152414,1746637.4121265993,16.456902589691868,4.040620921595152,0.41790563859194535,0.7136536716603119,Upregulated
Feature0477,N(6)-[(indol-3-yl)acetyl]-L-lysine,C16 H21 N3 O3,303.15835,NA,NA,N(6)-[(indol-3-yl)acetyl]-L-lysine,16,21,3,3,0,0,1.3125,0.1875,-0.375,70.9875,8,5,0.2,0.30434782608695654,2,Lignin,3250112.1076329034,3148129.67075386,0.9686218710303754,-0.0459945161984646,0.8199702270750628,0.9241442293136327,Downregulated
Feature0476,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak2,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,276637.58336454234,313114.1587544887,1.131856904424584,0.1786915762560823,0.697594004970115,0.856346251177756,Upregulated
Feature0475,Leu-Gly-Pro,C13 H23 N3 O4,285.16888,NA,NA,Leu-Gly-Pro-peak3,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,2291085.750308477,3115690.24253644,1.3599186508479382,0.4435203532929404,0.30229064887189705,0.7028461383187669,Upregulated
Feature0474,NA,C21 H32 N2 O8,440.21604,NA,NA,Feature0474,21,32,8,2,0,0,1.5238095238095235,0.380952380952381,-0.4761904761904763,73.87142857142857,7,-1,-0.2727272727272727,0.06666666666666667,-3,Protein,1040932.2604806367,1266370.8620789973,1.2165737485110388,0.28282377887577537,0.3935282565873511,0.7136536716603119,Upregulated
Feature0473,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10731,NA,NA,N(6)-OH-Me-Adenosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,4538738.19480446,5578279.430639233,1.2290374970349132,0.29752893195230135,0.189013405238519,0.6736684190877296,Upregulated
Feature0472,NA,C19 H35 P S,326.21985,NA,NA,Feature0472,19,35,0,0,1,1,1.8421052631578947,0,-2,117.3,3,3,0.0588235294117647,0.0588235294117647,1,Lipid,2553375.856505474,1154145.4931624488,0.45200767847080736,-1.1455808142874662,0.49964817564433056,0.7417294916342253,Downregulated
Feature0471,xylometazoline,C16 H24 N2,244.19396,NA,NA,xylometazoline,16,24,0,2,0,0,1.5,0,-1.125,92.3625,6,6,0.2857142857142857,0.2857142857142857,4,Lipid,158393.62594656966,135407.54841007,0.8548800344765549,-0.2262061144314218,0.22036971686302576,0.6777335289635477,Downregulated
Feature0470,Threonylglutamine,C9 H17 N3 O5,247.11681,NA,NA,Threonylglutamine,9,17,5,3,0,0,1.8888888888888888,0.5555555555555556,0.22222222222222232,53.96666666666666,3,-2,-5,-0.7142857142857143,-5,Amino Sugar,8323443.928790573,7560626.725206163,0.9083531756673646,-0.13867475583242647,0.46088890352216805,0.7162499996920834,Downregulated
Feature0469,(S)-(+)-2-Aminobutyric Acid,C4 H9 N O2,103.06328,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,(S)-(+)-2-Aminobutyric Acid,4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,1687922.5818621467,1745609.56157607,1.0341763184720723,0.048482174143886836,0.680309028100274,0.8434328503077431,Upregulated
Feature0468,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14231,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak2",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,264855.38003611437,233466.482431501,0.8814866528279194,-0.18198936997577156,0.2158374113325116,0.6777335289635477,Downregulated
Feature0467,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak1",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,10255007.402919844,8659483.59160566,0.8444151477784501,-0.24397563577970283,0.029182926190888008,0.5847007711817204,Downregulated
Feature0466,2'-deamino-2'-hydroxy-6'-dehydroparomamine,C12 H22 N2 O8,322.13771,Biosynthesis of secondary metabolites;Other,Kanamycin biosynthesis,2'-deamino-2'-hydroxy-6'-dehydroparomamine,12,22,8,2,0,0,1.8333333333333333,0.6666666666666666,0,60.3,3,-5,-3.5,-0.5,-7,Amino Sugar,11224732.234495733,9587368.791461974,0.854128953027331,-0.2274741961791307,0.34350616239591214,0.7116802007632078,Downregulated
Feature0465,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak2,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,6746691.815821454,7455925.42740735,1.1051231671680475,0.14420716849467535,0.5209037115714009,0.7512261752996295,Upregulated
Feature0464,NA,C16 H29 N3 O9,407.19049,NA,NA,Feature0464,16,29,9,3,0,0,1.8125,0.5625,-0.125,63.8625,4,-5,-2,-0.4117647058823529,-8,Amino Sugar,2954882.82962885,2916321.33751194,0.9869499082230094,-0.018951231069063955,0.9420035625537236,0.978637034430813,Downregulated
Feature0463,butoctamide,C16 H29 N O5,315.20464,NA,NA,butoctamide,16,29,5,1,0,0,1.8125,0.3125,-1,88.8,3,-2,-0.3,-0.04,-3,Protein,3810151.17316255,3356082.201076153,0.880826520668075,-0.18307018745158105,0.12676983339728476,0.6736684190877296,Downregulated
Feature0462,NA,C23 H33 N3 O5,431.24202,NA,NA,Feature0462,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,269896.05519342964,229146.648509746,0.8490181464324136,-0.2361327054338128,0.19256726124675633,0.6751889597464394,Downregulated
Feature0461,NA,C29 H28 O9,520.17353,NA,NA,Feature0461,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,188697.10278082266,209762.2523781997,1.1116347272265479,0.15268280983368474,0.7020957274691801,0.856365331384129,Upregulated
Feature0460,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23298,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak2,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,3439013.779260067,2233261.542655607,0.6493901118174968,-0.6228426778341507,0.23970412854136194,0.6938604136652682,Downregulated
Feature0459,NA,C14 H29 N O2,243.2198,NA,NA,Feature0459,14,29,2,1,0,0,2.0714285714285716,0.14285714285714285,-1.5714285714285712,105.08571428571427,1,-1,-0.18181818181818185,-0.08333333333333333,-2,Lipid,220287.41695922366,193595.472154266,0.8788312779122628,-0.186341878191827,0.13009151451071788,0.6736684190877296,Downregulated
Feature0458,NA,C32 H37 N4 O2 P3,602.213,NA,NA,Feature0458,32,37,2,4,0,3,1.15625,0.0625,-1.125,92.3625,18,16,0.391304347826087,0.4166666666666667,9,Unsaturated HC,348999.98628101934,292926.791528393,0.8393318138772776,-0.25268682939619724,0.1542926347426329,0.6736684190877296,Downregulated
Feature0457,Homo-L-arginine,C7 H16 N4 O2,188.12733,NA,NA,Homo-L-arginine,7,16,2,4,0,0,2.2857142857142856,0.2857142857142857,0,60.3,2,0,-4,-1.5,-4,Lipid,192024.845314962,192627.121513539,1.0031364493359656,0.004517858583556165,0.9886461329919249,0.994957412988361,Upregulated
Feature0456,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak1,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,979277.5780668797,961788.9366002777,0.9821412826574412,-0.025997521337141782,0.9255854886787753,0.9732960808787122,Downregulated
Feature0455,NA,C16 H23 N5 O10,445.14463,NA,NA,Feature0455,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,3133141.1425337167,3165171.6948094135,1.0102231437457025,0.014673998737506752,0.8077164524850082,0.9199739518079618,Upregulated
Feature0454,Isovalerylglutamic acid,C10 H17 N O5,231.11073,NA,NA,Isovalerylglutamic acid-peak3,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,7022029.36626946,7422712.859775457,1.0570609253545267,0.08005853109501365,0.8194828173966394,0.9241442293136327,Upregulated
Feature0453,propionylcarnitine,C10 H19 N O4,217.13149,NA,NA,propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,5514830.455508783,5942155.593924,1.0774865414018957,0.10766984910647924,0.27221245445703174,0.7028461383187669,Upregulated
Feature0452,Tetrahydrothiophene,C4 H8 S,88.03465,NA,NA,Tetrahydrothiophene,4,8,0,0,1,0,2,0,-1.5,103.05,1,1,0,0,0,Lipid,261419.392957726,204862.15886369167,0.7836532574950161,-0.3517126476225466,0.0500116541800374,0.6537090145871882,Downregulated
Feature0451,glu-asp,C9 H14 N2 O7,262.08011,NA,NA,glu-asp,9,14,7,2,0,0,1.5555555555555556,0.7777777777777778,0.6666666666666665,41.3,4,-3,-Inf,-0.42857142857142855,-5,Carbohydrate,617313.2235678076,1546387.395772683,2.5050287872260735,1.324827182641906,0.2700746097736406,0.7028461383187669,Upregulated
Feature0450,Succinic anhydride,C4 H4 O3,100.01602,NA,NA,Succinic anhydride,4,4,3,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,1488955.0949546234,1282409.62129071,0.8612815964942127,-0.2154430901974425,0.3771415871652466,0.7136536716603119,Downregulated
Feature0449,dapdiamide A,C12 H20 N4 O5,300.14339,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,dapdiamide A,12,20,5,4,0,0,1.6666666666666667,0.4166666666666667,0.16666666666666652,55.55,5,0,-1.3333333333333333,-0.2727272727272727,-4,Protein,3264098.998077113,2752793.3130910336,0.8433547250597208,-0.24578852131994947,0.37584772561429924,0.7136536716603119,Downregulated
Feature0448,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",C10 H11 N O2,177.07899,NA,NA,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",10,11,2,1,0,0,1.1,0.2,-0.4000000000000003,71.7,6,4,0.42857142857142855,0.5,3,Lignin,1837066.1726040954,1162820.1929791046,0.6329767595310803,-0.6597755644672006,0.5276364275033901,0.7540080121300391,Downregulated
Feature0447,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak3,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2007048.2567404234,2972277.78904715,1.4809199425400572,0.5664936516853211,0.38195163747368743,0.7136536716603119,Upregulated
Feature0446,NA,C61 H95 N10 O14 P3,1284.62434,NA,NA,Feature0446,61,95,14,10,0,3,1.5573770491803278,0.22950819672131148,-0.8524590163934427,84.5950819672131,21,7,-0.17647058823529413,0.02439024390243902,-6,Lipid,126615.97084090467,111357.58073037433,0.8794907940191622,-0.1852596183753585,0.04585815135514565,0.6431605727559178,Downregulated
Feature0445,NA,C16 H23 N5 O10,445.14459,NA,NA,Feature0445,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,4800666.730799323,4094015.8197561833,0.8528015064012826,-0.2297181083900149,0.1755883916736682,0.6736684190877296,Downregulated
Feature0444,MFCD00142316,C12 H14 N2 O3,234.1004,NA,NA,MFCD00142316,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,140519.23507305732,123875.56089860467,0.8815559011134707,-0.1818760384421872,0.0686248031351822,0.6632182304416021,Downregulated
Feature0443,NA,C13 H25 N3 O5,303.17945,NA,NA,Feature0443,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,3200582.2908770265,2586988.464392847,0.8082868144858597,-0.30706078159676914,0.4095470655662145,0.7136536716603119,Downregulated
Feature0442,2-Hexenoylcarnitine,C13 H23 N O4,257.16273,NA,NA,2-Hexenoylcarnitine,13,23,4,1,0,0,1.7692307692307692,0.3076923076923077,-0.9230769230769234,86.6076923076923,3,-1,-0.25,0,-2,Protein,235900.69321927067,208094.31555515033,0.8821267657815901,-0.18094210211686626,0.32869500929839024,0.707999712182741,Downregulated
Feature0441,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak2,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,4508895.544340527,6759800.21099446,1.4992141965850645,0.58420651955977565,0.4383623291029508,0.7146808569581701,Upregulated
Feature0440,Leonurine,C14 H21 N3 O5,311.14823,NA,NA,Leonurine-peak2,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,209111.371480159,173032.58851071002,0.8274661836222894,-0.27322774093403646,0.3150784646168773,0.7028461383187669,Downregulated
Feature0439,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak3,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1142328.3371850946,773693.2649004277,0.677294994543293,-0.5621437611322891,0.49821012734794345,0.7417294916342253,Downregulated
Feature0438,ile-his,C12 H20 N4 O3,268.15359,NA,NA,ile-his-peak1,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,1372998.6528810367,852264.8114651521,0.6207324454957032,-0.6879565377674074,0.16399944452220683,0.6736684190877296,Downregulated
Feature0437,Apaxifylline,C16 H22 N4 O3,318.1693,NA,NA,Apaxifylline,16,22,3,4,0,0,1.375,0.1875,-0.25,67.425,8,5,0.1111111111111111,0.23809523809523808,1,Lignin,79800.74265864736,58527.7434628616,0.7334235436030673,-0.4472815161922838,0.3358930310962634,0.7109768007209386,Downregulated
Feature0436,Levetiracetam,C8 H14 N2 O2,170.10558,NA,NA,Levetiracetam,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,507076.7913317947,619046.2299877637,1.2208135741371453,0.2878429085952634,0.1063580460889431,0.6736684190877296,Upregulated
Feature0435,Butenylcarnitine,C11 H19 N O4,229.13142,NA,NA,Butenylcarnitine,11,19,4,1,0,0,1.7272727272727273,0.3636363636363637,-0.7272727272727275,81.02727272727273,3,-1,-0.3333333333333333,0,-2,Protein,533471.7721974626,406239.33684787434,0.761501091565734,-0.39308199015727346,0.23900963586493748,0.6938604136652682,Downregulated
Feature0434,NA,C12 H24 N O13 P,421.09864,NA,NA,Feature0434,12,24,13,1,0,1,2,1.0833333333333333,0,60.3,2,-11,4.333333333333333,-1.8571428571428572,-13,Carbohydrate,460312.6044680697,463847.9819449363,1.0076803838142823,0.011038117205243224,0.9702293284741856,0.9883481899775874,Upregulated
Feature0433,NA,C10 H20 N2 O6,264.13219,NA,NA,Feature0433,10,20,6,2,0,0,2,0.6,-0.20000000000000015,66,2,-4,-3,-0.6,-6,Amino Sugar,3085626.28081366,3048295.1649329364,0.987901608139376,-0.01756073376365275,0.8587204291852696,0.9450967900820817,Downregulated
Feature0432,NA,C16 H14 O3 S,286.0665,NA,NA,Feature0432,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,6973409.488223823,5239664.025722643,0.7513776488489597,-0.41238989396539305,0.1700186079792776,0.6736684190877296,Downregulated
Feature0431,NA,C10 H22 N2 O4,234.15795,NA,NA,Feature0431,10,22,4,2,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-3,-1.25,-0.5,-5,Protein,158385.31533642934,147065.95158483865,0.9285327447967824,-0.10697530704982382,0.5317953564568603,0.7543471763776491,Downregulated
Feature0430,NP-021030,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,NP-021030,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,254658.50060918034,240094.25386158266,0.9428087155435304,-0.08496299962839532,0.8361796264965287,0.9363208991308435,Downregulated
Feature0429,NA,C7 H15 N O6,209.08992,NA,NA,Feature0429,7,15,6,1,0,0,2.142857142857143,0.8571428571428571,0,60.3,1,-5,-Inf,-1,-6,Carbohydrate,2304689.566822233,1010226.670213099,0.43833524686191305,-1.189893403183426,0.00466404089942638,0.34281259305519785,Downregulated
Feature0428,NA,C13 H25 N3 O4,287.18456,NA,NA,Feature0428,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,148065.40382332765,4710056.716143428,31.810649851490567,4.991437939507522,0.4249291350949125,0.7136536716603119,Upregulated
Feature0427,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",C10 H13 N O3,195.08955,Other,NA,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,2332937.359929207,2218296.1781827966,0.950859725719387,-0.07269556971705597,0.7928076146952001,0.9104709761392166,Downregulated
Feature0426,5-Pentylresorcinol,C11 H16 O2,180.11499,NA,NA,5-Pentylresorcinol,11,16,2,0,0,0,1.4545454545454546,0.18181818181818185,-1.0909090909090908,91.39090909090908,4,2,0.2222222222222222,0.3,2,Lignin,1851766.0952052134,1383545.0799262084,0.747148942573594,-0.4205322249744995,0.15937814090781557,0.6736684190877296,Downregulated
Feature0425,NA,C16 H28 N2 O5,328.19992,NA,NA,Feature0425,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,126853.52542065067,111343.50897614034,0.8777328703078722,-0.18814615890868025,0.15576757120598528,0.6736684190877296,Downregulated
Feature0424,NA,C16 H25 N O9,375.15307,NA,NA,Feature0424,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,11692639.948862532,11390189.364202334,0.9741332508327496,-0.03780896409225971,0.30885200395345025,0.7028461383187669,Downregulated
Feature0423,asn-phe,C13 H17 N3 O4,279.12194,NA,NA,asn-phe-peak1,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,3024449.349929807,3988330.53529593,1.3186964216770547,0.3991124786531315,0.47678856930656627,0.7288239438173942,Upregulated
Feature0422,4'-Methoxyacetophenone,C9 H10 O2,150.06812,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Other,Other,4'-Methoxyacetophenone,9,10,2,0,0,0,1.1111111111111112,0.2222222222222222,-0.666666666666667,79.30000000000001,5,3,0.42857142857142855,0.5,3,Lignin,963867.8137974871,804549.3875152307,0.8347092578446343,-0.2606543228193573,0.6987207626653653,0.856365331384129,Downregulated
Feature0421,NA,C20 H38 N4 O6,430.27924,NA,NA,Feature0421,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,126176.394545247,184576.81738785366,1.4628474529890312,0.5487793318203273,0.19573724155214023,0.6763335886956496,Upregulated
Feature0420,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0420,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,3595436.22652128,2842035.9798206235,0.790456512302097,-0.33924200132573795,0.42407774073034066,0.7136536716603119,Downregulated
Feature0419,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16772,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,3,1,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,765556.108651868,1020394.7547542104,1.3328804293013992,0.4145473642294253,0.7056654196308945,0.8578078015448143,Upregulated
Feature0418,NA,C22 H37 N2 O8 P3 S,582.1482,NA,NA,Feature0418,22,37,8,2,1,3,1.681818181818182,0.3636363636363637,-1.2727272727272725,96.57272727272726,7,-1,-0.875,-0.25,-7,Protein,224709.67045760565,207044.63928480534,0.9213873121845326,-0.11812036320797396,0.4836138327654678,0.7332631356254796,Downregulated
Feature0417,NA,C16 H29 N3 O6,359.20575,NA,NA,Feature0417,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,2529752.1953672133,2058990.1411593966,0.813909814933679,-0.29705914899050184,0.39396550832226207,0.7136536716603119,Downregulated
Feature0416,VLK,C17 H34 N4 O4,358.25811,NA,NA,VLK,17,34,4,4,0,0,2,0.2352941176470588,-0.8235294117647056,83.7705882352941,3,-1,-0.5555555555555556,-0.2727272727272727,-5,Lipid,6327513.155586217,4636160.4955767,0.7326986734881281,-0.4487080911300768,0.29512568006833406,0.7028461383187669,Downregulated
Feature0415,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16891,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak2,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,4951962.829012783,3891522.82890159,0.785854612256328,-0.3476656648183862,0.3759505329155863,0.7136536716603119,Downregulated
Feature0414,Methionylleucine,C11 H22 N2 O3 S,262.13515,NA,NA,Methionylleucine-peak1,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,1015348.9577595657,1195746.903615989,1.1776708829784819,0.23593641367122833,0.7839602672586021,0.907639449407689,Upregulated
Feature0413,NA,C11 H19 N3 O4,257.13761,NA,NA,Feature0413,11,19,4,3,0,0,1.7272727272727273,0.3636363636363637,-0.18181818181818168,65.48181818181817,4,0,-0.75,-0.16666666666666666,-3,Protein,539291.90401751,5920705.417916373,10.978665494159053,3.4566307938600254,0.1791559067560407,0.6736684190877296,Upregulated
Feature0412,NA,C11 H22 N4 O3,258.16921,NA,NA,Feature0412,11,22,3,4,0,0,2,0.2727272727272727,-0.3636363636363633,70.66363636363636,3,0,-1,-0.4545454545454546,-4,Lipid,420898.7280734897,437119.458791005,1.0385383220133733,0.054554452541342044,0.6742180766124181,0.8422546375904694,Upregulated
Feature0411,glu-leu,C11 H20 N2 O5,260.13722,NA,NA,glu-leu,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,9767328.466134083,7936187.954179119,0.8125239139541571,-0.29951782027692525,0.5216257908686869,0.7513018451279417,Downregulated
Feature0410,NA,C13 H24 N2 O10,368.14308,NA,NA,Feature0410,13,24,10,2,0,0,1.8461538461538465,0.7692307692307693,0.15384615384615374,55.91538461538462,3,-7,-9,-0.6666666666666666,-9,Carbohydrate,1080349.593296936,881827.673304405,0.8162428891311972,-0.2929295765098791,0.37193151903063026,0.7136536716603119,Downregulated
Feature0409,6-methyltetrahydropterin,C7 H11 N5 O,181.09637,NA,NA,6-methyltetrahydropterin,7,11,1,5,0,0,1.5714285714285714,0.14285714285714285,0.8571428571428572,35.87142857142857,5,4,-1,-0.3333333333333333,-1,Lipid,3664012.77984243,7035101.5243526995,1.9200537626550644,0.9411467078370198,0.40113828595718753,0.7136536716603119,Upregulated
Feature0408,NA,C39 H72 N2 O5,648.54423,NA,NA,Feature0408,39,72,5,2,0,0,1.8461538461538465,0.1282051282051282,-1.435897435897436,101.22307692307692,5,0,-0.0625,0.0144927536231884,-2,Lipid,244586.40449310266,218276.40477195,0.8924306533894258,-0.164188026471822,0.15432769936727989,0.6736684190877296,Downregulated
Feature0407,NA,C13 H24 N2 O3,256.17864,NA,NA,Feature0407,13,24,3,2,0,0,1.8461538461538465,0.2307692307692308,-0.9230769230769234,86.6076923076923,3,0,-0.25,-0.05263157894736842,-2,Lipid,429815.209677379,384117.6134203697,0.8936808302076836,-0.16216841660195347,0.37178084502023073,0.7136536716603119,Downregulated
Feature0406,NP-004713,C15 H24 O2,236.17762,Other,Other,NP-004713,15,24,2,0,0,0,1.6,0.13333333333333333,-1.333333333333333,98.29999999999998,4,2,0.15384615384615383,0.21428571428571427,2,Lipid,380556.81582977634,319494.27546858334,0.8395442209383358,-0.2523217772911952,0.08009259208578086,0.6736684190877296,Downregulated
Feature0405,NA,C16 H31 N3 O4,329.23156,NA,NA,Feature0405,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,516007.7102550327,672898.3419323587,1.3040470685986145,0.38299594350172567,0.31625166749326494,0.7028461383187669,Upregulated
Feature0404,1-Methyl-4-(1-methyl-2-propenyl)-benzene,C13 H18,174.14087,NA,NA,1-Methyl-4-(1-methyl-2-propenyl)-benzene,13,18,0,0,0,0,1.3846153846153846,0,-1.384615384615385,99.76153846153846,5,5,0.38461538461538464,0.38461538461538464,5,Unsaturated HC,1104758.780075341,925610.0716147986,0.8378390724821169,-0.2552549292771375,0.720186942353925,0.869805973434988,Downregulated
Feature0403,anthramycin,C16 H17 N3 O4,315.12196,NA,NA,anthramycin,16,17,4,3,0,0,1.0625,0.25,0,60.3,10,6,0.3333333333333333,0.4545454545454546,3,Lignin,4244168.4827557,3827526.5593025065,0.9018319076761364,-0.14906954007740647,0.30123797799661384,0.7028461383187669,Downregulated
Feature0402,"(8Z,11Z,14Z)-Heptadecatrienal",C17 H28 O,248.21402,Other,NA,"(8Z,11Z,14Z)-Heptadecatrienal",17,28,1,0,0,0,1.6470588235294117,0.0588235294117647,-1.5294117647058822,103.88823529411764,4,3,0.1875,0.21212121212121213,3,Lipid,837772.3427169253,565271.5635646749,0.6747317078187127,-0.5676141345652954,0.5367885512873013,0.7543471763776491,Downregulated
Feature0401,NA,C30 H51 N4 O17 P3,832.24652,NA,NA,Feature0401,30,51,17,4,0,3,1.7,0.5666666666666667,-0.666666666666667,79.30000000000001,9,-8,-2.5,-0.4482758620689655,-15,Amino Sugar,937737.5232626196,2565618.191823174,2.735966225278857,1.4520504206757634,0.43209809938257404,0.7136536716603119,Upregulated
Feature0400,NA,C17 H31 N3 O9,421.20619,NA,NA,Feature0400,17,31,9,3,0,0,1.8235294117647056,0.5294117647058824,-0.23529411764705888,67.00588235294117,4,-5,-1.6,-0.3684210526315789,-8,Protein,5078054.304836503,4255101.95443983,0.8379394348711736,-0.2550821232403949,0.4795266885332346,0.7310175876824582,Downregulated
Feature0399,Hopantenic acid,C10 H19 N O5,233.12632,NA,NA,Hopantenic acid,10,19,5,1,0,0,1.9,0.5,-0.5999999999999996,77.39999999999999,2,-3,-1,-0.2307692307692308,-4,Protein,2353372.8107762765,1663395.3737900353,0.7068133727785155,-0.5005987592158042,0.4629951879798352,0.7175146421455457,Downregulated
Feature0398,1726033,C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak1,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,6570913.9483081,9767272.479955697,1.4864404794816415,0.5718616955524124,0.030490874525045463,0.597363211479155,Upregulated
Feature0397,NA,C13 H24 N2 O8,336.15337,NA,NA,Feature0397,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,4451229.676574416,3910279.6868108767,0.8784717866592215,-0.18693214206343392,0.3617961659055648,0.7136536716603119,Downregulated
Feature0396,valienone,C7 H10 O5,174.05284,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,valienone,7,10,5,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,1618018.04233594,1528481.0656491066,0.9446625597835927,-0.08212901451115653,0.5517404488462729,0.7640181513957917,Downregulated
Feature0395,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0395,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,134991.054718968,185942.37365325566,1.3774421871164797,0.4619917684438654,0.048698066986269425,0.6537090145871882,Upregulated
Feature0394,NA,C37 H51 N3 O12,729.34763,NA,NA,Feature0394,37,51,12,3,0,0,1.3783783783783785,0.32432432432432434,-0.4864864864864869,74.16486486486487,14,2,-0.04545454545454545,0.17857142857142858,-1,Lignin,103149.7102028694,87380.8505431688,0.8471264763741241,-0.23935071421316007,0.10707453051106303,0.6736684190877296,Downregulated
Feature0393,NA,C9 H16 N2 O3,200.1161,NA,NA,Feature0393,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,6800948.55193842,6665952.971425827,0.9801504776162265,-0.02892483887868474,0.6242592051325138,0.8125508447316477,Downregulated
Feature0392,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,3342813.9925879533,3070973.45605538,0.9186791316730971,-0.12236703748197113,0.17069275595234684,0.6736684190877296,Downregulated
Feature0391,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0391,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,4410831.715151947,4197804.241221176,0.9517035589458139,-0.07141582874786792,0.7941424906712308,0.9110497731381503,Downregulated
Feature0390,Anhydroecgonine methyl ester,C10 H15 N O2,181.11031,NA,NA,Anhydroecgonine methyl ester,10,15,2,1,0,0,1.5,0.2,-0.7999999999999998,83.1,4,2,0.14285714285714285,0.25,1,Lipid,169282.92496769968,177814.88302613335,1.0504005826935092,0.07093962165646392,0.7713450759909193,0.9043790432179438,Upregulated
Feature0389,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10587,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,10296509.271038467,10117008.438464276,0.9825668264992407,-0.025372563362993754,0.9092226945350635,0.9715693935888964,Downregulated
Feature0388,NA,C14 H25 N3 O7,347.16934,NA,NA,Feature0388,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,2894301.3566563632,2344292.1988309966,0.8099682479295233,-0.3040627417697146,0.3589574260583559,0.7136536716603119,Downregulated
Feature0387,NA,C10 H21 N O10,315.11663,NA,NA,Feature0387,10,21,10,1,0,0,2.1,1,0.20000000000000015,54.599999999999994,1,-9,10,-1.25,-10,Carbohydrate,4386693.354766868,4015416.75913494,0.9153629931236305,-0.12758412796106391,0.9404890645511474,0.978637034430813,Downregulated
Feature0386,NA,C16 H14 O3 S,286.06646,NA,NA,Feature0386,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,9548556.452670943,7917120.487924417,0.8291431827592979,-0.2703068360857647,0.3007904443169941,0.7028461383187669,Downregulated
Feature0385,NA,C19 H34 N4 O5,398.25301,NA,NA,Feature0385,19,34,5,4,0,0,1.7894736842105263,0.2631578947368421,-0.6315789473684212,78.30000000000001,5,0,-0.4,-0.12,-4,Lipid,2536657.47619204,1554448.4441561396,0.612793985291871,-0.7065259579250392,0.15712314838308325,0.6736684190877296,Downregulated
Feature0384,gln-phe,C14 H19 N3 O4,293.13766,NA,NA,gln-phe-peak2,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,3234128.37277317,4385106.838219836,1.3558852131957075,0.4392350476756483,0.4615841905428062,0.7163173745353092,Upregulated
Feature0383,lys-gln,C11 H22 N4 O4,274.16413,NA,NA,lys-gln,11,22,4,4,0,0,2,0.3636363636363637,-0.18181818181818168,65.48181818181817,3,-1,-1.6666666666666667,-0.6,-5,Protein,8014379.325274207,4557390.7784414,0.568651743756273,-0.8143827136628009,0.001920967354895333,0.21553253721925636,Downregulated
Feature0382,2-O-ETHYL ASCORBIC ACID,C8 H12 O6,204.06331,NA,NA,2-O-ETHYL ASCORBIC ACID,8,12,6,0,0,0,1.5,0.75,0,60.3,3,-3,-1.5,0,-3,Carbohydrate,596546.1838381013,400838.71639934136,0.6719324123748419,-0.5736119708647389,0.013975773213807956,0.5000414976159331,Downregulated
Feature0381,4-Ethoxy-m-anisaldehyde,C10 H12 O3,180.07871,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,4-Ethoxy-m-anisaldehyde,10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,2099241.35606723,2033953.6623426734,0.9688993866589651,-0.04558123513402773,0.7574156401505857,0.895572642953768,Downregulated
Feature0380,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Lignin,4077665.0241561565,3269062.2641975833,0.8016995620855571,-0.3188664087000144,0.31234140366357743,0.7028461383187669,Downregulated
Feature0379,Gabexate,C16 H23 N3 O4,321.16895,NA,NA,Gabexate,16,23,4,3,0,0,1.4375,0.25,-0.375,70.9875,7,3,0,0.18181818181818185,0,Lignin,4759575.34893523,4304026.54227866,0.9042879304855462,-0.1451458866889599,0.7068940773820638,0.8583713796782202,Downregulated
Feature0378,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",C13 H12 N2 O2,228.08992,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",13,12,2,2,0,0,0.9230769230769232,0.15384615384615383,-0.1538461538461542,64.6846153846154,9,7,0.5555555555555556,0.6,5,Lignin,1862766.92806426,2589382.2035610364,1.3900731028394715,0.475160755129192,0.14607719881554893,0.6736684190877296,Upregulated
Feature0377,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,247797.67476794682,269000.82465973,1.0855663795539612,0.11844794569083038,0.814450135331841,0.9230434867094197,Upregulated
Feature0376,NA,C13 H17 N O5,267.11069,NA,NA,Feature0376,13,17,5,1,0,0,1.3076923076923077,0.38461538461538464,-0.3076923076923075,69.06923076923076,6,1,0,0.2631578947368421,0,Lignin,2362814.0796642136,1827595.27721036,0.7734824728444503,-0.3705594943919593,0.43900241829627307,0.7146808569581701,Downregulated
Feature0375,NA,C20 H20 N6 O5,424.14931,NA,NA,Feature0375,20,20,5,6,0,0,1,0.25,0.3999999999999999,48.9,14,9,0.3333333333333333,0.4782608695652174,3,Lignin,293722.66743559163,251434.82156406934,0.856027979587938,-0.2242701424746456,0.2192006460213209,0.6777335289635477,Downregulated
Feature0374,gamma-Glu-His,C11 H16 N4 O5,284.11217,NA,NA,gamma-Glu-His,11,16,5,4,0,0,1.4545454545454546,0.4545454545454546,0.5454545454545454,44.75454545454545,6,1,-1.5,-0.1111111111111111,-3,Lignin,1899874.1762777732,1765334.7617921499,0.9291850922732091,-0.10596208696970058,0.18783887123440918,0.6736684190877296,Downregulated
Feature0373,6-methoxymellein,C11 H12 O4,208.07356,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak2,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,148707.76979030934,126705.14061476933,0.8520411596074261,-0.23100497039019208,0.18996660376503463,0.6736684190877296,Downregulated
Feature0372,NA,C8 H18 N2 O3,190.13174,NA,NA,Feature0372,8,18,3,2,0,0,2.25,0.375,-0.75,81.675,1,-2,-1.3333333333333333,-0.5555555555555556,-4,Protein,377223.48900708335,707233.5635268757,1.8748396749853389,0.90676723027892,0.5359611636989844,0.7543471763776491,Upregulated
Feature0371,glutaral,C5 H8 O2,100.05243,NA,NA,glutaral,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,1164514.83134725,1116090.5152036033,0.9584167458926877,-0.061274979117431135,0.6504643341311251,0.8274614318538803,Downregulated
Feature0370,Pyridoxal,C8 H9 N O3,167.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak2,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,7576554.61467097,7061029.32930588,0.9319578209907119,-0.10166343273799058,0.500395584044835,0.7417294916342253,Downregulated
Feature0369,N-valeryl-Glycine,C7 H13 N O3,159.08952,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-valeryl-Glycine,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,1991175.5400680634,1610522.20459235,0.8088298455782046,-0.3060918616508319,0.3140996566814163,0.7028461383187669,Downregulated
Feature0368,gamma-Glutamyl-N~5~-acetylornithine,C12 H21 N3 O6,303.14309,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,gamma-Glutamyl-N~5~-acetylornithine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,1906761.2443236134,1292353.0530766973,0.6777739252483782,-0.5611239591549363,0.1860654530528672,0.6736684190877296,Downregulated
Feature0367,NA,C9 H7 N O3 S,209.01467,NA,NA,Feature0367,9,7,3,1,1,0,0.7777777777777778,0.3333333333333333,0.44444444444444464,47.633333333333326,7,4,0.5,0.6363636363636364,2,Condensed HC,174044.02037155034,144238.265116467,0.8287458816944482,-0.27099829886124277,0.017381121574885375,0.5000414976159331,Downregulated
Feature0366,Acetylcarnitine,C9 H17 N O4,203.1157,NA,NA,Acetylcarnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,193481.74220832955,134646.1566989943,0.6959114341342626,-0.5230243831604277,0.34276374586609676,0.7116802007632078,Downregulated
Feature0365,NA,C20 H31 N O14,509.17464,NA,NA,Feature0365,20,31,14,1,0,0,1.55,0.7,0,60.3,6,-8,-1.8,-0.16666666666666666,-9,Amino Sugar,1895416.27415184,1519814.9909939866,0.8018370485259618,-0.31861901677277715,0.15244153658208398,0.6736684190877296,Downregulated
Feature0364,NA,C16 H28 N2 O5,328.19969,NA,NA,Feature0364,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,169206.54066595834,147348.08299070966,0.8708178916180263,-0.19955704578633118,0.14619845616593166,0.6736684190877296,Downregulated
Feature0363,NA,C16 H29 N3 O4,327.21588,NA,NA,Feature0363,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,1857309.6117335432,1455463.2750629345,0.7836406304409632,-0.35173589404544636,0.6203341092584915,0.8121527078039995,Downregulated
Feature0362,NA,C9 H22 N2 O2,190.16816,NA,NA,Feature0362,9,22,2,2,0,0,2.4444444444444446,0.2222222222222222,-1.333333333333333,98.29999999999998,0,-2,-0.8,-0.5,-4,Lipid,93967.92285201527,78563.59764542694,0.8360682588371383,-0.25830736231113544,0.10424399485896631,0.6736684190877296,Downregulated
Feature0361,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0361,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,4875192.08295949,4948337.724923303,1.0150036430809533,0.021484905583252098,0.7410813573707771,0.8873994482070564,Upregulated
Feature0360,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,C10 H12 N6 O4,280.09207,NA,NA,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,10,12,4,6,0,0,1.2,0.4,1.4,20.4,8,4,-Inf,0,-2,Lignin,276819.35072274564,371767.8010620753,1.3429978796331594,0.4254570269953325,0.5093373866389195,0.7449197949921028,Upregulated
Feature0359,tyr-his,C15 H18 N4 O4,318.13296,NA,NA,tyr-his,15,18,4,4,0,0,1.2,0.26666666666666666,0.1333333333333333,56.5,9,5,0.14285714285714285,0.3333333333333333,1,Lignin,633210.0308305554,458604.22911966837,0.7242529441899968,-0.46543445062168126,0.3022286735267967,0.7028461383187669,Downregulated
Feature0358,NA,C16 H33 N O2,271.25118,NA,NA,Feature0358,16,33,2,1,0,0,2.0625,0.125,-1.625,106.6125,1,-1,-0.15384615384615383,-0.07142857142857142,-2,Lipid,197620.22093589298,198918.814339022,1.006571156519202,0.009449162849192668,0.9749833204897635,0.9908797876716618,Upregulated
Feature0357,NA,C89 H119 N4 O11 P3,1512.80906,NA,NA,Feature0357,89,119,11,4,0,3,1.3370786516853932,0.12359550561797752,-1.1235955056179776,92.32247191011236,34,23,0.22535211267605632,0.28104575163398693,16,Unsaturated HC,223921.54500439734,4001946.617831516,17.87209273566296,4.159636671773217,0.42794224805440817,0.7136536716603119,Upregulated
Feature0356,met-val,C10 H20 N2 O3 S,248.11947,NA,NA,met-val,10,20,3,2,1,0,2,0.3,-0.5999999999999996,77.39999999999999,2,-1,-1,-0.4545454545454546,-4,Lipid,2409916.63442321,2007246.2125149432,0.8329110575210242,-0.26376564938569075,0.28023530185476253,0.7028461383187669,Downregulated
Feature0355,"N,N-dimethyl-9H-purin-6-amine",C7 H9 N5,163.08581,NA,NA,"N,N-dimethyl-9H-purin-6-amine",7,9,0,5,0,0,1.2857142857142858,0,0.8571428571428572,35.87142857142857,6,6,0.5,0.5,1,Unsaturated HC,742691.001053218,4400196.576001227,5.924666610691743,2.5667339738194808,0.41589834095931605,0.7136536716603119,Upregulated
Feature0354,dihomomethionine,C7 H15 N O2 S,177.08241,2-Oxocarboxylic acid metabolism;Other,NA,dihomomethionine,7,15,2,1,1,0,2.142857142857143,0.2857142857142857,-0.8571428571428568,84.72857142857141,1,-1,-1,-0.5,-3,Lipid,350218.15460494667,211802.229225987,0.6047722724851436,-0.7255360982932849,0.27913267361326294,0.7028461383187669,Downregulated
Feature0353,NA,C25 H34 O2,366.25594,NA,NA,Feature0353,25,34,2,0,0,0,1.36,0.08,-1.2000000000000002,94.5,9,7,0.30434782608695654,0.3333333333333333,7,Unsaturated HC,463306.22842083935,399771.6323424903,0.8628669502352598,-0.21278997468811964,0.15365127228862935,0.6736684190877296,Downregulated
Feature0352,metharbital,C9 H14 N2 O3,198.10047,NA,NA,metharbital,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,2581415.7813757365,1823613.8836507967,0.706439426305406,-0.5013622330051407,0.07865155372144159,0.6736684190877296,Downregulated
Feature0351,NA,C17 H31 N3 O4,341.23157,NA,NA,Feature0351,17,31,4,3,0,0,1.8235294117647056,0.2352941176470588,-0.8235294117647056,83.7705882352941,4,0,-0.3,-0.08333333333333333,-3,Lipid,210125.491587618,693356.216936995,3.299724425143723,1.7223455435378991,7.261873271515675e-4,0.13579703017734313,Upregulated
Feature0350,Lys-phe,C15 H23 N3 O3,293.17398,NA,NA,Lys-phe,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,1652933.59523449,2458578.5340228733,1.487403088128348,0.572795672567578,0.4582073805630188,0.7162499996920834,Upregulated
Feature0349,NA,C25 H41 N5 O6,507.30589,NA,NA,Feature0349,25,41,6,5,0,0,1.64,0.24,-0.5599999999999996,76.25999999999999,8,2,-0.21428571428571427,0,-3,Lipid,130216.53667582467,112451.455200388,0.8635727694120524,-0.21161034255701533,0.054435180339451494,0.6632182304416021,Downregulated
Feature0348,NA,C14 H23 N3 O,249.18412,NA,NA,Feature0348,14,23,1,3,0,0,1.6428571428571428,0.07142857142857142,-0.8571428571428568,84.72857142857141,5,4,0.1,0.14285714285714285,1,Lipid,87698.16201325133,67500.40567516907,0.7696900838693705,-0.37765043410334614,0.2787450742819736,0.7028461383187669,Downregulated
Feature0347,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0347,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,1478298.7499800932,1094718.3057120442,0.7405257602543368,-0.43337817227699177,0.074431232355408,0.6736684190877296,Downregulated
Feature0346,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0346,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2714214.9541416867,3206844.333146523,1.1814997659832067,0.24061934356068015,0.24482521251655534,0.6979655491782245,Upregulated
Feature0345,NA,C17 H25 N3 O4,335.18463,NA,NA,Feature0345,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,987249.5293706913,790547.7807775789,0.8007578198406464,-0.3205621131078403,0.45946942791659884,0.7162499996920834,Downregulated
Feature0344,linatine,C10 H17 N3 O5,259.11681,Other,NA,linatine,10,17,5,3,0,0,1.7,0.5,0.20000000000000015,54.599999999999994,4,-1,-2,-0.3333333333333333,-4,Protein,1286090.0972379933,808932.6883709517,0.6289860174712606,-0.6689001489260253,0.025112272873057246,0.5618339157949356,Downregulated
Feature0343,NA,C6 H9 O P S,160.01125,NA,NA,Feature0343,6,9,1,0,1,1,1.5,0.16666666666666666,-1.666666666666667,107.8,3,2,0,0.14285714285714285,0,Lipid,322317.69991775363,403418.24258178833,1.2516167827107518,0.32379290866689925,0.5814977780359076,0.7823027661346383,Upregulated
Feature0342,mycosporine,C11 H19 N O6,261.12129,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak1,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,375367.96394436137,231612.640033008,0.6170282556860356,-0.6965915384061183,0.30971474963498724,0.7028461383187669,Downregulated
Feature0341,NA,C12 H20 N2 O5,272.13725,NA,NA,Feature0341,12,20,5,2,0,0,1.6666666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,4,-1,-0.6,-0.06666666666666667,-3,Protein,129931.04080801533,3790240.7671397007,29.17117221234392,4.8664714554448985,0.4233561651999311,0.7136536716603119,Upregulated
Feature0340,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,C13 H14 N2 O3,246.10046,NA,Superpathway of indole-3-acetate conjugate biosynthesis,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,13,14,3,2,0,0,1.0769230769230769,0.2307692307692308,-0.1538461538461542,64.6846153846154,8,5,0.375,0.47368421052631576,3,Lignin,158935.19485408167,282984.715492388,1.780503781759579,0.8322854999638213,0.16600234833344726,0.6736684190877296,Upregulated
Feature0339,D-PANTOTHENIC ACID,C9 H17 N O5,219.11065,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak1,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,3970961.7158869337,2807537.3081235965,0.7070169669204477,-0.500183257790064,0.326385581639511,0.707999712182741,Downregulated
Feature0338,(−)-trans-Methyl dihydrojasmonate,C13 H22 O3,226.15687,NA,NA,(−)-trans-Methyl dihydrojasmonate,13,22,3,0,0,0,1.6923076923076923,0.2307692307692308,-1.2307692307692308,95.37692307692308,3,0,0,0.13043478260869565,0,Lipid,1486488.6808475733,1039147.1143250967,0.6990615722230665,-0.516508563422902,0.212063476164154,0.6777335289635477,Downregulated
Feature0337,7-hydroxyflavanone 7-O-beta-D-glucoside,C21 H22 O8,402.13151,NA,NA,7-hydroxyflavanone 7-O-beta-D-glucoside,21,22,8,0,0,0,1.0476190476190477,0.380952380952381,-0.2857142857142856,68.44285714285714,11,3,0.2307692307692308,0.4117647058823529,3,Lignin,244758.01010768634,214143.34815488267,0.8749186515312242,-0.19277921107192011,0.1678067534352215,0.6736684190877296,Downregulated
Feature0336,Alpha-Methyltryptamine,C11 H14 N2,174.11571,Metabolic pathways;Other,NA,Alpha-Methyltryptamine,11,14,0,2,0,0,1.2727272727272727,0,-0.7272727272727275,81.02727272727273,6,6,0.4444444444444444,0.4444444444444444,4,Unsaturated HC,3438330.20467192,3576319.7904066364,1.0401327323208283,0.05676764379160849,0.7774939346887413,0.907639449407689,Upregulated
Feature0335,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",C7 H9 N O3,155.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",7,9,3,1,0,0,1.2857142857142858,0.42857142857142855,0,60.3,4,1,0,0.3333333333333333,0,Lignin,203457.78256864866,215721.233262472,1.06027516145609,0.08443872002672825,0.8626822216767018,0.945243606173105,Upregulated
Feature0334,acetoacetic acid,C4 H6 O3,102.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak1,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,1252047.57158629,1918260.5118573583,1.5320987440014004,0.615509282178233,0.5734814580020845,0.7778356690938046,Upregulated
Feature0333,NA,C28 H40,376.313,NA,NA,Feature0333,28,40,0,0,0,0,1.4285714285714286,0,-1.4285714285714288,101.01428571428572,9,9,0.32142857142857145,0.32142857142857145,9,Unsaturated HC,203336.59360586034,348053.6797848727,1.7117119629707491,0.7754399537513977,0.4408998228861095,0.7146808569581701,Upregulated
Feature0332,NA,C16 H29 N3 O6,359.20566,NA,NA,Feature0332,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,406336.9293103293,393414.159509652,0.9681969103260908,-0.04662760455591342,0.902282747713576,0.9678405764193425,Downregulated
Feature0331,2-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,5040299.914133034,5088952.414103377,1.009652699402653,0.013859119694824657,0.9678221414971142,0.9883481899775874,Upregulated
Feature0330,orciprenaline,C11 H17 N O3,211.12082,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,orciprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,119387.0856833522,97125.59804652873,0.8135352118748661,-0.29772330412433823,0.37835307972427457,0.7136536716603119,Downregulated
Feature0329,GLY-MET,C7 H14 N2 O3 S,206.07248,NA,NA,GLY-MET,7,14,3,2,1,0,2,0.42857142857142855,0,60.3,2,-1,-4,-1,-4,Protein,1419908.5248943034,928114.9037796486,0.6536441520757378,-0.6134226575645043,0.09731263275157706,0.6736684190877296,Downregulated
Feature0328,NA,C11 H21 N O12,359.10644,NA,NA,Feature0328,11,21,12,1,0,0,1.9090909090909092,1.0909090909090908,0.5454545454545454,44.75454545454545,2,-10,5.5,-1.25,-11,Carbohydrate,1200181.5976290968,1044900.70393888,0.870618834685545,-0.19988686362726482,0.21260681180485794,0.6777335289635477,Downregulated
Feature0327,NA,C17 H33 N O15,491.18523,NA,NA,Feature0327,17,33,15,1,0,0,1.9411764705882353,0.8823529411764706,0,60.3,2,-13,-14,-0.7647058823529411,-14,Carbohydrate,2434420.8625078634,2499710.96120212,1.0268195609476485,0.03818268467747386,0.851305702087793,0.9413744745889566,Upregulated
Feature0326,NA,C8 H19 N O4,193.13145,NA,NA,Feature0326,8,19,4,1,0,0,2.375,0.5,-1,88.8,0,-4,-1.6666666666666667,-0.6,-5,Other,138721.60935301706,96791.91591218623,0.6977421640623512,-0.5192340775764791,0.23520543526398546,0.6875073975489493,Downregulated
Feature0325,NA,C16 H28 N4 O5,356.20606,NA,NA,Feature0325,16,28,5,4,0,0,1.75,0.3125,-0.375,70.9875,5,0,-0.5714285714285714,-0.15789473684210523,-4,Protein,1487095.80263817,1526273.7208870365,1.0263452550799774,0.037516124711138556,0.8733398283517352,0.9522714163368774,Upregulated
Feature0324,Chelidonic acid,C7 H4 O6,184.00082,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Chelidonic acid,7,4,6,0,0,0,0.5714285714285714,0.8571428571428571,1.1428571428571428,27.728571428571428,6,0,0,0.75,0,Condensed HC,5498967.48976612,5597848.020520103,1.017981653999229,0.025711561489413292,0.8014354114044534,0.9165189181495585,Upregulated
Feature0323,NA,C11 H19 N3 O7,305.12233,NA,NA,Feature0323,11,19,7,3,0,0,1.7272727272727273,0.6363636363636364,0.36363636363636376,49.93636363636363,4,-3,-6,-0.5555555555555556,-6,Amino Sugar,700549.372674498,1292720.3868005967,1.8452951886393938,0.8838516201456983,0.033263969925038515,0.5992830975343959,Upregulated
Feature0322,NA,C13 H18 N2 O6,298.11654,NA,NA,Feature0322,13,18,6,2,0,0,1.3846153846153846,0.4615384615384616,0,60.3,6,0,-0.4,0.125,-2,Lignin,3016727.338093707,2671315.049871953,0.8855009917999344,-0.17543417202756917,0.31372876061566757,0.7028461383187669,Downregulated
Feature0321,Gly-Lys,C8 H17 N3 O3,203.12694,NA,NA,Gly-Lys,8,17,3,3,0,0,2.125,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,2236403.3579825135,2154211.6785364132,0.963248275784988,-0.0540203964252452,0.9080625412476984,0.971254691401256,Downregulated
Feature0320,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.1212,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak1,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,709250.3980745054,907939.5695442123,1.2801396685981627,0.356301222882568,0.4732181610816362,0.7253425911661145,Upregulated
Feature0319,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10552,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak2",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,4341938.525822117,3987330.5763350464,0.9183295785101131,-0.12291608073697055,0.002364230255643448,0.2411514860756317,Downregulated
Feature0318,eutypine,C12 H10 O2,186.06813,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,eutypine,12,10,2,0,0,0,0.8333333333333334,0.16666666666666666,-0.5,74.55,8,6,0.6,0.6363636363636364,6,Lignin,310127.3511836843,183754.26390863,0.5925122798981854,-0.755083040514223,0.26124465804368174,0.7028461383187669,Downregulated
Feature0317,threonylphenylalanine,C13 H18 N2 O4,266.12661,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak1,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,180414.77717697967,216431.32772537734,1.1996319321064641,0.2625918298522241,0.6036423621744385,0.7977464432976679,Upregulated
Feature0316,NA,C19 H34 N4 O7,430.24288,NA,NA,Feature0316,19,34,7,4,0,0,1.7894736842105263,0.3684210526315789,-0.4210526315789478,72.30000000000001,5,-2,-0.75,-0.21739130434782608,-6,Protein,742361.2464599507,164774.69162519727,0.22196025507924547,-2.1716267288232047,0.30275956298687146,0.7028461383187669,Downregulated
Feature0315,NA,C13 H25 N3 O5,303.17947,NA,NA,Feature0315,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,1021711.0815573146,1001237.335741504,0.9799613156934698,-0.029203295413322082,0.7339891519533881,0.8798459706107921,Downregulated
Feature0314,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08989,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak1,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,800559.8698464833,824220.1028982673,1.0295546078974969,0.04202035299449918,0.5931975376547358,0.7932868143606837,Upregulated
Feature0313,2'-Deoxycytidine-5'-monophosphorate,C9 H14 N3 O7 P,307.05702,Metabolic pathways;Other,Other,2'-Deoxycytidine-5'-monophosphorate,9,14,7,3,0,1,1.5555555555555556,0.7777777777777778,0.44444444444444464,47.633333333333326,5,-2,3,-1.6666666666666667,-6,Carbohydrate,1031131.8213592833,625381.2556043103,0.6064998118086447,-0.7214208971966093,0.02004518359758057,0.536051174383958,Downregulated
Feature0312,NA,C12 H18 N4 O6,314.12269,NA,NA,Feature0312,12,18,6,4,0,0,1.5,0.5,0.5,46.05,6,0,-2,-0.2,-4,Protein,2976968.1356609534,2966596.61253002,0.9965160785543207,-0.0050350120875072785,0.9840840437931144,0.9929337204459302,Downregulated
Feature0311,NA,C8 H18 N O9 P,303.07198,NA,NA,Feature0311,8,18,9,1,0,1,2.25,1.125,-0.25,67.425,1,-8,3.3333333333333335,-3.6666666666666665,-10,Carbohydrate,441017.97489993664,359755.29227895365,0.8157383888050803,-0.2938215477005305,0.035455622489521575,0.5992830975343959,Downregulated
Feature0310,TC2700000,C2 H7 O4 P,126.00817,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,TC2700000,2,7,4,0,0,1,3.5,2,-2,117.3,0,-4,1.6666666666666667,3,-5,Other,600593.1799749407,487356.811516703,0.8114591170299962,-0.30140968421006714,0.0032595451295224947,0.3047674696103533,Downregulated
Feature0309,dictyoquinazol B,C18 H20 N2 O4,328.14238,NA,NA,dictyoquinazol B,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,1478580.7003781267,1844059.0159957367,1.247181851842205,0.31867184016585903,0.10769337820130918,0.6736684190877296,Upregulated
Feature0308,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",C20 H20 O7,372.12097,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",20,20,7,0,0,0,1,0.35,-0.2999999999999998,68.85,11,4,0.3076923076923077,0.4545454545454546,4,Lignin,234613.45011069134,205267.68334651666,0.8749186512950163,-0.19277921146141447,0.16780675288045438,0.6736684190877296,Downregulated
Feature0307,NA,C7 H16 O6,196.09463,NA,NA,Feature0307,7,16,6,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,1995070.60511538,1590924.1841662533,0.7974275096265309,-0.32657471865020343,0.16217232576909538,0.6736684190877296,Downregulated
Feature0306,"4,5,7-Trihydroxycoumarin",C9 H6 O5,194.02152,Biosynthesis of various plant secondary metabolites,NA,"4,5,7-Trihydroxycoumarin",9,6,5,0,0,0,0.6666666666666666,0.5555555555555556,0.44444444444444464,47.633333333333326,7,2,0.5,0.6923076923076923,2,Condensed HC,117019.73927594701,99798.5940435959,0.8528355528827362,-0.22966051267855694,0.1620361236665241,0.6736684190877296,Downregulated
Feature0305,Clavamycin D,C13 H21 N3 O6,315.14297,NA,NA,Clavamycin D,13,21,6,3,0,0,1.6153846153846154,0.4615384615384616,0,60.3,5,-1,-1,-0.14285714285714285,-4,Protein,325553.73075356765,298528.60535039334,0.9169872041072343,-0.1250264926917198,0.7781246026077184,0.907639449407689,Downregulated
Feature0304,NA,C21 H38 N4 O7,458.27426,NA,NA,Feature0304,21,38,7,4,0,0,1.8095238095238095,0.3333333333333333,-0.5714285714285712,76.58571428571427,5,-2,-0.6,-0.18518518518518515,-6,Protein,217312.17944342768,3613311.7462085723,16.627285941647905,4.055480792792485,0.4076762825857044,0.7136536716603119,Upregulated
Feature0303,pro-gln,C10 H17 N3 O4,243.1219,NA,NA,pro-gln,10,17,4,3,0,0,1.7,0.4,0,60.3,4,0,-1,-0.2,-3,Protein,7401144.85150982,3194391.0804062816,0.43160769644369706,-1.212207503643097,0.3775995208544025,0.7136536716603119,Downregulated
Feature0302,NA,C11 H15 N5 O,233.12763,NA,NA,Feature0302,11,15,1,5,0,0,1.3636363636363635,0.09090909090909093,0.18181818181818168,55.11818181818182,7,6,0.2,0.2727272727272727,1,Unsaturated HC,7119806.781065706,6055037.384633277,0.8504496780356372,-0.23370222219244333,0.06587182833664938,0.6632182304416021,Downregulated
Feature0301,NA,C19 H36 N4 O6,416.26354,NA,NA,Feature0301,19,36,6,4,0,0,1.894736842105263,0.3157894736842105,-0.6315789473684212,78.30000000000001,4,-2,-0.6666666666666666,-0.25,-6,Protein,225687.49666723135,175497.08611015335,0.7776110272024415,-0.36287941712489835,0.15017379403071598,0.6736684190877296,Downregulated
Feature0300,Monoethyl malonic acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Monoethyl malonic acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,2131155.22620158,1824958.1550894133,0.856323430903759,-0.22377229355207368,0.4083619190971808,0.7136536716603119,Downregulated
Feature0299,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10595,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,806120.1413998593,771486.1953423406,0.957036247726827,-0.06335452709831911,0.8413032623308643,0.9411189036243566,Downregulated
Feature0298,NA,C7 H7 O2 P S,185.99051,NA,NA,Feature0298,7,7,2,0,1,1,1,0.2857142857142857,-0.8571428571428568,84.72857142857141,5,3,0.3333333333333333,0.5,1,Lignin,915998.84716698,938830.6272172107,1.0249255554423953,0.03551912466295185,0.8502706507756701,0.9413744745889566,Upregulated
Feature0297,gln-phe,C14 H19 N3 O4,293.13756,NA,NA,gln-phe-peak1,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,176638.072204646,510575.9967642903,2.8905206583819414,1.5313293832486412,0.31138044643048174,0.7028461383187669,Upregulated
Feature0296,asn-tyr,C13 H17 N3 O5,295.11689,NA,NA,asn-tyr-peak2,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,1369623.4218800534,1064500.4482843117,0.7772212648226285,-0.36360272119716863,0.14764230861244634,0.6736684190877296,Downregulated
Feature0295,6-Hydroxymelatonin,C13 H16 N2 O3,248.11602,Other,Other,6-Hydroxymelatonin-peak2,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,147708.700679287,118407.578416202,0.8016290027037395,-0.31899338912378755,0.057532449807085814,0.6632182304416021,Downregulated
Feature0294,beta-Aspartylaspartic acid,C8 H12 N2 O7,248.0644,NA,NA,beta-Aspartylaspartic acid,8,12,7,2,0,0,1.5,0.875,1,31.799999999999997,4,-3,5,-0.6,-5,Carbohydrate,1202178.9611033767,1222128.2310816399,1.0165942597763926,0.023743989710216316,0.9381832031222688,0.978637034430813,Upregulated
Feature0293,Asp-Trp,C15 H17 N3 O5,319.11688,NA,NA,Asp-Trp,15,17,5,3,0,0,1.1333333333333333,0.3333333333333333,0.1333333333333333,56.5,9,4,0.14285714285714285,0.3684210526315789,1,Lignin,371909.656351484,244847.85405051932,0.6583530431893889,-0.6030666551996174,0.2767015010089309,0.7028461383187669,Downregulated
Feature0292,asn-val,C9 H17 N3 O4,231.12194,NA,NA,asn-val-peak1,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,1342180.46512154,1008695.5947054534,0.7515349991434362,-0.41208780256885535,0.350854460664291,0.7136536716603119,Downregulated
Feature0291,NA,C26 H43 N5 O5,505.32642,NA,NA,Feature0291,26,43,5,5,0,0,1.6538461538461535,0.19230769230769232,-0.6923076923076925,80.03076923076924,8,3,-0.125,0.02702702702702703,-2,Lipid,263440.01239786064,220986.36786015533,0.8388489123148475,-0.25351710911245295,0.12365451084737106,0.6736684190877296,Downregulated
Feature0290,cis-acetylacrylic acid,C5 H6 O3,114.03164,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,6026731.09838039,6026691.067424513,0.9999933577663873,-9.582749318912976e-6,0.9999185624555997,0.9999185624555997,Downregulated
Feature0289,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,C14 H19 N O6,297.12132,NA,NA,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,14,19,6,1,0,0,1.3571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,6,0,-0.14285714285714285,0.2,-1,Lignin,347540.5381760867,446022.883534767,1.2833693757727416,0.35993646263320644,0.3079209719787708,0.7028461383187669,Upregulated
Feature0288,NA,C8 H19 N O7,241.11608,NA,NA,Feature0288,8,19,7,1,0,0,2.375,0.875,-0.25,67.425,0,-7,-Inf,-1.2857142857142858,-8,Carbohydrate,1052169.7483503525,867579.2264323013,0.8245620326877274,-0.27830006164366344,0.18434375688846544,0.6736684190877296,Downregulated
Feature0287,Kyotorphin,C15 H23 N5 O4,337.17513,NA,NA,Kyotorphin,15,23,4,5,0,0,1.5333333333333334,0.26666666666666666,0,60.3,7,3,-0.3333333333333333,0,-2,Lipid,851283.6416892523,625891.2780288017,0.7352323566171302,-0.44372783573609564,0.33613886163541074,0.7109768007209386,Downregulated
Feature0286,NA,C17 H25 N3 O4,335.18464,NA,NA,Feature0286,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,1871687.33560967,1573182.8589693557,0.8405158431319505,-0.2506530813837086,0.581230500542129,0.7823027661346383,Downregulated
Feature0285,S-Allyl-L-cysteine,C6 H11 N O2 S,161.05105,NA,Other,S-Allyl-L-cysteine,6,11,2,1,1,0,1.8333333333333333,0.3333333333333333,-0.33333333333333304,69.79999999999998,2,0,-1,-0.3333333333333333,-2,Protein,131949.43610735633,111484.89429462,0.8449061821220211,-0.2431369405950883,0.2573800517212787,0.7028461383187669,Downregulated
Feature0284,?-Ribazole,C14 H18 N2 O4,278.12667,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak2,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,2919105.78794523,3543598.719106407,1.2139329563663261,0.2796887459850941,0.5098916243796212,0.7449197949921028,Upregulated
Feature0283,Pheneturide,C11 H14 N2 O2,206.10554,Other,NA,Pheneturide,11,14,2,2,0,0,1.2727272727272727,0.18181818181818185,-0.3636363636363633,70.66363636363636,6,4,0.2857142857142857,0.375,2,Lignin,465443.7981059473,346599.759716538,0.7446651155885479,-0.42533631991564974,0.5616239288444076,0.7700004054129788,Downregulated
Feature0282,pyricarbate,C11 H15 N3 O4,253.10625,NA,NA,pyricarbate,11,15,4,3,0,0,1.3636363636363635,0.3636363636363637,0.18181818181818168,55.11818181818182,6,2,-0.25,0.16666666666666666,-1,Lignin,7174355.353504163,6118973.394878116,0.852895221016538,-0.22955957890625547,0.18559996484411506,0.6736684190877296,Downregulated
Feature0281,NA,C31 H37 N O11,599.23689,NA,NA,Feature0281,31,37,11,1,0,0,1.1935483870967742,0.3548387096774194,-0.387096774193548,71.33225806451611,14,3,0.10526315789473684,0.30612244897959184,2,Lignin,232682.538457207,203578.29278931834,0.8749186515633562,-0.192779211018936,0.16780675373862328,0.6736684190877296,Downregulated
Feature0280,NA,C7 H14 N2 O2,158.10555,NA,NA,Feature0280,7,14,2,2,0,0,2,0.2857142857142857,-0.5714285714285712,76.58571428571427,2,0,-0.6666666666666666,-0.25,-2,Lipid,301151.7227124614,345828.4634387207,1.1483529309540643,0.19956610323800614,0.6604135477884276,0.8325662928299055,Upregulated
Feature0279,NA,C15 H27 N3 O6,345.19011,NA,NA,Feature0279,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,5555161.5065744035,5153915.9675931595,0.927770679843173,-0.1081598411907165,0.5556816492337534,0.7676307183901608,Downregulated
Feature0278,arg-gln,C11 H22 N6 O4,302.17037,NA,NA,arg-gln,11,22,4,6,0,0,2,0.3636363636363637,0.36363636363636376,49.93636363636363,4,0,-6,-1.3333333333333333,-6,Protein,420823.8047811933,339640.64492936234,0.8070851531461201,-0.3092071989052163,0.22189606503370357,0.6783852451439112,Downregulated
Feature0277,NA,C18 H31 N6 O4 P3,488.16202,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0277,18,31,4,6,0,3,1.7222222222222223,0.2222222222222222,-1.1111111111111107,91.96666666666664,8,4,-1,-0.42857142857142855,-5,Lipid,7440933.174192723,6993799.361068906,0.9399089062277022,-0.08940715395009746,0.39671640414550474,0.7136536716603119,Downregulated
Feature0276,L-Hydroxyproline,C5 H9 N O3,131.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,L-Hydroxyproline,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,3551591.0519515,3989164.7560496666,1.1232049798801391,0.16762123715152719,0.4930622782947649,0.7405835023383216,Upregulated
Feature0275,Penicillic acid,C8 H10 O4,170.05799,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak1,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,1067745.9570165647,812379.7388693936,0.7608361647552374,-0.3943422715687382,0.5235388895095476,0.7521262919714629,Downregulated
Feature0274,Desthiobiotin,C10 H18 N2 O3,214.13169,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,7560614.850584763,6541941.70132582,0.8652658322913835,-0.20878466039286092,0.4147909748726104,0.7136536716603119,Downregulated
Feature0273,NA,C13 H17 N5 O7,355.11296,NA,NA,Feature0273,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Lignin,4304487.609726616,4200644.044079747,0.9758755106154285,-0.03523097545247567,0.07967016652580726,0.6736684190877296,Downregulated
Feature0272,Aniflorine,C20 H21 N3 O3,351.15844,NA,NA,Aniflorine,20,21,3,3,0,0,1.05,0.15,-0.2999999999999998,68.85,12,9,0.42857142857142855,0.4838709677419355,6,Lignin,111957.84624536634,139000.46833312736,1.2415428931036645,0.3121341049291573,0.5947014087086752,0.7934066356374954,Upregulated
Feature0271,N6-Methyladenine,C6 H7 N5,149.07016,NA,NA,N6-Methyladenine,6,7,0,5,0,0,1.1666666666666667,0,1.3333333333333337,22.29999999999999,6,6,1,1,1,Unsaturated HC,2728233.0183519535,4814958.76474148,1.7648634601050528,0.8195565727037728,0.4675970577092254,0.7216559817740728,Upregulated
Feature0270,NA,C43 H57 N6 O4 P3,814.36502,NA,NA,Feature0270,43,57,4,6,0,3,1.3255813953488371,0.09302325581395347,-1.0697674418604652,90.78837209302326,20,16,0.23333333333333336,0.28125,7,Unsaturated HC,277101.756828544,223920.04694526334,0.8080787704417669,-0.3074321630653619,0.2272444234783306,0.6843823216756625,Downregulated
Feature0269,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",C11 H11 N O4,221.06882,NA,NA,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",11,11,4,1,0,0,1,0.3636363636363637,0,60.3,7,3,0.3333333333333333,0.5,2,Lignin,395625.53319456865,204497.76151957133,0.5168972787684037,-0.9520504877236063,0.04041745433032268,0.6212107364194801,Downregulated
Feature0268,NA,C13 H25 N3 O5,303.17954,NA,NA,Feature0268,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,939335.8546663737,2735820.618069377,2.912505260475834,1.5422606555198948,0.21207245076527687,0.6777335289635477,Upregulated
Feature0267,Phosphonoacetic acid,C2 H5 O5 P,139.98747,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of L-lysine degradation;Other,Phosphonoacetic acid,2,5,5,0,0,1,2.5,2.5,0,60.3,1,-4,1.25,1.6666666666666667,-5,Other,1160656.0158708468,971157.580115996,0.8367316128433891,-0.25716315181526117,0.18896510835879055,0.6736684190877296,Downregulated
Feature0266,"Hydroxy-1,4-benzoquinone",C6 H4 O3,124.01601,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,"Hydroxy-1,4-benzoquinone",6,4,3,0,0,0,0.6666666666666666,0.5,0.3333333333333335,50.8,5,2,0.6666666666666666,0.7777777777777778,2,Condensed HC,719823.404622927,799439.768933753,1.1106054121045597,0.15134633147392526,0.4348446252511189,0.7136536716603119,Upregulated
Feature0265,Leu-Gly-Pro,C13 H23 N3 O4,285.16889,NA,NA,Leu-Gly-Pro-peak2,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,1183101.8579958966,705352.978581321,0.5961895620518647,-0.7461569777062743,0.12477496023777622,0.6736684190877296,Downregulated
Feature0264,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak2,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,415055.5586530083,299499.0529034863,0.7215878613346588,-0.4707530253345175,0.3460450886130345,0.7116802007632078,Downregulated
Feature0263,NA,C22 H41 N5 O5,455.31091,NA,NA,Feature0263,22,41,5,5,0,0,1.8636363636363635,0.2272727272727273,-0.7272727272727275,81.02727272727273,5,0,-0.4166666666666667,-0.1724137931034483,-5,Lipid,160709.624325224,257846.90016773433,1.6044272472813208,0.6820583721275933,0.10843343532004816,0.6736684190877296,Upregulated
Feature0262,Bicine,C6 H13 N O4,163.08447,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,Bicine,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,605383.641552159,2033731.8292791958,3.3594099504652246,1.748207859107767,0.5094007529629183,0.7449197949921028,Upregulated
Feature0261,Ethyl L-tyrosinate,C11 H15 N O3,209.1052,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Ethyl L-tyrosinate,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,141188.30637596064,193084.7526708482,1.3675690121014417,0.451613638066693,0.4448433299663003,0.7147297968682652,Upregulated
Feature0260,Gly-Ser,C5 H10 N2 O4,162.06409,NA,NA,Gly-Ser,5,10,4,2,0,0,2,0.8,0.7999999999999998,37.5,2,-2,4,-2,-4,Carbohydrate,2705776.0670469967,2271034.567477193,0.839328352089289,-0.25269277974215176,0.18622545167800628,0.6736684190877296,Downregulated
Feature0259,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23296,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak1,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,5394057.57849583,3973369.7389907124,0.7366198230495555,-0.44100787300882166,0.5075078207447714,0.744344803758998,Downregulated
Feature0258,Oglufanide,C16 H19 N3 O5,333.13251,NA,NA,Oglufanide,16,19,5,3,0,0,1.1875,0.3125,0,60.3,9,4,0.125,0.3333333333333333,1,Lignin,522208.3772307873,336152.0565779553,0.6437124933930247,-0.6355116254474596,0.15238098635420888,0.6736684190877296,Downregulated
Feature0257,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",C13 H14 N2 O4,262.09538,NA,NA,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",13,14,4,2,0,0,1.0769230769230769,0.3076923076923077,0,60.3,8,4,0.2857142857142857,0.4444444444444444,2,Lignin,3521367.3803601298,2168371.0426551923,0.6157752964796969,-0.6995241040247937,0.31778299458919634,0.7028461383187669,Downregulated
Feature0256,ophthalmic acid,C11 H19 N3 O6,289.12729,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,ophthalmic acid,11,19,6,3,0,0,1.7272727272727273,0.5454545454545454,0.18181818181818168,55.11818181818182,4,-2,-2.5,-0.4,-5,Protein,608716.0968487824,342659.742251396,0.5629220978799248,-0.8289928116202923,0.0990810622047306,0.6736684190877296,Downregulated
Feature0255,Leu-Glu,C11 H20 N2 O5,260.13726,NA,NA,Leu-Glu-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,1453698.46340999,1467940.1673773767,1.0097968762613805,0.014065119628625673,0.9065771820728611,0.971254691401256,Upregulated
Feature0254,N-Acetyl-L-leucine,C8 H15 N O3,173.10526,Other,NA,N-Acetyl-L-leucine-peak2,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,3170260.4259058833,2475418.2975207167,0.7808249055165177,-0.35692902445053765,0.0558961090891348,0.6632182304416021,Downregulated
Feature0253,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak2,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,1987201.1398573534,2945516.1057201168,1.482243566915201,0.5677825353010486,0.24802296324327064,0.7019200023813293,Upregulated
Feature0252,N-Acetylvanilalanine,C12 H15 N O5,253.09505,NA,NA,N-Acetylvanilalanine-peak1,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,5498749.98511644,4691059.84978193,0.8531138645108983,-0.22918978499432477,0.07209198196786404,0.6684892873383756,Downregulated
Feature0251,tyr-thr,C13 H18 N2 O5,282.12167,NA,NA,tyr-thr,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Lignin,1051577.390880538,1005726.6081940933,0.9563980900653908,-0.06431684590844092,0.779448688608354,0.907639449407689,Downregulated
Feature0250,Alanyltryptophan,C14 H17 N3 O3,275.12702,NA,NA,Alanyltryptophan,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Lignin,804659.924864985,650686.38870178035,0.8086476890357872,-0.3064168075445438,0.7335771916555793,0.8798459706107921,Downregulated
Feature0249,pre-putrebactin,C16 H30 N4 O7,390.2116,NA,NA,pre-putrebactin,16,30,7,4,0,0,1.875,0.4375,-0.25,67.425,4,-3,-1.4,-0.4117647058823529,-7,Protein,546123.222840936,407014.10203628166,0.745278876658993,-0.4241477247640004,0.5724152346975095,0.7775422437416534,Downregulated
Feature0248,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",C13 H10 N2 O,210.07933,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",13,10,1,2,0,0,0.7692307692307693,0.07692307692307693,-0.1538461538461542,64.6846153846154,10,9,0.7,0.7142857142857143,7,Condensed HC,5819619.6723811105,5145432.469105656,0.8841527039172289,-0.17763253278386393,0.1680090058194736,0.6736684190877296,Downregulated
Feature0247,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",C18 H20 N2 S,296.13484,NA,NA,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",18,20,0,2,1,0,1.1111111111111112,0,-0.666666666666667,79.30000000000001,10,10,0.4666666666666667,0.4666666666666667,7,Unsaturated HC,119855.69838354267,3031062.6553687616,25.28926614460373,4.660453267716821,0.42546178006621055,0.7136536716603119,Upregulated
Feature0246,3-Buten-1-amine,C4 H9 N,71.07351,NA,NA,3-Buten-1-amine,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,1030996.4758449683,809141.5579710234,0.7848150570135358,-0.3495753743414518,0.54040005298648075,0.7560210217591414,Downregulated
Feature0245,NA,C14 H26 N4 O5,330.1904,NA,NA,Feature0245,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,533609.380004828,475132.3469687697,0.8904122842901877,-0.16745459838641763,0.7872534630799338,0.907639449407689,Downregulated
Feature0244,Bis(methylbenzylidene)sorbitol,C22 H26 O6,386.17299,NA,NA,Bis(methylbenzylidene)sorbitol,22,26,6,0,0,0,1.181818181818182,0.2727272727272727,-0.6363636363636367,78.43636363636364,10,4,0.25,0.3684210526315789,4,Lignin,205063.217737325,517126.04413449566,2.5217884018425303,1.334447227125512,0.4962237037579813,0.7409615456815796,Upregulated
Feature0243,6-Quinolinecarboxylic acid,C10 H7 N O2,173.04768,Other,NA,6-Quinolinecarboxylic acid,10,7,2,1,0,0,0.7,0.2,0,60.3,8,6,0.7142857142857143,0.75,5,Condensed HC,226858.25416901332,445513.37566029566,1.9638402723860358,0.9736775938035358,0.01244954817708187,0.5000414976159331,Upregulated
Feature0242,Asp-tyr,C13 H16 N2 O6,296.10088,NA,NA,Asp-tyr,13,16,6,2,0,0,1.2307692307692308,0.4615384615384616,0.15384615384615374,55.91538461538462,7,1,-0.2,0.25,-1,Lignin,3048608.972454483,2879767.5269225133,0.94461689017597,-0.08219876313034671,0.6261958262174088,0.8131865534587971,Downregulated
Feature0241,4-Amino-3-hydroxybenzoic acid,C7 H7 N O3,153.04263,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,4-Amino-3-hydroxybenzoic acid,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,232660.76901028902,226356.454926983,0.9729034073508661,-0.039631517685068784,0.9414924359944741,0.978637034430813,Downregulated
Feature0240,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13725,NA,NA,L-gamma-Glutamyl-L-leucine,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,4871494.856736586,1920344.2405001898,0.39420019870176526,-1.3429995912964783,0.3673019926540814,0.7136536716603119,Downregulated
Feature0239,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07399,NA,NA,Phenyl D-glucopyranosiduronic acid-peak1,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1598717.3438846034,416591.4800854153,0.26057857048899646,-1.9402096507375193,0.033208510612567056,0.5992830975343959,Downregulated
Feature0238,NA,C13 H23 N3 O6,317.15873,NA,NA,Feature0238,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,3083025.4813403,2622485.5033568465,0.8506207682126453,-0.23341201557426228,0.6214487724342284,0.8121601742211405,Downregulated
Feature0237,Leu-Gly-Pro,C13 H23 N3 O4,285.16893,NA,NA,Leu-Gly-Pro-peak1,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,344113.85222997033,520959.0411236726,1.513914763232249,0.5982839806711797,0.21146994175312583,0.6777335289635477,Upregulated
Feature0236,2-Methoxy-5-methylaniline,C8 H11 N O,137.08405,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,2-Methoxy-5-methylaniline,8,11,1,1,0,0,1.375,0.125,-0.75,81.675,4,3,0.3333333333333333,0.38461538461538464,2,Unsaturated HC,4142727.3979407535,3651631.29734523,0.8814558493905162,-0.1820397856488096,0.38804527473266875,0.7136536716603119,Downregulated
Feature0235,Salsolinol,C10 H13 N O2,179.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Salsolinol,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,666143.4364127157,363310.592710845,0.5453939389800613,-0.8746294273661183,0.10678609474876097,0.6736684190877296,Downregulated
Feature0234,L-Phenylalanine,C9 H11 N O2,165.079,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak1,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,638355.5065942823,621331.3078808803,0.9733311633759869,-0.03899734797565027,0.9322024400687678,0.9775057362216425,Downregulated
Feature0233,(E)-5-(methylsulfanyl)pentanal oxime,C6 H13 N O S,147.0718,2-Oxocarboxylic acid metabolism;Other,NA,(E)-5-(methylsulfanyl)pentanal oxime,6,13,1,1,1,0,2.1666666666666665,0.16666666666666666,-1,88.8,1,0,-0.6666666666666666,-0.42857142857142855,-2,Lipid,130116.73079564967,112470.617465028,0.8643824416528328,-0.21025832810139794,0.00662334798935344,0.41285535800303114,Downregulated
Feature0232,NA,C16 H31 N3 O5,345.2265,NA,NA,Feature0232,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1381733.82623551,953178.7401405497,0.6898425167294738,-0.5356610464242011,0.4162262397694228,0.7136536716603119,Downregulated
Feature0231,NA,C9 H15 N O5,217.09502,NA,NA,Feature0231,9,15,5,1,0,0,1.6666666666666667,0.5555555555555556,-0.22222222222222232,66.63333333333333,3,-2,-1,-0.09090909090909093,-3,Amino Sugar,1170054.9646536866,1542089.7267823569,1.3179634917738974,0.398310407549122,0.4785709752427492,0.7305532438399519,Upregulated
Feature0230,ser-trp,C14 H17 N3 O4,291.12193,NA,NA,ser-trp,14,17,4,3,0,0,1.2142857142857142,0.2857142857142857,0,60.3,8,4,0.14285714285714285,0.3333333333333333,1,Lignin,2507768.46777546,1963255.07330094,0.7828693511895316,-0.3531565308165388,0.04244029246549046,0.626552738766846,Downregulated
Feature0229,Caffeic acid,C9 H8 O4,180.04231,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak1,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,439107.965059322,384717.7040567997,0.8761346517702671,-0.1907754824666474,0.381855972940255,0.7136536716603119,Downregulated
Feature0228,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,273626.851797245,205350.195509739,0.750475306648273,-0.4141234921448874,0.10514950240663691,0.6736684190877296,Downregulated
Feature0227,Adenylsuccinic acid,C14 H18 N5 O11 P,463.07418,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of purine nucleotide salvage;Other,Adenylsuccinic acid,14,18,11,5,0,1,1.2857142857142858,0.7857142857142857,1,31.799999999999997,9,-2,2.6666666666666665,-1,-8,Tannin,93212.11376632846,127470.23821545373,1.3675286726680855,0.45157108199947577,0.27768129836925454,0.7028461383187669,Upregulated
Feature0226,NA,C16 H21 N5 O9,427.13397,NA,NA,Feature0226,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2819009.3343892167,2614606.063261687,0.927491098154942,-0.10859465974082179,0.12962641175191356,0.6736684190877296,Downregulated
Feature0225,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.07946,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak1",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,305028.9508334493,218700.60544482968,0.7169831088074119,-0.47998896358476867,0.3934403853187051,0.7136536716603119,Downregulated
Feature0224,Succinyladenosine,C14 H17 N5 O8,383.10785,NA,NA,Succinyladenosine,14,17,8,5,0,0,1.2142857142857142,0.5714285714285714,1,31.799999999999997,9,1,-4,0,-4,Lignin,1153828.5821661535,2199989.06944631,1.906686230043058,0.9310674489964811,0.3904679727164014,0.7136536716603119,Upregulated
Feature0223,NA,C14 H28 N6 O4,344.21736,NA,NA,Feature0223,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,196267.10761379666,185034.1082350437,0.9427667757714318,-0.08502717770189215,0.8454459845777922,0.9413744745889566,Downregulated
Feature0222,cys-val,C8 H16 N2 O3 S,220.08817,NA,NA,cys-val-peak1,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,2137422.21119186,1527845.9184751133,0.7148077298322649,-0.4843728593182857,0.01556991221744802,0.5000414976159331,Downregulated
Feature0221,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.29814,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak1,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,166356.92561295434,148852.037892215,0.894775118882239,-0.16040295512452946,0.10894042229972933,0.6736684190877296,Downregulated
Feature0220,Deoxyadenosine monophosphate,C10 H14 N5 O6 P,331.06822,Metabolic pathways;Other,NA,Deoxyadenosine monophosphate,10,14,6,5,0,1,1.4,0.6,0.7999999999999998,37.5,7,1,2.5,-2,-5,Lignin,1774899.0300223299,853013.8641455787,0.4805985296723313,-1.0570958601475917,0.003784876597183251,0.3266639647722775,Downregulated
Feature0219,PYRIDOXAMINE,C8 H12 N2 O2,168.08993,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,2320333.4852468,1998145.43841118,0.86114580128927,-0.2156705727251883,0.3891763412474936,0.7136536716603119,Downregulated
Feature0218,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,C9 H15 N O2,169.11033,NA,NA,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,9,15,2,1,0,0,1.6666666666666667,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,1,0,0.14285714285714285,0,Lipid,498797.5403128727,461233.22628571297,0.924690258088287,-0.11295790542502394,0.8908707512691919,0.9657555390570371,Downregulated
Feature0217,NA,C13 H22 N2 O10,366.12745,NA,NA,Feature0217,13,22,10,2,0,0,1.6923076923076923,0.7692307692307693,0.3076923076923075,51.53076923076924,4,-6,-8,-0.5,-8,Carbohydrate,603022.0679205867,452842.371381378,0.7509548911583345,-0.4132018452792595,0.070341327471079,0.6632182304416021,Downregulated
Feature0216,NA,C19 H41 N O,299.31886,NA,NA,Feature0216,19,41,1,1,0,0,2.1578947368421053,0.05263157894736842,-1.8947368421052628,114.29999999999998,0,-1,-0.1176470588235294,-0.08571428571428572,-2,Lipid,216059.47321476368,187446.62084484298,0.8675695541408663,-0.2049486698862797,0.14230229143169434,0.6736684190877296,Downregulated
Feature0215,NA,C16 H35 N O,257.27187,NA,NA,Feature0215,16,35,1,1,0,0,2.1875,0.0625,-1.875,113.7375,0,-1,-0.14285714285714285,-0.10344827586206896,-2,Lipid,5228081.364986519,6852716.5773588335,1.3107517077398245,0.39039442550040276,0.5885871317349487,0.788120360758212,Upregulated
Feature0214,NA,C19 H29 N3 O4,363.21589,NA,NA,Feature0214,19,29,4,3,0,0,1.5263157894736843,0.21052631578947367,-0.6315789473684212,78.30000000000001,7,3,0,0.14285714285714285,0,Lipid,243272.890970359,196800.535440067,0.8089702664981512,-0.30584141715668145,0.5596134558828442,0.7700004054129788,Downregulated
Feature0213,Trigonelline,C7 H7 N O2,137.04766,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak2,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,320877.1840109997,270795.415916207,0.8439223148596446,-0.2448178934963929,0.23354522058948826,0.6875073975489493,Downregulated
Feature0212,N-(5-acetamidopentyl)acetamide,C9 H18 N2 O2,186.13687,NA,NA,N-(5-acetamidopentyl)acetamide,9,18,2,2,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,2,0,-0.4,-0.16666666666666666,-2,Lipid,214067.39111768632,147139.47610308265,0.6873511903650511,-0.5408806870503585,0.07742527522651733,0.6736684190877296,Downregulated
Feature0211,Prolylaspartic acid,C9 H14 N2 O5,230.09029,Biosynthesis of secondary metabolites;Other,NA,Prolylaspartic acid,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,7030286.379403063,5973977.30725314,0.8497487847373276,-0.23489170137982626,0.36673226794420427,0.7136536716603119,Downregulated
Feature0210,NA,C12 H22 N4 O3,270.16921,NA,NA,Feature0210,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,138478.71174275567,113945.751641858,0.822839483468974,-0.2813170724899926,0.014847005231755762,0.5000414976159331,Downregulated
Feature0209,NA,C19 H29 N3 O5,379.21071,NA,NA,Feature0209,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,1621881.4949551034,1331518.44319401,0.8209714750033996,-0.28459599905488553,0.2895627314243422,0.7028461383187669,Downregulated
Feature0208,Enicoflavine,C10 H13 N O4,211.0845,NA,NA,Enicoflavine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,316330.1509409377,238647.163400038,0.7544243338492133,-0.4065518842012286,0.35186971203969947,0.7136536716603119,Downregulated
Feature0207,Phenethylamine,C8 H11 N,121.0891,Metabolic pathways;Phenylalanine metabolism;Other,Other,Phenethylamine,8,11,0,1,0,0,1.375,0,-1,88.8,4,4,0.42857142857142855,0.42857142857142855,3,Unsaturated HC,2761818.56764305,2835360.01749219,1.0266279076803733,0.03791338417352115,0.8102773580762237,0.9211055681474397,Upregulated
Feature0206,Norsolorinic acid,C20 H18 O7,370.10536,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Norsolorinic acid,20,18,7,0,0,0,0.9,0.35,-0.20000000000000015,66,12,5,0.38461538461538464,0.5151515151515151,5,Lignin,152970.90549941268,133961.83710996434,0.8757340925230954,-0.1914352177937713,0.15208191928244486,0.6736684190877296,Downregulated
Feature0205,NA,C7 H16 N2 O3,176.11612,NA,NA,Feature0205,7,16,3,2,0,0,2.2857142857142856,0.42857142857142855,-0.5714285714285712,76.58571428571427,1,-2,-2,-0.7142857142857143,-4,Protein,178227.169679201,110995.805157724,0.6227771296458912,-0.68321212984146,0.0892927018368701,0.6736684190877296,Downregulated
Feature0204,NP-003800,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,NP-003800,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,510334.90605739004,287101.46533019864,0.5625746189854246,-0.8298836291345943,0.045280763106203124,0.6431014709513911,Downregulated
Feature0203,asn-leu,C10 H19 N3 O4,245.13756,NA,NA,asn-leu,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,2431980.8602078333,1908010.994645328,0.7845501689031682,-0.35006239006033735,0.38010717068765987,0.7136536716603119,Downregulated
Feature0202,Isovalerylglutamic acid,C10 H17 N O5,231.11066,NA,NA,Isovalerylglutamic acid-peak2,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,176177.192658288,281160.1770537843,1.595894297164336,0.6743650989243136,0.44293124802289374,0.7147297968682652,Upregulated
Feature0201,NA,C13 H24 N4 O6,332.1696,NA,NA,Feature0201,13,24,6,4,0,0,1.8461538461538465,0.4615384615384616,0,60.3,4,-2,-2,-0.5,-6,Protein,1463220.40037165,869356.6547242854,0.5941392386980618,-0.7511270233916346,0.05737884391318894,0.6632182304416021,Downregulated
Feature0200,NA,C8 H10 N2 O2,166.07426,NA,NA,Feature0200,8,10,2,2,0,0,1.25,0.25,0,60.3,5,3,0.25,0.4,1,Lignin,525207.3853303053,959889.656635025,1.827639297248926,0.86998136830719075,0.5173713745686632,0.7480550029201548,Upregulated
Feature0199,Isovalerylglutamic acid,C10 H17 N O5,231.11064,NA,NA,Isovalerylglutamic acid-peak1,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,1990820.7176343733,1603142.5927983439,0.8052671838292428,-0.3124605528642226,0.6261971320752234,0.8131865534587971,Downregulated
Feature0198,L-dihydroanticapsin,C9 H15 N O4,201.10006,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,L-dihydroanticapsin,9,15,4,1,0,0,1.6666666666666667,0.4444444444444444,-0.44444444444444464,72.96666666666667,3,-1,-0.5,0,-2,Protein,456215.02651112364,382360.53932806663,0.838114742191079,-0.25478032511782517,0.7883534511531299,0.907639449407689,Downregulated
Feature0197,NA,C14 H25 N3 O4,299.18456,NA,NA,Feature0197,14,25,4,3,0,0,1.7857142857142858,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,0,-0.42857142857142855,-0.1111111111111111,-3,Lipid,473406.71812563465,1006856.13478896,2.126831107879961,1.0887054731207249,0.0018171345789772793,0.21553253721925636,Upregulated
Feature0196,SLH,C15 H25 N5 O5,355.18569,NA,NA,SLH,15,25,5,5,0,0,1.6666666666666667,0.3333333333333333,0,60.3,6,1,-0.8,-0.2,-4,Protein,1120270.1834028133,873222.58054238,0.7794749815530858,-0.35942537673471114,0.5308335279998103,0.7543471763776491,Downregulated
Feature0195,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16894,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak1,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1273864.5298016618,1990724.0328485083,1.5627439074376772,0.6440813779916507,0.5371866256022653,0.7543471763776491,Upregulated
Feature0194,asn-lys,C10 H20 N4 O4,260.14846,NA,NA,asn-lys,10,20,4,4,0,0,2,0.4,0,60.3,3,-1,-2.5,-0.75,-5,Protein,990634.7281538896,1356263.1744441162,1.3690850279109417,0.4532120488866411,0.6553513597613533,0.829722313882859,Upregulated
Feature0193,Tyrosyltyrosine,C18 H20 N2 O5,344.13731,NA,NA,Tyrosyltyrosine,18,20,5,2,0,0,1.1111111111111112,0.2777777777777778,-0.22222222222222232,66.63333333333333,10,5,0.2727272727272727,0.4074074074074074,3,Lignin,1763617.9867146467,1733032.6604245068,0.982657623974954,-0.025239252312443224,0.8206288871197887,0.9241442293136327,Downregulated
Feature0192,7-Methylguanine,C6 H7 N5 O,165.06507,NA,NA,7-Methylguanine,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,1149284.45531762,1141005.4283501697,0.9927963639209213,-0.01043026322535917,0.962582674439692,0.9881223794339749,Downregulated
Feature0191,Leonurine,C14 H21 N3 O5,311.14813,NA,NA,Leonurine-peak1,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,2190787.3509306633,2180748.65960082,0.9954177700881928,-0.006625952809864518,0.9608655108677817,0.9877112482048052,Downregulated
Feature0190,Neostigmine,C12 H18 N2 O2,222.13678,Other,NA,Neostigmine,12,18,2,2,0,0,1.5,0.16666666666666666,-0.666666666666667,79.30000000000001,5,3,0.125,0.2222222222222222,1,Lipid,5557848.192313886,4837107.947995123,0.8703202715548266,-0.20038169489477844,0.10934196411755656,0.6736684190877296,Downregulated
Feature0189,NA,C14 H21 N O10,363.11672,NA,NA,Feature0189,14,21,10,1,0,0,1.5,0.7142857142857143,0.1428571428571428,56.22857142857143,5,-5,-2,-0.125,-6,Carbohydrate,100158.76019998624,2903251.102636568,28.986492013675772,4.857308841853314,0.31188255460793196,0.7028461383187669,Upregulated
Feature0188,NA,C20 H36 N4 O7,444.25844,NA,NA,Feature0188,20,36,7,4,0,0,1.8,0.35,-0.5,74.55,5,-2,-0.6666666666666666,-0.2,-6,Protein,5663086.4057010505,4809435.934119534,0.8492605603329407,-0.23572084213585692,0.21183513994083922,0.6777335289635477,Downregulated
Feature0187,NA,C19 H37 N O2,311.28246,NA,NA,Feature0187,19,37,2,1,0,0,1.9473684210526316,0.10526315789473684,-1.5789473684210522,105.29999999999998,2,0,-0.0625,0,-1,Lipid,184320.698319969,164925.57478672432,0.8947751190722163,-0.1604029548182187,0.10894042252983448,0.6736684190877296,Downregulated
Feature0186,NA,C13 H25 N O9,339.15309,NA,NA,Feature0186,13,25,9,1,0,0,1.9230769230769231,0.6923076923076923,-0.3076923076923075,69.06923076923076,2,-7,-2.6666666666666665,-0.4666666666666667,-8,Amino Sugar,114854.669837102,120754.9041851525,1.0513713056371046,0.07227226606393439,0.8184762786752684,0.9241442293136327,Upregulated
Feature0185,NA,C47 H83 N10 O10 P3,1040.55075,NA,NA,Feature0185,47,83,10,10,0,3,1.7659574468085106,0.2127659574468085,-1.0212765957446803,89.4063829787234,13,3,-0.4166666666666667,-0.1724137931034483,-10,Lipid,194525.80939063366,230829.46468396732,1.1866264194301903,0.24686580889201135,0.6440239144358839,0.8230009476048539,Upregulated
Feature0184,NA,C20 H29 N3 O4,375.2159,NA,NA,Feature0184,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Lignin,514358.32707776735,231328.52885755,0.4497419730167502,-1.1528305623650714,0.001234698489905227,0.1731664632092081,Downregulated
Feature0183,NA,C9 H21 N O7,255.13179,NA,NA,Feature0183,9,21,7,1,0,0,2.3333333333333335,0.7777777777777778,-0.44444444444444464,72.96666666666667,0,-7,-8,-1,-8,Carbohydrate,307178.2121119513,256957.18819337434,0.8365085089424446,-0.25754787949327035,0.036125739306363376,0.5992830975343959,Downregulated
Feature0182,NA,C18 H32 N4 O7,416.22724,NA,NA,Feature0182,18,32,7,4,0,0,1.7777777777777777,0.3888888888888889,-0.33333333333333304,69.79999999999998,5,-2,-0.8571428571428571,-0.23809523809523808,-6,Protein,827097.0587497914,642729.5184219577,0.7770908040629275,-0.3638449056275169,0.3371119946377356,0.7109768007209386,Downregulated
Feature0181,Succinyl proline,C9 H13 N O5,215.07938,Other,NA,Succinyl proline-peak1,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,209129.82816062402,674351.4355079036,3.2245588371543152,1.6891017940285828,0.24439951485137953,0.6979655491782245,Upregulated
Feature0180,NA,C17 H31 N O9,393.19997,NA,NA,Feature0180,17,31,9,1,0,0,1.8235294117647056,0.5294117647058824,-0.5882352941176467,77.06470588235292,3,-6,-1,-0.21739130434782608,-7,Protein,357396.79810455133,343345.1188949547,0.960683253783695,-0.05786725548099075,0.8687710115209165,0.9482111623798329,Downregulated
Feature0179,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.2629,NA,NA,Leucyl-leucyl-norleucine-peak1,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,1615306.28833208,1354263.7497699808,0.8383944020724117,-0.25429901079984835,0.44132731576363166,0.7146808569581701,Downregulated
Feature0178,NA,C10 H23 N O6,253.15257,NA,NA,Feature0178,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,133725.090513818,169123.02060335767,1.2647067199844741,0.33880286896756295,0.3708488551505489,0.7136536716603119,Upregulated
Feature0177,Tryptophyl-tyrosine,C20 H21 N3 O4,367.15331,NA,NA,Tryptophyl-tyrosine,20,21,4,3,0,0,1.05,0.2,-0.20000000000000015,66,12,8,0.38461538461538464,0.4666666666666667,5,Lignin,210273.48892578602,393516.96951997635,1.8714530848863422,0.9041588820341926,0.08246401235201527,0.6736684190877296,Upregulated
Feature0176,Arachidonoyl Serinol,C23 H39 N O3,377.29295,NA,NA,Arachidonoyl Serinol,23,39,3,1,0,0,1.6956521739130437,0.13043478260869565,-1.304347826086956,97.47391304347823,5,2,0.05263157894736842,0.12195121951219512,1,Lipid,220205.18762322134,181845.15243747534,0.8257986762265503,-0.27613798904331566,0.19798942350976273,0.6777335289635477,Downregulated
Feature0175,Amino-levulinic acid,C5 H9 N O3,131.05828,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,Amino-levulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,3630713.93061324,3134002.950745343,0.8631919260617702,-0.2122467243676428,0.37155907911695046,0.7136536716603119,Downregulated
Feature0174,NA,C16 H21 N5 O9,427.13399,NA,NA,Feature0174,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2363137.69744034,2266456.5242160666,0.9590877952947918,-0.06026520869620428,0.37701976321015107,0.7136536716603119,Downregulated
Feature0173,NA,C20 H33 N O11,463.2054,NA,NA,Feature0173,20,33,11,1,0,0,1.65,0.55,-0.4000000000000003,71.7,5,-6,-0.875,-0.1111111111111111,-7,Protein,135187.707855201,1136252.8405307827,8.405001154008902,3.0712480175438706,0.2546516679307781,0.7028461383187669,Upregulated
Feature0172,2-Keto-glutaramic acid,C5 H7 N O4,145.03751,Metabolic pathways;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Keto-glutaramic acid,5,7,4,1,0,0,1.4,0.8,0.7999999999999998,37.5,3,-1,-Inf,0,-2,Tannin,420594.52837755036,241371.43811138766,0.5738815458262891,-0.8011751121409342,0.10436361212513186,0.6736684190877296,Downregulated
Feature0171,NA,C14 H28 N6 O4,344.21733,NA,NA,Feature0171,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,4681074.399593463,3641548.72316576,0.7779301101221585,-0.36228754675732133,0.5051174720150718,0.7430681588649243,Downregulated
Feature0170,Diacetin,C7 H12 O5,176.0685,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,Diacetin,7,12,5,0,0,0,1.7142857142857142,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-3,-1.5,-0.1111111111111111,-3,Carbohydrate,4820231.848163007,4129781.7190801264,0.8567599752808547,-0.22303701070557252,0.023513378898198222,0.5618339157949356,Downregulated
Feature0169,Marimastat,C15 H29 N3 O5,331.21071,NA,NA,Marimastat-peak2,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2395982.31783622,2443699.1332285833,1.0199153453834566,0.028449411153769297,0.9431754019108908,0.9789480119741161,Upregulated
Feature0168,melanostatin,C13 H24 N4 O3,284.18484,NA,NA,melanostatin,13,24,3,4,0,0,1.8461538461538465,0.2307692307692308,-0.4615384615384617,73.45384615384616,4,1,-0.5,-0.2,-3,Lipid,77861.60556192407,67409.91483258481,0.8657657949138111,-0.20795129189198933,0.08485240429501752,0.6736684190877296,Downregulated
Feature0167,NA,C17 H31 N5 O6,401.22757,NA,NA,Feature0167,17,31,6,5,0,0,1.8235294117647056,0.35294117647058826,-0.23529411764705888,67.00588235294117,5,-1,-1,-0.3333333333333333,-6,Protein,107585.22466227613,242703.84412739208,2.2559217112690955,1.1737170018131056,0.28480579782077187,0.7028461383187669,Upregulated
Feature0166,NA,C17 H32 N4 O5,372.2374,NA,NA,Feature0166,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,280803.42095858266,384128.5993104493,1.3679626765199087,0.45202886828360456,0.5413963272665695,0.7564715805642478,Upregulated
Feature0165,N-Acetyl-L-leucine,C8 H15 N O3,173.10521,Other,NA,N-Acetyl-L-leucine-peak1,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,1062969.4921439188,1129480.6785903582,1.0625711151053754,0.08755940028703835,0.7841104021025737,0.907639449407689,Upregulated
Feature0164,NA,C15 H20 N2 O3,276.14743,NA,NA,Feature0164,15,20,3,2,0,0,1.3333333333333333,0.2,-0.5333333333333332,75.5,7,4,0.2,0.30434782608695654,2,Lignin,5311303.290856207,4968330.157434,0.9354258051855822,-0.09630486657977771,0.3457325289137544,0.7116802007632078,Downregulated
Feature0163,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0163,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,861549.4883280777,619978.0901949374,0.7196082158879421,-0.4747164367121885,0.539271545960761,0.7560210217591414,Downregulated
Feature0162,NA,C14 H25 N3 O7,347.1693,NA,NA,Feature0162,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,1936408.90662586,1274200.18619154,0.6580222709323308,-0.6037916817172762,0.3545824936121427,0.7136536716603119,Downregulated
Feature0161,Methionylphenylalanine,C14 H20 N2 O3 S,296.11939,NA,NA,Methionylphenylalanine-peak2,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,197877.30737224466,170484.02662213266,0.8615643142011223,-0.21496959986977107,0.7699540615973074,0.9043790432179438,Downregulated
Feature0160,NA,C18 H26 N4 O5,378.19035,NA,NA,Feature0160,18,26,5,4,0,0,1.4444444444444444,0.2777777777777778,-0.22222222222222232,66.63333333333333,8,3,-0.1111111111111111,0.13043478260869565,-1,Lignin,591850.9706670031,579636.265480486,0.9793618566296319,-0.030086086632061387,0.9216282867492618,0.9725088410337925,Downregulated
Feature0159,glu-tyr,C14 H18 N2 O6,310.11656,NA,NA,glu-tyr,14,18,6,2,0,0,1.2857142857142858,0.42857142857142855,0,60.3,7,1,-0.16666666666666666,0.2222222222222222,-1,Lignin,1684608.4756339735,1609812.48410747,0.9556003708824061,-0.06552068116207463,0.6559391197986595,0.829722313882859,Downregulated
Feature0158,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03171,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak2",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,92544.8832044746,81608.10356467654,0.881821887271351,-0.18144080905871987,0.14194132662199715,0.6736684190877296,Downregulated
Feature0157,DLK,C16 H30 N4 O6,374.21636,NA,NA,DLK,16,30,6,4,0,0,1.875,0.375,-0.375,70.9875,4,-2,-1,-0.3333333333333333,-6,Protein,699508.6330843254,627053.0804364653,0.8964193589314493,-0.157754289487493,0.4661686196848318,0.7204424122401946,Downregulated
Feature0156,NP-007065,C8 H10 O3,154.06303,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak1,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,436878.7813610355,230058.15911636222,0.5265949479158677,-0.9252344144674708,0.39569412071565024,0.7136536716603119,Downregulated
Feature0155,NA,C12 H22 N2 O3,242.16305,NA,NA,Feature0155,12,22,3,2,0,0,1.8333333333333333,0.25,-0.833333333333333,84.04999999999998,3,0,-0.2857142857142857,-0.0588235294117647,-2,Lipid,66596.6407635554,56718.907671444504,0.8516782081069105,-0.2316196588743653,0.16619990337484036,0.6736684190877296,Downregulated
Feature0154,NA,C9 H9 O P S,196.01126,NA,NA,Feature0154,9,9,1,0,1,1,1,0.1111111111111111,-1.1111111111111107,91.96666666666664,6,5,0.5,0.5384615384615384,3,Unsaturated HC,165734.48026912133,141859.51793650867,0.8559445065755523,-0.22441082943321017,0.09811027849950175,0.6736684190877296,Downregulated
Feature0153,DH2090000,C9 H10 O5,198.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak1,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,110492.37371541167,91846.63129485656,0.8312486030159892,-0.26664808395591477,0.06826254581298914,0.6632182304416021,Downregulated
Feature0152,NA,C8 H11 N O7,233.05354,NA,NA,Feature0152,8,11,7,1,0,0,1.375,0.875,0.75,38.925,4,-3,-Inf,-0.14285714285714285,-4,Tannin,850780.0347730797,695748.4134079413,0.8177770809978064,-0.29022046439547766,0.20386057054671042,0.6777335289635477,Downregulated
Feature0151,NA,C23 H32,308.25044,NA,NA,Feature0151,23,32,0,0,0,0,1.391304347826087,0,-1.391304347826087,99.95217391304348,8,8,0.34782608695652173,0.34782608695652173,8,Unsaturated HC,365857.66124892666,266032.9698836933,0.7271488287973464,-0.459677417684612,0.30638568197347743,0.7028461383187669,Downregulated
Feature0150,NA,C15 H27 N3 O5,329.19521,NA,NA,Feature0150,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,338811.71891011833,681548.1354714723,2.011583712818023,1.008331777513331,0.3597032854427172,0.7136536716603119,Upregulated
Feature0149,NA,C13 H26 N2 O6,306.17912,NA,NA,Feature0149,13,26,6,2,0,0,2,0.4615384615384616,-0.615384615384615,77.83846153846153,2,-4,-1.2,-0.375,-6,Protein,2250705.93734356,2150977.0413332367,0.9556899484932134,-0.06538544982262724,0.604871085299474,0.7984298325953056,Downregulated
Feature0148,NA,C20 H29 N3 O6,407.20564,NA,NA,Feature0148,20,29,6,3,0,0,1.45,0.3,-0.4000000000000003,71.7,8,2,-0.09090909090909093,0.14285714285714285,-1,Lignin,185277.56650056434,115778.01568659686,0.6248895528657767,-0.6783268740942948,0.4301345014806532,0.7136536716603119,Downregulated
Feature0147,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",C13 H18 N2 O3,250.13174,NA,NA,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,620209.756573439,343555.65254178236,0.5539346147017633,-0.8522124013071496,0.11211338430716747,0.6736684190877296,Downregulated
Feature0146,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0146,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,95963.8727912617,182116.66786055567,1.8977627993056454,0.9242996816894785,0.17990584704939325,0.6736684190877296,Upregulated
Feature0145,NA,C16 H32 N6 O4,372.24864,NA,NA,Feature0145,16,32,4,6,0,0,2,0.25,-0.375,70.9875,4,0,-1,-0.5,-6,Lipid,734714.980421819,650177.1153328194,0.8849378774875881,-0.1763519131225758,0.7865122933187321,0.907639449407689,Downregulated
Feature0144,Etilevodopa,C11 H15 N O4,225.10013,NA,NA,Etilevodopa,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Lignin,301254.7931371127,148935.74428064033,0.49438464606554466,-1.0162941562346015,0.40698698918147436,0.7136536716603119,Downregulated
Feature0143,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10555,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak1",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,1811920.2431551632,1809615.3450201068,0.9987279251701262,-0.0018363843056152993,0.989636785111418,0.994957412988361,Downregulated
Feature0142,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",C12 H11 N O3,217.07394,Metabolic pathways;Other,NA,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",12,11,3,1,0,0,0.9166666666666666,0.25,-0.16666666666666696,65.05000000000001,8,5,0.5,0.5789473684210527,4,Lignin,4557229.455251424,3600411.0220256466,0.7900438319770781,-0.33999539802579254,0.149519913611909,0.6736684190877296,Downregulated
Feature0141,N-(2-Acetylphenyl)formamide,C9 H9 N O2,163.06336,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N-(2-Acetylphenyl)formamide,9,9,2,1,0,0,1,0.2222222222222222,-0.22222222222222232,66.63333333333333,6,4,0.5,0.5714285714285714,3,Lignin,3853311.16262548,2722594.1016348866,0.7065596280005139,-0.5011167772288917,0.020844184480752617,0.536051174383958,Downregulated
Feature0140,NA,C17 H32 N4 O5,372.23738,NA,NA,Feature0140,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,113185.48085061634,171763.03638354997,1.5175359515435116,0.6017306953930803,0.5059751099579342,0.7430681588649243,Upregulated
Feature0139,Ser-met,C8 H16 N2 O4 S,236.08315,Microbial metabolism in diverse environments;Other,NA,Ser-met,8,16,4,2,1,0,2,0.5,0,60.3,2,-2,-5,-1,-5,Protein,779445.5382784146,483826.13907470764,0.6207311676237821,-0.6879595077771022,0.015402510503802232,0.5000414976159331,Downregulated
Feature0138,DL-TYROSINE,C9 H11 N O3,181.07393,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,DL-TYROSINE,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,2117819.012860377,1880456.8169987167,0.8879213972391942,-0.17149612645657025,0.32198120775030853,0.7028461383187669,Downregulated
Feature0137,NA,C9 H19 N O8,269.11107,NA,NA,Feature0137,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,297237.209514623,316516.86151893233,1.0648628482140317,0.09066762674839625,0.91724658723224906,0.9725088410337925,Upregulated
Feature0136,LLK,C18 H36 N4 O4,372.27367,NA,NA,LLK,18,36,4,4,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,-1,-0.5,-0.25,-5,Lipid,3094864.11106746,2307425.2488604765,0.7455659331241573,-0.4235921539344305,0.2971315140341589,0.7028461383187669,Downregulated
Feature0135,Paracetamol,C8 H9 N O2,151.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak1,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,3625103.53463281,2913031.03261899,0.8035718165809721,-0.31550112911367806,0.13284690923458856,0.6736684190877296,Downregulated
Feature0134,Leucylasparagine,C10 H19 N3 O4,245.13751,NA,NA,Leucylasparagine,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,842729.9379916914,654004.7263756067,0.7760549339616016,-0.3657693159944103,0.3200239534945107,0.7028461383187669,Downregulated
Feature0133,2-Pentadecylfuran,C19 H34 O,278.26093,NA,NA,2-Pentadecylfuran,19,34,1,0,0,0,1.7894736842105263,0.05263157894736842,-1.6842105263157894,108.3,3,2,0.1111111111111111,0.13513513513513514,2,Lipid,523039.28845708596,639328.5780286073,1.2223337560636471,0.28963826426828243,0.655869908339635,0.829722313882859,Upregulated
Feature0132,Maclurin,C13 H10 O6,262.04778,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Maclurin,13,10,6,0,0,0,0.7692307692307693,0.4615384615384616,0.15384615384615374,55.91538461538462,9,3,0.42857142857142855,0.6,3,Condensed HC,148113.42942212266,131629.51035890667,0.8887074647617746,-0.1702194886456154,0.23885668952416997,0.6938604136652682,Downregulated
Feature0131,NA,C17 H32 N4 O6,388.23229,NA,NA,Feature0131,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,299187.403432596,204601.72189139834,0.6838580753868306,-0.5482311486957111,0.40003999124210077,0.7136536716603119,Downregulated
Feature0130,2-Aminooctanedioic acid,C8 H15 N O4,189.10016,NA,NA,2-Aminooctanedioic acid-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,283469.77417804097,407465.642170044,1.4374218321919714,0.5234835036220526,0.24317936035877216,0.6979655491782245,Upregulated
Feature0129,NP-019811,C6 H7 N O2,125.04763,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak1,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,3411680.1903253067,2637182.62508047,0.7729864694114287,-0.37148493388585235,0.0824030578449478,0.6736684190877296,Downregulated
Feature0128,nitrilotriacetic acid,C6 H9 N O6,191.04305,NA,NA,nitrilotriacetic acid,6,9,6,1,0,0,1.5,1,1,31.799999999999997,3,-3,4,-0.5,-4,Carbohydrate,736370.1830018177,643078.742909081,0.8733090472071622,-0.19543580876106695,0.2868510409668953,0.7028461383187669,Downregulated
Feature0127,NA,C9 H20 N2 O3,204.14739,NA,NA,Feature0127,9,20,3,2,0,0,2.2222222222222223,0.3333333333333333,-0.8888888888888893,85.63333333333334,1,-2,-1,-0.4545454545454546,-4,Protein,138197.997620645,146240.764033131,1.0581974163950152,0.081608800500443765,0.5169157484335429,0.7480550029201548,Upregulated
Feature0126,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,C9 H12 O6 S,248.0355,NA,NA,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,9,12,6,0,1,0,1.3333333333333333,0.6666666666666666,0.22222222222222232,53.96666666666666,4,-2,-1.5,0,-3,Tannin,169980.05632462466,131057.60562632266,0.7710175444113947,-0.3751644060215856,0.1020186680099342,0.6736684190877296,Downregulated
Feature0125,2H-Pyran,C5 H6 O,82.04189,NA,NA,2H-Pyran,5,6,1,0,0,0,1.2,0.2,-0.7999999999999998,83.1,3,2,0.5,0.5555555555555556,2,Lignin,543521.8743844817,4389950.213085033,8.076860233190224,3.0137945743723837,0.08739667883584804,0.6736684190877296,Upregulated
Feature0124,Pivagabine,C9 H17 N O3,187.12087,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak1,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,4584017.66596457,3701606.474960997,0.807502663535679,-0.3084610763645424,0.05616770944346475,0.6632182304416021,Downregulated
Feature0123,NA,C16 H32 N4 O4,344.24234,NA,NA,Feature0123,16,32,4,4,0,0,2,0.25,-0.75,81.675,3,-1,-0.625,-0.3,-5,Lipid,1967082.41815152,1789044.9196110044,0.9094915917616616,-0.1368677946464737,0.8056742040898967,0.9186650985659187,Downregulated
Feature0122,VLH,C17 H29 N5 O4,367.22207,NA,NA,VLH,17,29,4,5,0,0,1.7058823529411764,0.2352941176470588,-0.35294117647058787,70.35882352941175,6,2,-0.375,-0.1,-3,Lipid,1702615.43848463,1600480.3942233534,0.9400128520200783,-0.08924761318338496,0.5984247651666882,0.795085753247542,Downregulated
Feature0121,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17443,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak2,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,1768118.6297026034,1390769.520699737,0.7865815660421289,-0.3463317185369114,0.6021016669391482,0.7967535715000916,Downregulated
Feature0120,NA,C9 H13 N O4 S,231.05654,NA,NA,Feature0120,9,13,4,1,1,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Lignin,3733226.2092286535,3691032.569941263,0.9886978080291288,-0.01639846114004087,0.7819312131762695,0.907639449407689,Downregulated
Feature0119,NA,C17 H25 N3 O5,351.17943,NA,NA,Feature0119,17,25,5,3,0,0,1.4705882352941178,0.29411764705882354,-0.35294117647058787,70.35882352941175,7,2,-0.1111111111111111,0.13043478260869565,-1,Lignin,1362168.29722593,1255410.9703726973,0.921626918589542,-0.11774523970816822,0.7499464412835518,0.8923010679959122,Downregulated
Feature0118,6-methoxymellein,C11 H12 O4,208.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak1,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,97603.53024066887,84311.01780262597,0.8638111510386306,-0.21121215430411452,0.16061176067684835,0.6736684190877296,Downregulated
Feature0117,Isobutyric acid,C4 H8 O2,88.05244,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-lysine degradation;Other,Isobutyric acid,4,8,2,0,0,0,2,0.5,-1,88.8,1,-1,-0.5,0,-1,Protein,364790.8142499237,293433.3521935733,0.8043879964382483,-0.31403654184705926,0.6392779489480144,0.8201291637679481,Downregulated
Feature0116,6-Hydroxymelatonin,C13 H16 N2 O3,248.11607,Other,Other,6-Hydroxymelatonin-peak1,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,3999903.3004963,3903732.2684409036,0.9759566607414074,-0.03511101136324427,0.6274756843852918,0.8139048761621934,Downregulated
Feature0115,NA,C15 H27 N3 O5,329.19515,NA,NA,Feature0115,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,1106976.6025847634,1271321.5279931533,1.1484628717758338,0.19970421712444908,0.28415787581898294,0.7028461383187669,Upregulated
Feature0114,Metalaxyl,C15 H21 N O4,279.14696,NA,NA,Metalaxyl,15,21,4,1,0,0,1.4,0.26666666666666666,-0.666666666666667,79.30000000000001,6,2,0.1,0.25,1,Lignin,197145.75919627468,158033.79991651367,0.8016089240812841,-0.3190295251564521,0.3396876281746698,0.7116802007632078,Downregulated
Feature0113,Icacine,C22 H31 N O6,405.21514,NA,NA,Icacine-peak1,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,169990.56996264067,145025.50228567235,0.8531385141984349,-0.22914810067796607,0.0997014090803419,0.6736684190877296,Downregulated
Feature0112,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",C20 H34 O,290.261,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",20,34,1,0,0,0,1.7,0.05,-1.5999999999999996,105.89999999999998,4,3,0.15789473684210523,0.1794871794871795,3,Lipid,196927.60194219733,198698.801644664,1.0089941668156126,0.012917833977953,0.9707369979183753,0.9883481899775874,Upregulated
Feature0111,lamifiban,C24 H28 N4 O6,468.20092,NA,NA,lamifiban-peak1,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,513241.56633627065,461141.58819038264,0.8984883891657508,-0.15442823444788725,0.5010971075389864,0.7417294916342253,Downregulated
Feature0110,N-Acetyl-L-aspartic acid,C6 H9 N O5,175.04806,Metabolic pathways;Other,NA,N-Acetyl-L-aspartic acid,6,9,5,1,0,0,1.5,0.8333333333333334,0.6666666666666665,41.3,3,-2,-Inf,-0.2,-3,Carbohydrate,587739.933839116,849808.5688157834,1.4458921708192185,0.531959965549789,0.5512289686626365,0.7640181513957917,Upregulated
Feature0109,NA,C20 H26 O7 S,410.14012,NA,NA,Feature0109,20,26,7,0,1,0,1.3,0.35,-0.5,74.55,8,1,0,0.2258064516129032,0,Lignin,212775.18704798867,227871.90465037499,1.07095149491741,0.09889313963364536,0.7256712551049129,0.8736085281413222,Upregulated
Feature0108,Cyclo(leucylleucine),C12 H22 N2 O2,226.16814,Microbial metabolism in diverse environments;Other,NA,Cyclo(leucylleucine),12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,5059757.49664515,5055486.986735457,0.9991559852596642,-0.0012181700293954192,0.993930165670603,0.9957050409664433,Downregulated
Feature0107,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10002,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak2",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,186146.22375468566,199192.22826017867,1.0700847121276325,0.09772501057861746,0.7515486770103392,0.893260186022882,Upregulated
Feature0106,Trigonelline,C7 H7 N O2,137.04768,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak1,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,1048797.2924316814,539180.6793318357,0.5140942708592642,-0.9598951603112473,0.06997845146095473,0.6632182304416021,Downregulated
Feature0105,Pyrazinoic acid,C5 H4 N2 O2,124.02723,NA,NA,Pyrazinoic acid,5,4,2,2,0,0,0.8,0.4,1.2000000000000002,26.09999999999999,5,3,1,1,1,Condensed HC,81427.63945972933,68502.5667262834,0.8412692198962968,-0.249360534531629,0.06537658324143232,0.6632182304416021,Downregulated
Feature0104,NA,C13 H23 N3 O6,317.15875,NA,NA,Feature0104,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1294538.88594021,1026204.7881683497,0.7927183951859645,-0.3351196400825601,0.21395039437887925,0.6777335289635477,Downregulated
Feature0103,NA,C13 H24 N4 O5,316.17479,NA,NA,Feature0103,13,24,5,4,0,0,1.8461538461538465,0.38461538461538464,-0.1538461538461542,64.6846153846154,4,-1,-1.25,-0.38461538461538464,-5,Protein,5394966.12300103,3602889.6283003166,0.6678243284864513,-0.5824594439130536,0.18642880214010274,0.6736684190877296,Downregulated
Feature0102,delta-guanidinovaleric acid,C6 H13 N3 O2,159.10079,NA,NA,delta-guanidinovaleric acid,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,4444527.022987103,4145904.3250058033,0.9328111413347646,-0.10034307494626903,0.4140614029419486,0.7136536716603119,Downregulated
Feature0101,NA,C14 H28 N6 O4,344.2173,NA,NA,Feature0101,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,284017.2924045893,316926.92467148066,1.115871931558346,0.15817145879083416,0.7120388519443143,0.8636838831151574,Upregulated
Feature0100,NA,C27 H39 N5 O6,529.28996,NA,NA,Feature0100,27,39,6,5,0,0,1.4444444444444444,0.2222222222222222,-0.44444444444444464,72.96666666666667,11,5,0,0.15789473684210523,0,Lignin,125848.10858394866,205398.770259925,1.632116466199498,0.7067440102587033,0.21085474761145476,0.6777335289635477,Upregulated
Feature0099,L-Glutaminyl-L-Leucine,C11 H21 N3 O4,259.15319,NA,NA,L-Glutaminyl-L-Leucine,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,2394458.4448660333,1944483.752712417,0.8120766333955769,-0.3003122179657684,0.45724131135092205,0.7162499996920834,Downregulated
Feature0098,NA,C9 H19 N O8,269.11113,NA,NA,Feature0098,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,5539738.02732795,5197783.312850003,0.9382724033535416,-0.09192126179090639,0.3648598290715594,0.7136536716603119,Downregulated
Feature0097,Pyridoxal,C8 H9 N O3,167.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak1,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,301581.923390344,421736.6705652557,1.3984149508171708,0.4837925142607076,0.31670011688035216,0.7028461383187669,Upregulated
Feature0096,Fasoracetam,C10 H16 N2 O2,196.12116,NA,NA,Fasoracetam,10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,3370105.3440978867,2957803.8972085034,0.8776591813037974,-0.18826728371463067,0.1435068141394015,0.6736684190877296,Downregulated
Feature0095,NA,C22 H42 N4 O5,442.31572,NA,NA,Feature0095,22,42,5,4,0,0,1.9090909090909092,0.2272727272727273,-0.9090909090909092,86.2090909090909,4,-1,-0.38461538461538464,-0.16129032258064516,-5,Lipid,470167.79943313467,608072.2665099996,1.293309042522971,0.3710670553813919,0.6219453647938875,0.8121601742211405,Upregulated
Feature0094,DL-Ornithine,C5 H12 N2 O2,132.08986,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Other,DL-Ornithine,5,12,2,2,0,0,2.4,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Other,134052.28815679657,99566.37940328306,0.7427428563309828,-0.42906527053912863,0.3723778626896723,0.7136536716603119,Downregulated
Feature0093,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,C14 H25 N3 O6 S,363.1465,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,14,25,6,3,1,0,1.7857142857142858,0.42857142857142855,-0.14285714285714324,64.37142857142858,4,-2,-1.5,-0.42857142857142855,-6,Protein,130911.0050591113,72616.59055642113,0.5547019559099098,-0.8502152823922741,0.12211330607140743,0.6736684190877296,Downregulated
Feature0092,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10628,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak1,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,703072.5076684364,612428.7084070813,0.8710747493712242,-0.19913156903682497,0.4165943324555495,0.7136536716603119,Downregulated
Feature0091,NA,C14 H27 N3 O5,317.19514,NA,NA,Feature0091,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,2071460.9226692633,2605126.466869613,1.2576276184407447,0.3307048057164594,0.42188332690982167,0.7136536716603119,Upregulated
Feature0090,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14221,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak1",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,124892.43925610432,108235.85318557433,0.8666325506192252,-0.20650766979961468,0.059484417628667456,0.6632182304416021,Downregulated
Feature0089,NA,C14 H27 N3 O4,301.20018,NA,NA,Feature0089,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,4082667.461542283,3502344.50439163,0.8578569127617786,-0.2211910630879601,0.31952024419240765,0.7028461383187669,Downregulated
Feature0088,NA,C14 H27 N O10,369.16362,NA,NA,Feature0088,14,27,10,1,0,0,1.9285714285714288,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-8,-3,-0.5,-9,Carbohydrate,1583093.15652738,1502457.3657980734,0.9490644057193788,-0.0754220996756754,0.7015842424183616,0.856365331384129,Downregulated
Feature0087,NA,C15 H28 N4 O5,344.20609,NA,NA,Feature0087,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,1094860.984325242,1040599.6412611234,0.9504399701505852,-0.07333258584728534,0.7145545879698201,0.8657994035660238,Downregulated
Feature0086,NP-006105,C15 H16 O5,276.09975,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,NP-006105,15,16,5,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,8,3,0.3,0.44,3,Lignin,157446.07868736066,121546.183558259,0.7719860956309508,-0.3733532317786216,0.2258794970165142,0.6843823216756625,Downregulated
Feature0085,"N,N-diacetyllegionaminic acid",C13 H22 N2 O8,334.13758,Metabolic pathways;Other,NA,"N,N-diacetyllegionaminic acid",13,22,8,2,0,0,1.6923076923076923,0.6153846153846154,0,60.3,4,-4,-2,-0.2857142857142857,-6,Amino Sugar,1858155.9391334401,1599079.4713056567,0.8605733445877503,-0.21662993996788607,0.3301902131529691,0.707999712182741,Downregulated
Feature0084,NA,C16 H31 N3 O9,409.20616,NA,NA,Feature0084,16,31,9,3,0,0,1.9375,0.5625,-0.25,67.425,3,-6,-2.25,-0.5294117647058824,-9,Amino Sugar,249907.95384580598,286296.710788638,1.145608638632142,0.19611427661212025,0.43663200774663175,0.7146446291665095,Upregulated
Feature0083,NA,C14 H27 N3 O4,301.20024,NA,NA,Feature0083,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2271218.454346697,2298988.9372889735,1.0122271298426309,0.017533047276798774,0.9716114559227085,0.9883481899775874,Upregulated
Feature0082,imazamox,C15 H19 N3 O4,305.13767,NA,NA,imazamox,15,19,4,3,0,0,1.2666666666666666,0.26666666666666666,-0.13333333333333375,64.10000000000001,8,4,0.125,0.3,1,Lignin,103775.68313522493,133909.78010047396,1.2903772449850586,0.36779290278422694,0.5265784830727546,0.7540080121300391,Upregulated
Feature0081,Proglumide,C18 H26 N2 O4,334.18921,NA,NA,Proglumide,18,26,4,2,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,7,3,0.08333333333333333,0.21428571428571427,1,Lignin,184950.4637580267,160839.37180514768,0.8696348662070732,-0.20151831149584953,0.024398553302769455,0.5618339157949356,Downregulated
Feature0080,3477,C12 H20 N2 O3,240.14735,NA,NA,3477,12,20,3,2,0,0,1.6666666666666667,0.25,-0.666666666666667,79.30000000000001,4,1,-0.14285714285714285,0.0588235294117647,-1,Lipid,142038.564940039,144427.23417481335,1.0168170470870548,0.024060122652397282,0.9006911925125786,0.9678405764193425,Upregulated
Feature0079,NA,C14 H27 N3 O5,317.19523,NA,NA,Feature0079,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,1760291.46533143,1504471.52742959,0.8546718296713016,-0.22655752353203196,0.29895536041920434,0.7028461383187669,Downregulated
Feature0078,NA,C14 H25 N3 O5,315.17946,NA,NA,Feature0078,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,1438388.9872904767,1694689.94000049,1.178186120009729,0.23656746209290358,0.27671465461026,0.7028461383187669,Upregulated
Feature0077,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,C25 H30 N4 O7,498.21169,NA,NA,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,25,30,7,4,0,0,1.2,0.28,-0.16000000000000014,64.86,13,6,0.14285714285714285,0.3142857142857143,2,Lignin,265666.4445331397,228685.71111629534,0.8608001342366317,-0.21624979201314615,0.6853070147252058,0.8468221040987676,Downregulated
Feature0076,NA,C19 H34 N4 O8,446.2376,NA,NA,Feature0076,19,34,8,4,0,0,1.7894736842105263,0.42105263157894735,-0.3157894736842106,69.3,5,-3,-1,-0.2727272727272727,-7,Protein,385120.4474622807,286033.08095185837,0.7427107099523012,-0.4291277126405399,0.4600415195256735,0.7162499996920834,Downregulated
Feature0075,HC blue 2,C12 H19 N3 O5,285.13253,NA,NA,HC blue 2-peak1,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,3876159.2311017867,3242607.463204583,0.8365516661922275,-0.25747344971342206,0.36580852219782384,0.7136536716603119,Downregulated
Feature0074,NA,C10 H15 N O5,229.09499,NA,NA,Feature0074,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,125019.40167460234,122002.80063959736,0.9758709368738101,-0.03523773710367246,0.9560228522287115,0.9868055567622946,Downregulated
Feature0073,NA,C15 H27 N3 O7,361.18494,NA,NA,Feature0073,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,1113503.9069592417,1130700.9223880067,1.0154440548625703,0.022110757609773903,0.8491409236822225,0.9413744745889566,Upregulated
Feature0072,NA,C19 H29 N3 O6,395.20574,NA,NA,Feature0072,19,29,6,3,0,0,1.5263157894736843,0.3157894736842105,-0.4210526315789478,72.30000000000001,7,1,-0.2,0.07692307692307693,-2,Protein,392817.8075371787,2271610.3867273894,5.782860000592998,2.5317831758037377,0.411489380088439,0.7136536716603119,Upregulated
Feature0071,(+)-sesamin monocatechol,C19 H18 O6,342.11027,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak1,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,312275.828449702,284308.0427572027,0.910438839178345,-0.13536599078549474,0.24405686094304369,0.6979655491782245,Downregulated
Feature0070,S-methyl D-thioglycerate,C4 H8 O3 S,136.0194,NA,NA,S-methyl D-thioglycerate,4,8,3,0,1,0,2,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,755865.879150004,1237325.2692454252,1.636964047956283,0.7110226367755647,0.37491994774398163,0.7136536716603119,Upregulated
Feature0069,NA,C15 H25 N3 O6,343.17444,NA,NA,Feature0069,15,25,6,3,0,0,1.6666666666666667,0.4,-0.2666666666666666,67.89999999999999,5,-1,-0.6666666666666666,-0.1111111111111111,-4,Protein,109480.51843285284,109152.91535965304,0.9970076587333596,-0.004323507842427929,0.9933643663464762,0.9957050409664433,Downregulated
Feature0068,Deferiprone,C7 H9 N O2,139.06334,NA,NA,Deferiprone,7,9,2,1,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,4,2,0.25,0.4,1,Lignin,2613160.58114891,2996182.82527307,1.146574323402567,0.19732987653137163,0.27273112428884105,0.7028461383187669,Upregulated
Feature0067,NA,C15 H21 N3 O7,355.13805,NA,NA,Feature0067,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,296592.9336212283,296005.2859583143,0.9980186727453714,-0.002861286514072096,0.9835597645224838,0.9929337204459302,Downregulated
Feature0066,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0066,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,394823.3191627547,1699242.123500507,4.303803856124422,2.105612329231725,0.42977843243646785,0.7136536716603119,Upregulated
Feature0065,Tiglic acid,C5 H8 O2,100.0524,NA,NA,Tiglic acid-peak1,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,624339.1998984714,885912.9227226094,1.4189609155835075,0.5048348517871789,0.4111696673610688,0.7136536716603119,Upregulated
Feature0064,Anhydroecgonine,C9 H13 N O2,167.09465,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak1,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,409042.0390238047,279397.08184810966,0.6830522420504798,-0.5499321701570135,0.32569032158211414,0.707999712182741,Downregulated
Feature0063,NA,C17 H30 N4 O8,418.20647,NA,NA,Feature0063,17,30,8,4,0,0,1.7647058823529411,0.4705882352941176,-0.117647058823529,63.65294117647058,5,-3,-1.4,-0.3333333333333333,-7,Protein,1007006.1327236147,1551271.7950610234,1.540478994765754,0.6233790106123276,0.2399445993780072,0.6938604136652682,Upregulated
Feature0062,NA,C18 H27 N3 O5,365.19518,NA,NA,Feature0062,18,27,5,3,0,0,1.5,0.2777777777777778,-0.44444444444444464,72.96666666666667,7,2,-0.1,0.12,-1,Lipid,1190713.92529865,763599.017788938,0.6412951100722327,-0.6409396883376285,0.2986852308129344,0.7028461383187669,Downregulated
Feature0061,NP-016455,C11 H18 N2 O4,242.12667,NA,NA,NP-016455,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,3900933.2144546364,3465477.5357959303,0.8883714089118072,-0.17076513253477693,0.08253359276829579,0.6736684190877296,Downregulated
Feature0060,Methionylphenylalanine,C14 H20 N2 O3 S,296.11937,NA,NA,Methionylphenylalanine-peak1,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,525004.838948913,327691.3298137189,0.6241682085631325,-0.6799932181114093,0.25719307586057377,0.7028461383187669,Downregulated
Feature0059,NA,C14 H25 N3 O5,315.17952,NA,NA,Feature0059,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,185460.95074575802,206968.54331493165,1.115968307520744,0.15829605652920659,0.7425145355158627,0.8881677066618315,Upregulated
Feature0058,NA,C19 H29 N3 O5,379.21082,NA,NA,Feature0058,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,508447.4268425743,93801.80439773103,0.18448673244397001,-2.438411027791645,0.11664833256862839,0.6736684190877296,Downregulated
Feature0057,NA,C11 H13 N3 O3,235.09569,NA,NA,Feature0057,11,13,3,3,0,0,1.181818181818182,0.2727272727272727,0.18181818181818168,55.11818181818182,7,4,0.2,0.38461538461538464,1,Lignin,176343.289118144,91305.45751077843,0.517771092778058,-0.9496136732373994,0.02739251294961372,0.5736428866742609,Downregulated
Feature0056,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",C16 H23 N O3,277.16771,NA,NA,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",16,23,3,1,0,0,1.4375,0.1875,-0.875,85.2375,6,3,0.16666666666666666,0.25925925925925924,2,Lignin,289364.8848671737,282285.0685522473,0.9755332568491294,-0.0357370383795884,0.916757373867432,0.9725088410337925,Downregulated
Feature0055,allobarbital,C10 H12 N2 O3,208.08478,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,allobarbital,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Lignin,2063901.6372277266,2378305.00228162,1.1523344714606683,0.20455952778790673,0.3717178678909172,0.7136536716603119,Upregulated
Feature0054,Glu-Lys,C11 H21 N3 O5,275.14821,Metabolic pathways;Other,NA,Glu-Lys,11,21,5,3,0,0,1.9090909090909092,0.4545454545454546,-0.18181818181818168,65.48181818181817,3,-2,-1.6666666666666667,-0.4545454545454546,-5,Protein,1878272.4445757132,1398414.7776271966,0.74452179803078955,-0.4256140063881773,0.38741428168029923,0.7136536716603119,Downregulated
Feature0053,NA,C16 H31 N3 O5,345.22649,NA,NA,Feature0053,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1088535.1325292834,779185.9197917946,0.7158114575331203,-0.4823484586576218,0.43693958610358785,0.7146446291665095,Downregulated
Feature0052,Acetyl-L-methionine,C7 H13 N O3 S,191.0617,NA,NA,Acetyl-L-methionine-peak1,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,442757.89835295366,314503.64888915897,0.7103287147651194,-0.4934412879953595,0.22173675927491004,0.6783852451439112,Downregulated
Feature0051,Ajmaline,C20 H26 N2 O2,326.19951,Biosynthesis of secondary metabolites;Other,NA,Ajmaline,20,26,2,2,0,0,1.3,0.1,-0.7999999999999998,83.1,9,7,0.3125,0.35294117647058826,5,Unsaturated HC,131121.64599631,127173.59622921767,0.9698901753627817,-0.04410670060795238,0.7879941683883155,0.907639449407689,Downregulated
Feature0050,Uric acid,C5 H4 N4 O3,168.02837,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Uric acid,5,4,3,4,0,0,0.8,0.6,2.8,-19.5,6,3,0.5,-1,-1,Condensed HC,298705.500245249,116165.97403569744,0.38889800803909064,-1.3625362496742162,0.00420816344867707,0.3372542421011195,Downregulated
Feature0049,NA,C21 H33 N3 O4,391.24697,NA,NA,Feature0049,21,33,4,3,0,0,1.5714285714285714,0.1904761904761905,-0.7619047619047619,82.0142857142857,7,3,0,0.125,0,Lipid,440962.933174056,408634.6073815307,0.9266869767038566,-0.1098459981297433,0.7549681278505875,0.8954273144274411,Downregulated
Feature0048,NA,C16 H30 N4 O5,358.22173,NA,NA,Feature0048,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,2112842.896524283,812391.4276861537,0.38450157795573553,-1.3789385760130224,0.06039701561805921,0.6632182304416021,Downregulated
Feature0047,NA,C25 H54 N2 O5 P2 S,556.32268,NA,NA,Feature0047,25,54,5,2,1,2,2.16,0.2,-1.84,112.74,1,-4,-0.6,-0.37142857142857144,-9,Lipid,156074.89162615698,132184.61413707602,0.8469306802640307,-0.23968420246319688,0.08997790070629672,0.6736684190877296,Downregulated
Feature0046,NA,C19 H30 N4 O6,410.21666,NA,NA,Feature0046,19,30,6,4,0,0,1.5789473684210529,0.3157894736842105,-0.3157894736842106,69.3,7,1,-0.3333333333333333,0,-3,Protein,4648702.553398526,4080434.0100894035,0.8777576029480142,-0.18810550741232987,0.514602066496221,0.7469385751730401,Downregulated
Feature0045,NA,C15 H33 N O,243.2562,NA,NA,Feature0045,15,33,1,1,0,0,2.2,0.06666666666666667,-1.8666666666666665,113.5,0,-1,-0.15384615384615383,-0.1111111111111111,-2,Lipid,1536392.6805422853,1520242.905841816,0.9894885110395286,-0.015245138663107855,0.9864833289315491,0.9944602830738528,Downregulated
Feature0044,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10007,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak1",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,2643166.2257339065,2298083.7667254563,0.8694435273692883,-0.20183577112795717,0.452706286710556,0.7162499996920834,Downregulated
Feature0043,NA,C27 H42 N2 O2,426.32469,NA,NA,Feature0043,27,42,2,2,0,0,1.5555555555555556,0.07407407407407407,-1.1851851851851851,94.07777777777778,8,6,0.17391304347826086,0.20833333333333337,4,Lipid,154077.250795528,135399.50909223533,0.878776771996799,-0.18643135822574916,0.3137889934179574,0.7028461383187669,Downregulated
Feature0042,NA,C14 H27 N3 O5,317.19516,NA,NA,Feature0042,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,304923.171081128,254018.22392181767,0.8330564811495859,-0.2635137813949684,0.5344339696722193,0.7543471763776491,Downregulated
Feature0041,asn-tyr,C13 H17 N3 O5,295.11678,NA,NA,asn-tyr-peak1,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,1592793.1509719433,992252.2113465067,0.6229636351343056,-0.682780145029127,0.22994497272880157,0.6871102073774262,Downregulated
Feature0040,NA,C7 H9 N O3 S,187.03034,NA,NA,Feature0040,7,9,3,1,1,0,1.2857142857142858,0.42857142857142855,0.2857142857142856,52.15714285714286,4,1,-0.5,0.14285714285714285,-1,Lignin,2811087.2223885334,2349869.3298162767,0.8359289996770831,-0.25854768387751537,0.10766208869619852,0.6736684190877296,Downregulated
Feature0039,Vinylbital,C11 H16 N2 O3,224.11608,NA,NA,Vinylbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,4643673.242255193,4811404.557853917,1.0361203958264007,0.05119165203003363,0.7216636383815074,0.8706522604989799,Upregulated
Feature0038,NA,C12 H17 N O4,239.11576,NA,NA,Feature0038,12,17,4,1,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Lignin,3302450.2960223034,1095550.64391323,0.33173872298177687,-1.5918806709642073,4.0037060001032825e-4,0.08984316264231766,Downregulated
Feature0037,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17436,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak1,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,1550208.75665712,1144804.1632397366,0.7384838708487232,-0.4373616833091755,0.426264517799469,0.7136536716603119,Downregulated
Feature0036,NA,C19 H27 N3 O6,393.19014,NA,NA,Feature0036,19,27,6,3,0,0,1.4210526315789471,0.3157894736842105,-0.3157894736842106,69.3,8,2,-0.1,0.15384615384615383,-1,Lignin,434019.3201751583,380467.2910442373,0.8766137205382727,-0.1899868351468416,0.7028174666182341,0.856365331384129,Downregulated
Feature0035,NA,C26 H48 N2 O6,484.35117,NA,NA,Feature0035,26,48,6,2,0,0,1.8461538461538465,0.2307692307692308,-1.1538461538461542,93.1846153846154,4,-2,-0.2222222222222222,-0.04761904761904761,-4,Lipid,85926.0722052284,137446.09329880183,1.5995854316548006,0.6776980468664046,0.21821296895852182,0.6777335289635477,Upregulated
Feature0034,NA,C14 H25 N3 O6,331.17447,NA,NA,Feature0034,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1154068.5847343267,1176038.0797718926,1.0190365592896053,0.027205811032354768,0.8940357471045348,0.9672120958552067,Upregulated
Feature0033,Anhalamine,C11 H15 N O3,209.10523,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak1,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,382530.3746047417,194131.66834000032,0.5074934730100619,-0.9785388273019997,0.30637099391807154,0.7028461383187669,Downregulated
Feature0032,NA,C8 H9 N5 O3,223.07052,NA,NA,Feature0032,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,2699578.0647866335,2277383.376409133,0.8436071570277522,-0.24535676011061097,0.1815512738411286,0.6736684190877296,Downregulated
Feature0031,NA,C12 H23 N3 O5,289.16377,NA,NA,Feature0031,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,892138.6800900233,753334.4629166943,0.8444140801525133,-0.24397745983463864,0.6748546516879073,0.8422546375904694,Downregulated
Feature0030,Isoquinoline,C9 H7 N,129.05782,NA,NA,Isoquinoline,9,7,0,1,0,0,0.7777777777777778,0,-0.44444444444444464,72.96666666666667,7,7,0.75,0.75,6,Condensed HC,3389179.126283163,3087455.36891223,0.9109743846139442,-0.13451760695223572,0.19472758018816555,0.6763335886956496,Downregulated
Feature0029,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03174,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak1",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,160506.09661368566,160235.92242223865,0.9983167356433988,-0.0024304832870737044,0.9917316339085742,0.995279868734723,Downregulated
Feature0028,NA,C14 H27 N3 O5,317.19507,NA,NA,Feature0028,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,2635060.58651869,1935653.8794920365,0.7345766125435945,-0.44501513062352566,0.2499039001509963,0.7019200023813293,Downregulated
Feature0027,NA,C15 H19 N3 O3 S,321.11473,NA,NA,Feature0027,15,19,3,3,1,0,1.2666666666666666,0.2,-0.13333333333333375,64.10000000000001,8,5,0.125,0.2631578947368421,1,Lignin,348246.80972064135,187720.86585189146,0.5390454718091415,-0.8915211165542823,0.16751262046763463,0.6736684190877296,Downregulated
Feature0026,MFCD08277025,C12 H19 N O4,241.13144,Other,NA,MFCD08277025,12,19,4,1,0,0,1.5833333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,4,0,-0.14285714285714285,0.1111111111111111,-1,Protein,353509.316681518,143966.48230064532,0.40724947125041955,-1.2960152692486449,0.017209680402940724,0.5000414976159331,Downregulated
Feature0025,NA,C12 H23 N3 O5,289.16387,NA,NA,Feature0025,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,418133.8122984507,298988.877132329,0.7150554878324936,-0.483872896472285,0.343468412649425,0.7116802007632078,Downregulated
Feature0024,NA,C16 H21 N5 O9,427.13396,NA,NA,Feature0024,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2691721.8118808935,2434162.31057715,0.9043142199290762,-0.14510394529261417,0.575584889607845,0.7790183910012088,Downregulated
Feature0023,NA,C17 H32 N6 O6,416.23845,NA,NA,Feature0023,17,32,6,6,0,0,1.8823529411764703,0.35294117647058826,-0.117647058823529,63.65294117647058,5,-1,-1.4,-0.5,-7,Protein,446284.08460325236,423897.04340914334,0.9498367923785336,-0.07424845413226114,0.8021582688260842,0.9165189181495585,Downregulated
Feature0022,NA,C11 H19 N3 O5,273.13255,Biosynthesis of secondary metabolites;Other,NA,Feature0022,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,2573851.3692005435,2298013.20126413,0.8928305762962175,-0.16354165966070944,0.411925197920238,0.7136536716603119,Downregulated
Feature0021,NA,C20 H38 N4 O6,430.27919,NA,NA,Feature0021,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,3377975.5921415435,3040004.7907650135,0.899948714205402,-0.1520853066336488,0.31377531389657576,0.7028461383187669,Downregulated
Feature0020,NA,C16 H30 N4 O5,358.22177,NA,NA,Feature0020,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,245131.70078720368,352804.52632479335,1.4392448026583855,0.5253120024628832,0.16341375434433583,0.6736684190877296,Upregulated
Feature0019,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C19 H20 O7,360.12104,NA,NA,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",19,20,7,0,0,0,1.0526315789473684,0.3684210526315789,-0.3157894736842106,69.3,10,3,0.25,0.41935483870967744,3,Lignin,166500.01487883533,173307.19555416098,1.0408839643664858,0.05780924888361081,0.8948004950959934,0.9672120958552067,Upregulated
Feature0018,Crotanecine,C8 H13 N O3,171.08956,Other,NA,Crotanecine-peak1,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,214705.48481079066,117385.17563377233,0.546726487854831,-0.8711088218355101,0.3407592657552666,0.7116802007632078,Downregulated
Feature0017,NA,C14 H27 N3 O4,301.20015,NA,NA,Feature0017,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1375476.52122804,1373541.1160441868,0.9985929202323821,-0.002031416520818869,0.9831387802849688,0.9929337204459302,Downregulated
Feature0016,?-Ribazole,C14 H18 N2 O4,278.12676,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak1,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,2929633.93572467,3059740.42385753,1.0444104932518394,0.06268885767563138,0.6845626209481126,0.8468221040987676,Upregulated
Feature0015,NA,C15 H21 N3 O7,355.1381,NA,NA,Feature0015,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,4171012.0488922135,3990164.941121657,0.9566419119267258,-0.06394909553025052,0.5774774350588621,0.7806381712482449,Downregulated
Feature0014,NA,C17 H31 N3 O6,373.22133,NA,NA,Feature0014,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,2855400.72516914,2313651.587284167,0.810272115885632,-0.3035216013213053,0.22020679700268536,0.6777335289635477,Downregulated
Feature0013,Marimastat,C15 H29 N3 O5,331.21086,NA,NA,Marimastat-peak1,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1477600.6286191668,1472913.1697653234,0.9968276550760378,-0.004584001156662072,0.9676788645285388,0.9883481899775874,Downregulated
Feature0012,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,C10 H14 N2 O3,210.10041,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,10,14,3,2,0,0,1.4,0.3,-0.20000000000000015,66,5,2,0,0.2307692307692308,0,Lignin,402250.9382596853,536158.9615552346,1.3328967332553514,0.41456501134100265,0.4453612827056446,0.7147297968682652,Upregulated
Feature0011,Pentoxifylline,C13 H18 N4 O3,278.13793,NA,NA,Pentoxifylline,13,18,3,4,0,0,1.3846153846153846,0.2307692307692308,0,60.3,7,4,0,0.2,0,Lignin,120425.06717976867,97348.45458586431,0.8083736788831851,-0.30690574739399645,0.09326856003281629,0.6736684190877296,Downregulated
Feature0010,NA,C16 H30 N4 O5,358.22167,NA,NA,Feature0010,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,351050.979208221,392204.7127001013,1.1172300774796315,0.1599263187292517,0.6011168484517951,0.7967535715000916,Upregulated
Feature0009,NA,C16 H30 N6 O6,402.22286,NA,NA,Feature0009,16,30,6,6,0,0,1.875,0.375,0,60.3,5,-1,-1.75,-0.5714285714285714,-7,Protein,331523.223902266,215200.43361644834,0.6491262695969983,-0.6234289528689163,0.30565404436585764,0.7028461383187669,Downregulated
Feature0008,APM,C7 H13 N O4,175.08446,NA,NA,APM-peak1,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,193072.87871715214,1740611.0248572677,9.015305704366835,3.172376413531853,0.41738353402081296,0.7136536716603119,Upregulated
Feature0007,NA,C15 H27 N3 O7,361.18502,NA,NA,Feature0007,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,319918.49620326934,343681.74899262533,1.0742790838021985,0.10336883551466379,0.200410215273406,0.6777335289635477,Upregulated
Feature0006,(Z)-dehydrobutyrine,C4 H7 N O2,101.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak1,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,3610942.1630187435,3653247.83707274,1.011715965569116,0.016804317126399654,0.9165455559245533,0.9725088410337925,Upregulated
Feature0005,NA,C14 H27 N3 O6,333.19005,NA,NA,Feature0005,14,27,6,3,0,0,1.9285714285714288,0.42857142857142855,-0.4285714285714288,72.51428571428572,3,-3,-1.2,-0.375,-6,Protein,1263559.4235147967,949823.9162173823,0.7517049839850761,-0.41176152560462104,0.13110003864660755,0.6736684190877296,Downregulated
Feature0004,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",C16 H19 N O5,305.12642,NA,NA,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",16,19,5,1,0,0,1.1875,0.3125,-0.375,70.9875,8,3,0.2,0.36,2,Lignin,2413671.3202840933,129996.57626467866,0.053858441773827696,-4.214683699216446,3.6638551535168434e-4,0.08984316264231766,Downregulated
Feature0003,NA,C15 H28 N4 O5,344.20604,NA,NA,Feature0003,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,436403.444635801,276577.7079398303,0.6337660972649913,-0.6579776087485962,0.03792254895271133,0.5992830975343959,Downregulated
Feature0002,NA,C21 H21 O6 P S,432.07976,NA,NA,Feature0002,21,21,6,0,1,1,1,0.2857142857142857,-0.5714285714285712,76.58571428571427,12,6,0.3076923076923077,0.4375,4,Lignin,79492.74799803837,68920.38042203213,0.8670021122396332,-0.20589258666063043,0.09963116210063895,0.6736684190877296,Downregulated
Feature0001,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,C12 H24 N4 O4,288.17983,NA,NA,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,12,24,4,4,0,0,2,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,-1,-1.25,-0.5,-5,Protein,1590000.5010162499,721050.8238330533,0.4534909412746683,-1.1408543624547154,0.07817798996039185,0.6736684190877296,Downregulated
